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I 
 
General Introduction 
 
 
 
 
Cartilage structure and contents 
Within the body three subtypes of cartilage can be distinguished: hyaline 
cartilage, elastic cartilage and fibrocartilage. Hyaline cartilage is the predominant 
subtype and is mainly located in articular joints and in less extent in the nasal 
septum and cricoid. Elastic cartilage can be found in the outer ear and in parts of 
the respiratory tract. The menisci and intervertebral discs are made from the third 
subtype: fibrocartilage. 
Hyaline cartilage in joints, further refered to as articular cartilage, is a highly 
specialized tissue that ensures low-friction movement of articulating bones, 
whilst transmitting load. The only cell-type present in articular cartilage is the 
chondrocyte, which only composes less than 5% of the total tissue volume. 
Water (up to 80% wet weight) is the predominant molecule in cartilage, followed 
by different collagens (10-20% wet weight) and the group of GAG 
(GlycosAminoGlycan, 4-7% wet weight) 181. From the latter two groups, 
collagen type II and aggrecan are the most prominent respectively. A simplified 
reflection of the cartilage structure and function would be as follows. The 
collagen molecules form a tightly woven network in which the GAG are 
contained (Figure I-1 next page). In solution, the GAG is negatively charged and 
creates an osmotic pressure via attraction of positive counter-ions. This osmotic 
pressure, together with repulsive forces of the negatively charged GAG, result in 
a swelling pressure within the matrix that accounts for the excellent capabilities 
of cartilage to absorb and transmit forces during joint movement and loading. 
Several smaller molecules also play a crucial role in the extracellular matrix of 
articular cartilage: decorin, anchorin, collagen type VI, IX and XI. Articular 
cartilage lacks blood vessels; chondrocytes receive oxygen and nutrients through 
diffusion from the synovium and the underlying bone. 
Articular cartilage can be divided in four zones with respect to the architecture 68, 
181, 213 (Figure I-2, next page). The superficial zone comprises approximately 10% 
of the cartilage and is characterized by a high cell density, flattened chondrocytes 
and thin collagen fibers that are oriented tangential to the articular surface. The 
middle zone or intermediate zone has randomly orientated collagen fibers and 
chondrocytes with a more spherical configuration. 
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Figure I-1   A simplified overview of the articular cartilage matrix. Collagen fibres 
form a network in which the glycosaminoglycan are contained. 
 
 
 
 
Figure I-2   Architecture of articular cartilage. Four zones can be distinguished with respect to cellular 
(A) and collagen fibre (B) orientation. 
A B
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Furthermore, relatively more GAG is present than in the superficial zone. The 
deep zone has collagen fibers that are orientated perpendicular to the articular 
surface. The cell density is similar to the middle zone. However, the 
chondrocytes are orientated in a columnar fashion. The last zone is the calcified 
layer, rich in calcium salts and with a relatively low number of chondrocytes. 
The calcified layer connects the visco-elastic cartilage to the underlying bone. 
Ear cartilage is of the elastic type and can be found in the outer ear, the inner ear 
and parts of the respiratory system where it has a supportive function. Similar to 
articular cartilage, it is of mesenchymal origin 137. A major difference between 
articular cartilage and ear cartilage is that the latter contains an extracellular 
network of elastin, a long macromolecule that enhances the tensile properties of 
the tissue. Also, ear cartilage is structurally different. Surrounded by 
perichondrium, the ear cartilage has a more symmetrical architecture from top to 
bottom (Figure I-3, below). The chondrocytes are larger, contain more lipid 
vesicles and occasionally have two nuclei. 
Fibrocartilage is an intermediate between dense regular connective tissue and 
hyaline cartilage. It is characterized by the presence of both collagen type I and II 
and can be found in the meniscus, intervertebral disc and pubic symphysis. 
 
 
 
 
 
Figure I-3   Elastic cartilage (rabbit ear). Ear cartilage is covered by perichondrium on 
both sides and has a more symmetrical architecture from ‘top to bottom’ compared to 
articular cartilage. 
 
 
Traumatic articular cartilage defects 
Unfortunately, there are no reliable estimates of the prevalence of traumatic 
articular cartilage defects. However, it is clear that most cartilage defects arise 
during sport-related accidents. Around 16-20% of patients with a traumatic 
hemarthros undergoing arthroscopy have a cartilage defect 52, 146. Furthermore, 
Hjelle et al. found some sort of cartilage defect in 60% of 1000 consecutive 
arthroscopies 58.  
perichondrium 
perichondrium 
ear cartilage 
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In case of a traumatic defect, articular cartilage itself has little capacity to repair 
or regenerate, as it lacks the prerequisite for classical wound healing: blood 
supply 18, 67-69. Traumatic cartilage defects occur in two forms: chondral defects 
and osteochondral defects. Chondral defects are limited to the cartilage layer 
itself and occur either as partial or full thickness defects, which are both 
characterized by the absence of spontaneous repair. In osteochondral defects, 
full-thickness cartilage defects with a concurrent defect in the underlying 
subchondral bone, some sort of repair exists as blood and mesenchymal stem 
cells from the bone marrow cavity can enter the defect. Although this natural 
repair process is not well defined in humans, Shapiro et al. described this process 
in rabbits 67. Briefly, from the blood a fibrin clot was formed in the cartilage 
defects. In subsequent days, mesenchymal cells began to invade the fibrin clot 
and differentiated into chondrocytes, which formed a proteoglycan-rich matrix. 
However, the repair tissue started to degenerate after 48 weeks. Also, the 
temporal sequence and the quality of the repair tissue have been shown to depend 
on the size of the initial cartilage defect 104. Evenmore, Jackson et al. found no 
repair in 6 mm cartilage defects in a goat model 72. Instead, the surrounding 
cartilage and underlying bone underwent progressive changes, leading to both 
bone and cartilage collapse. This, among other indirect evidence 18, 118, 132, 190, 
suggests that cartilage defects may lead to general symptomatic degeneration of a 
joint (i.e. secondary osteoarthrosis), when left untreated. 
 
 
Current surgical treatments 
The most widely accepted choice of initial surgical treatment of a cartilage defect 
is subchondral plate perforation, which is based on the natural repair observed in 
osteochondral defects. Pridie first described this concept in 1959 71, 170. Since, 
several other subchondral plate perforation techniques, i.e. microfracturing and 
abrasion arthroplasty, have been introduced 76, 184. Clinical studies reported good 
symptomatic relief and improvement of joint function with these techniques. 
However, similar to the natural repair tissue observed in osteochondral defects, 
the resulting tissue represents fibrocartilage at best and with time the results 
deteriorate 68. An alternative to subchondral plate perforation is osteochondral 
transplantation. This technique composes of transplantation of either allograft or 
autograft osteochondral plugs into the defect 51. The autograft plugs are harvested 
from the less-load bearing surfaces of the joint. Short-term results are good to 
very good, like other current surgical treatments for cartilage defects 68.  
Total knee arthroplasty or unicompartimental knee arthroplasty are successful 
treatment options for generalized osteoarthritis 7, 33, 54, 117, 121, 122. However, as 
prostheses have a limited life-span and revision is difficult, knee arthroplasty is 
not a valid option for the treatment of cartilage defects in the often young patient 
with a cartilage defect. Therefore, knee arthroplasty should be reserved as final 
treatment option for generalized osteoarthritis or cartilage defects in the elderly.  
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A relatively new and promising technique to treat cartilage defects is ACT 
(Autologous Chondrcyte Transplantation). Although currently not widely 
employed in the Netherlands, it will be discussed in more detail, as it comprises 
several techniques employed in this thesis. 
 
 
Tissue engineering and Autologous Chondrocyte Transplantation 
Tissue engineering is a relatively new field and is being developed to overcome 
the general shortage of organs and tissue for transplantation purposes. The term 
‘tissue engineering’ itself was only introduced in 1987 43. Since, many attempts 
have been made to give a proper definition; for instance: “Tissue engineering is 
the application of principles and methods of engineering and life sciences toward 
fundamental understanding and development of biological substitutes to restore, 
maintain and improve (human) tissue functions”.43 or “Tissue engineering is the 
art of reconstituting mammalian tissues, both structurally and functionally” 68. 
Nowadays, for virtually every tissue or organ in the human body tissue 
engineering techniques are being developed 74, 147, 153, 161, 193, 216. However, tissue 
engineering of musculoskeletal tissues is most widely investigated and at the 
forefront of this field.  
As cartilage defects are not uncommon and present surgical treatments are not 
optimal, cartilage repair using tissue engineering techniques could offer wide 
potentials. In 1987 the first patient with cartilage lesions was treated with culture 
expanded autologous chondrocytes 15. Since, thousands of patients have been 
treated. The procedure is known as ACT and can be regarded as first-generation 
cartilage tissue engineering. Briefly, autologous chondrocytes are harvested from 
a less-load bearing part of the involved knee and are culture expanded in vitro for 
several weeks. During a second procedure an arthrotomy is performed and the 
culture expanded chondrocytes are implanted in the defect behind a periostal 
flap, without any structural support. Several publications showed that ACT has 
good clinical results 2-9 years follow-up, especially for isolated cartilage defects 
on the femoral condyle 15, 62, 135, 156, 157. However, most often the repair tissue 
represented fibrocartilage 62. Interestingly, a relation was shown between the 
clinical outcome and the quality of repair tissue, assessed by taking a biopsy 
from the repair site 156. As the first prospective randomized study comparing 
ACT with another surgical treatment for cartilage defects, osteochondral 
transplantation, Horas et al. found that both ACT and osteochondral 
transplantation decreased symptoms 62. However, the improvement by ACT 
lagged behind that of osteochondral transplantation. Recently, Knutsen et al. 
compared ACT with the microfracture technique to repair articular defects in a 
randomized prospective study. Both techniques improved clinical signs and were 
comparable in macroscopic and histological outcome after 2 years 205. Thus, 
these studies show that no current surgical technique is superior at present. 
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To date, cartilage repair using ACT remains the first and only cartilage tissue 
engineering technique that has been used clinically on a wide scale. Currently, 
new (second generation) cartilage repair techniques using tissue engineering are 
being developed, which aim at the implantation of a cell-seeded matrix scaffold 
95, 106. 
 
 
The tissue engineering process 
Three constituents are involved in tissue engineering (Figure I-4, next page): 
Cells, Biomaterials and Bioactives. 
 
Cells 
The cartilage tissue engineering process with respect to cells can be divided in 
several parts: Choice of donor source, expansion of donor cell-population 
(expansion culture) and tissue formation. Articular cartilage as donor tissue 
represents the most obvious choice. Many studies involving cartilage tissue 
engineering in vitro use articular cartilage from, often immature, bovine, porcine 
or human origin. Small amounts of articular cartilage can be harvested from less 
load-bearing areas of the affected knee, which is in fact the procedure of ACT 15, 
157. However, there are several theoretical disadvantages of using articular 
cartilage as donor tissue. In a clinical setting, tissue-engineering techniques will 
be initiated only after several weeks or months from the initial trauma, during 
which the presence of a cartilage defect influences joint homeostasis and can 
result in degeneration of surrounding cartilage 72, 118, 132, 171.  Therefore, the 
quality of donor cartilage from the compromised joint could be inferior. 
Furthermore, harvesting the donor cartilage itself is very likely to inflict 
additional joint morbidity, as it is merely creating an additional cartilage defect 
within the joint 203. However, no reports can be found in literature on negative 
effects of harvesting cartilage from the joint for tissue engineering purposes like 
ACT. And although the cartilage is harvested from the ‘less weight-bearing’ 
parts of the joint, filling one cartilage defect by creating another cartilage defect 
is not an ideal solution. And, as the limited possibilities to use autologous 
articular cartilage for transplantation purposes is one of the main reason why 
cartilage tissue engineering techniques are being developed, it is obvious that 
other cell sources suitable for articular cartilage tissue engineering should be 
sought after.  
Next to articular cartilage, the nasal septum cartilage is also of the hyaline type. 
Several in vitro studies have been performed with nasal septum chondrocytes, 
which showed the possibility of this cell-type to multiply in vitro and form 
hyaline cartilage-like tissue during subsequent culture 19, 20, 79, 93, 167, 196. In fact, 
Kafienah showed that chondrocytes from the nasal septum had superior qualities 
over articular chondrocytes in the ability to multiply and form extracellular 
matrix in vitro 79.  
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Figure I-4   The cartilage tissue engineering process as it was used during the experiments in 
this thesis. The three essential constituents are: Cells, Bioactives and Scaffold. 
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Another cartilage subtype that could be a very relevant donor tissue is elastic 
cartilage, which is mainly located in the outer ear. Cartilage from the outer ear 
has the advantage that a relatively large amount can be harvested without 
cosmetic changes and without major donor-site morbidity 46, 50, 103, 144. 
Furthermore, chondrocytes from the outer ear, called ear chondrocytes, have 
proven to multiply and to form extracellular matrix in vitro 75, 99, 110, 138, 159, 201.  
A cell source which has gained much interest in recent years are BMSC (Bone 
Marrow Stromal Cells), in which mesenchymal progenitor cell can be found 26, 44, 
82, 136, 164, 172. These cells are characterized by their ability to differentiate into the 
different mesenchymal tissues, i.e. cartilage, given the right stimuli 78. Harvesting 
BMSC is done via a bone marrow aspiration. However, a complicating factor is 
that the frequency of BMSC in bone marrow is 1:104 to 1:106 and decreases with 
age, which makes identification of BMSC in bone marrow aspirates difficult 164. 
Various studies using culture expanded BMSC as donor cells for cartilage tissue 
engineering in vitro have been performed 34, 111, 125, 214, showing collagen type II 
and GAG production by proper use of chondrogenic medium.  However, the 
repair of cartilage defects with BMSC in animal studies showed variable results 
68, 70, 173. Next to bone marrow, other sources of mesenchymal progenitor cells, 
i.e. the periosteum 91, 148 and fat tissue 39, have recently been explored. 
For cartilage tissue engineering to be successful it is vital that the limited amount 
of harvested donor cells is expanded in number. Classically, this is performed in 
vitro using monolayer culture (2D culture). The donor cells are seeded at a 
certain density in plastic culture flasks. Monolayer culture of chondrocytes has 
been performed this way as early as the 1960’s 59, 102, 113, 183. However, these early 
experiments also showed a phenomenon that nowadays, 40 years later, is still one 
of the major limiting factors in successful cartilage tissue engineering: loss of the 
differentiated phenotype during multiplication in vitro. Isolated chondrocytes in 
suspension have a spherical configuration. When introduced in monolayer 
culture they attach to the culture plastic and start to spread, assuming a more 
flattened (monolayer, 2D) configuration. During this process the chondrocytes 
gradually shift the expression of the differentiated phenotype towards a more 
fibroblast-like phenotype (dedifferentiation) 59, 209, 210. On molecular level this is 
represented by a shift in expression of collagen type II and aggrecan, both typical 
molecules of cartilage, towards collagen type I and versican. Ongoing 
multiplication, passaging and low seeding densities enhance dedifferentiation 
during monolayer culture 112, 211. Unfortunately, to go from a low number of cells 
after biopsy to a sufficient number of cells to repair a cartilage defect, monolayer 
cultures of several weeks using several passages are usually needed. 
After sufficient numbers of cells are obtained during expansion culture a second 
part of the engineering process is initiated, which is aimed at restoring the typical 
chondrogenic phenotype from the dedifferentiated stage (redifferentiation) and, 
more importantly, at the actual tissue formation. This can be done in vitro, in vivo 
or in situ, in the actual defect. Regardless which system is chosen, Benya 10 and 
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Bonaventure 12 showed in the mid 1980’s that a prerequisite for restoration of the 
chondrogenic phenotype and production of the proper extracellular matrix is 
allowing the dedifferentiated chondrocytes to regain a spherical configuration 
(3D), like in cartilage. For this purpose many matrix scaffolds, both biological 
and artificial have been designed and will be discussed below. For experimental 
purposes, redifferentiation and tissue formation is usually assessed during in vitro 
cultures or in vivo using different animal species. 
 
Biomaterials 
In general, the biomaterials used in the cartilage tissue engineering process are 
scaffold matrices. Scaffold matrices are essential in cartilage tissue engineering 
for several reasons. During a significant part of the tissue engineering process, in 
vitro and in situ, the chondrocytes lack structural support of a mature and 
functional extracellular matrix; a scaffold matrix can substitute for this 13. 
Furthermore, scaffold matrices can provide a structural template in which the 
chondrocytes are contained and can deposit their extracellular matrix. Within 
time the produced extracellular matrix within a cell-scaffold construct should 
substitute for the functions of the scaffold. Furthermore, the waste products of 
the degrading scaffold should be eliminated from the body and should be non-
toxic, like the scaffold itself (biodegradable and biocompatible respectively). 
Also, the material should allow easy cell seeding and medium or nutrient 
diffusion. Next generation scaffold design and production are the so-called 
‘smart scaffolds’, which are scaffolds loaded with bioactive factors (see below) 
that can direct and stimulate extracellular matrix production by the cells 27, 65, 93, 
182, 213. 
Scaffold matrices can be divided in two categories: natural or synthetic. 
Examples of natural scaffolds include the hydrogels alginate and agarose. Both 
hydrogels are polysaccharides derived from brown algae and red algae 
respectively and have an inert nature. Therefore, they are popular scaffold 
matrices for in vitro culture of chondrocytes 36, 90, 101, 105, 120, 130, 141, 160, 201, 212.  
Other natural scaffolds are composed of collagen i.e. DBM. (Demineralized 
Bone Matrix), fibrin or hyaluronic acid 213. Synthetic scaffolds include the 
copolymers PGLA (PolyGlycolic Lactid Acid) and PEGT/PBT (Polyethylene 
Glycol-Therephthalate/PolyButylene Therephthalate). 
Advantage of using synthetic scaffolds is the possibility of tailor-made design 
and absence of animal or human substances, thus reducing the risk of disease 
transmission 213. 
Scaffold matrices are essential in cartilage tissue engineering for several reasons. 
During a significant part of the tissue engineering process, in vitro and in situ, the 
chondrocytes lack structural support of a mature and functional extracellular 
matrix; a scaffold matrix can substitute for this 13. Furthermore, scaffold matrices 
can provide a structural template in which the chondrocytes are contained and 
can deposit their extracellular matrix. Within time the produced extracellular 
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matrix within a cell/scaffold construct will substitute for the functions of the 
scaffold. Ideally, the scaffold should thus degrade and lose function in linear 
function with the elaborate extracellular matrix. Furthermore, the waste products 
of the degrading scaffold should be eliminated from the body and should be non-
toxic, like the scaffold itself (biodegradable and biocompatible respectively). 
Also, the material should allow easy cell seeding and medium/nutrient diffusion. 
Next generation scaffold design and production are the so-called ‘smart 
scaffolds’, which are scaffolds loaded with bioactive factors (next paragraph) that 
can direct and stimulate extracellular matrix production by the cells 27, 65, 93, 182, 
213.  
 
Bioactives 
Bioactives comprise all molecules, signals or stimuli that can improve the quality 
of the tissue engineering process. One of the most powerful bioactives is the 
group of growth factors. FGF2 (Fibroblast Growth Factor 2) is the most widely 
studied growth factor with respect to cartilage tissue engineering. Formally 
known as cartilage derived growth factor or basic FGF2, it is a molecule of 
18 kDa and larger. It is a member of the large family of FGF2 and has a 
ubiquitous distribution in the human body. FGF2 is known to be one of the key 
regulators during embryonic limb formation where it acts as a mitogen 123. For 
cartilage tissue engineering purposes FGF2 has been shown to enhance cell 
multiplication during monolayer culture as well as in suspension culture (3D 
environment) 6, 20, 29, 73, 99, 126, 127, 129. Other relevant growth factors in cartilage 
tissue engineering are IGF1 (Insulin-like Growth Factor 1) and TGFß-2 
(Transforming Growth Factor ß-2) 42, 65, 73, 145, 154, 196, 197, 199, 201, 215. IGF1, a protein 
of 7.5 kDa, is structurally homologous to pro-insulin and is known as an anabolic 
factor of proteoglycan synthesis. TGFß-2 is a 25 kDa protein, known for 
enhancing proliferation and proteoglycan synthesis. Also, addition of TGFß-2 is 
thought to enhance autocrine TGFß-2 production. For tissue engineering 
purposes the combination of IGF1 and TGFß-2 significantly increases GAG 
production and collagen type II expression of dedifferentiated chondrocytes 
during suspension culture 201, 215.  
Another important bioactive might be mechanical loading (Figure I-5, next 
page). Animal experiments have shown that the absence of loading can have 
negative effects on cartilage 204. The chondrocyte, as the only cell type present in 
cartilage, plays a central role in this process. Within a joint the mechanical 
loading on cartilage is a combination of factors like compression, shear stress, 
hydrostatic pressure and osmotic stress. However, in vitro experiments with 
cartilage explants or chondrocytes have shown that these factors separately can 
elicit effects on the cell’s metabolism. The most frequently used form of 
mechanical loading in in vitro experiments is compression. In general, cyclic 
compression 
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Figure I-5   An in vitro bioreactor-loading device for controlled mechanical loading of 
 cell-seeded scaffolds. This actual device was developed in our laboratory and used in 
 the experiments discussed in chapter VIII. 
 
 
with specific regimes stimulates GAG and collagen synthesis 23, 25, 92, 97, 130, 150, 185-
187, whereas static compression inhibits extracellular matrix synthesis 22-24, 30, 48, 66, 
92, 97, 169. For the cartilage tissue engineering process, mechanical loading in vitro 
could offer several advantages. Mechanical loading could be useful to stimulate 
(re)differentiation towards the chondrocyte phenotype. Furthermore, the 
production and organization of extracellular matrix could be enhanced. However, 
few studies have been published with positive results of mechanical loading on 
longer-term basis, which is a prerequisite for implemantation of mechanical 
compression as a bioactive during the tissue engineering process. Mauck et al. 
showed an increase of the compressive modulus of a chondrocyte-seeded agarose 
gel after several weeks of cyclic loading, indicating an increase in extracellular 
matrix 130. Only recently, Lee et al. performed experiments in which cyclic 
mechanical loading was found to increase the accumulation of radioactive 
molecules in the extracellular matrix, synthesized by dedifferentiated 
chondrocytes 96. This scarcity of studies with either long-term loading 
experiments and/or with dedifferentiated cells, which are both relevant with 
respect to cartilage tissue engineering, indicates that the use of mechanical 
loading as a bioactive is difficult and yet to be established. 
 
Summary 
Summarizing, no solid therapy to treat articular cartilage defects, which occur 
mainly in young and active adults, exists. Tissue engineering techniques do form 
a new and promising treatment for such defects. However, many problems have 
to be addressed. In this thesis we focus on the chondrocyte phenotype and 
extracellular matrix production during the tissue engineering process in vitro and 
on using ear cartilage as an alternative cell source for articular cartilage repair. 
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II 
 
Aims of this thesis 
 
 
 
 
 
Introduction 
As stated in the General Introduction (Chapter I), the expansion culture is a 
necessary step in cartilage tissue engineering since the low number of cells after 
biopsy should be multiplied to a sufficient number of cells for the repair of a 
defect. First generation cartilage tissue engineering techniques, the ACT 
(Autologous Chondrcyte Transplantation), have shown promising clinical results 
15, 156, 157. However, as yet, there have been no reports that ACT is superior to 
other surgical techniques for articular cartilage repair, like subchondral plate 
drilling or mosaic plasty. Histology from repair sites in both animal and human 
joints most often show inferior repair tissue, resembling fibrocartilage, after ACT 
14, 62, 156. Although not entirely consistent 89, a better long-term functional 
outcome has been shown to correlate to a more hyaline cartilage-like repair tissue 
at biopsy during a second-look arthroscopy 156. Furthermore, animal studies have 
shown that cartilage repair with differentiated chondrocytes results in a longer 
durability of the repair tissue than with culture-expanded, and hence 
dedifferentiated, chondrocytes 81. Thus, to further elucidate the potentials of 
tissue engineering for cartilage repair the process should be improved in such 
ways that dedifferentiation during monolayer expansion culture is minimized and 
redifferentiation during subsequent in vitro culture or after in situ implantation is 
maximal. This thesis focuses on this for the in vitro part of the cartilage tissue 
engineering process. 
Besides phenotype modulation the choice of donor tissue used for the cartilage 
tissue engineering process is also adressed. As briefly discussed in the general 
introduction, new cell sources should be sought after to bypass shortage of donor 
articular cartilage and donor-site morbidity. In this thesis ear chondrocytes were 
used in a substantial part of the experiments to assess the feasibility of ear 
cartilage as donor tissue for cartilage tissue engineering in general and articular 
repair in particular. 
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The specific aims of this thesis 
 
Chondrocyte phenotype and extracellular matrix production during the tissue 
engineering process 
To achieve minimal dedifferentiation during monolayer culture, without losing 
the high cell yield needed, experiments were performed with various seeding 
densities and growth factor supplemented culture media. Chapter III, V and VI 
describe the effects of FGF2 (Fibroblast Growth Factor 2) on cell yield, 
dedifferentiation during monolayer and redifferentiation during 3D culture. 
Chapter IV describes the effect of different seeding densities in monolayer 
culture on these outcome measures. 
To increase redifferentiation after monolayer expansion culture chemical and 
mechanical stimuli can be used. Chemical stimuli are described in Chapter III, 
IV, V and VI, where experiments with a SFM (Serum-Free Medium) with IGF1 
(Insulin-like Growth Factor 1) and TGFß-2 (Transforming Growth Factor β-2) on 
dedifferentiated chondrocytes were performed.  To test whether mechanical 
loading can have effects on matrix production of isolated chondrocytes in 3D 
culture a custom-designed loading device was built. Eventually, mechanical 
loading might be used to direct dedifferentiated chondrocytes seeded onto a 
scaffold towards the differentiated phenotype. In Chapter VIII (paragraph: The 
loading device, page 17) the loading device is introduced and loading 
experiments on isolated bovine articular chondrocytes are discussed. 
 
The feasibility of ear cartilage as donor tissue for cartilage tissue engineering 
Harvesting articular cartilage as donor tissue for cartilage tissue engineering has 
several disadvantages. Firstly, because articular cartilage has the important 
function of transferring loads and stresses through a joint, only a limited amount 
can be harvested without compromising its function. Secondly, the articular 
cartilage is usually harvested from the injured and/or arthritic joint. This is likely 
to inflict additional morbidity to an already diseased joint 94, 203. In turn, the only 
function of ear cartilage is offering structural support to the outer ear. 
Transplantation of ear cartilage has been used for many years to repair nasal 
septum defects 28, 77, 83, 155, 189. Harvesting ear cartilage for this purpose has proven 
to be relatively easy and is without major donor-site morbidity 50, 77, 103, 133, 144. In 
Chapter III, IV and V either immature or mature human ear chondrocytes were 
used for the experiments. Furthermore, in Chapter VII the considerations of using 
ear chondrocytes as donor cells for cartilage tissue engineering in general and for 
articular cartilage tissue engineering in particular are discussed. 
.
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Serum-free medium supplemented with high 
concentration FGF2 for cell expansion culture of 
human ear chondrocytes promotes redifferentiation 
capacity 
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Abstract 
For tissue engineering of autologous cartilage, cell expansion is needed to obtain 
the number of cells required. Standard expansion media contain bovine serum. 
This has several disadvantages, i.e. risk of transmitting diseases and serum-batch 
variations. The aim of this study was to find a SFM (Serum-Free Medium) with 
at least the same potentials to expand the number of cells as serum-containing 
media. Ear chondrocytes of three young children were expanded in either SCM 
(Serum-Containing Medium; DMEM with 10% fetal calf serum) or SFM 
(Serum-Free Medium; DMEM with ITS+) supplemented with 5 ng/ml or 
100 ng/ml FGF2. To promote cell adherence onto the culture flask the serum-free 
conditions were cultured with 10% serum for one day after each trypsinisation. 
After the fourth passage the chondrocytes were encapsuled in alginate beads and 
redifferentiated in a SFM (DMEM with ITS+, hydrocortisone and L-ascorbic 
acid) supplemented with 10 ng/ml IGF1 and 10 ng/ml TGFß-2. Results showed 
that expansion in SFM with 100 ng/ml FGF2  was comparable to expansion in 
SCM. Redifferentiation with SFM with IGF1 and TGFß-2 showed high collagen 
type II expression and high GAG/DNA production regardless which expansion 
medium had been used. However, chondrocytes expanded in SFM with 
100 ng/ml FGF2  resulted in less positive cells for collagen type I and 11-fibrau 
(a fibroblast membrane marker). The present study shows that it is possible to 
use SFM for tissue engineering of cartilage. Expansion of immature ear 
chondrocytes in SFM supplemented with high concentration FGF2 resulted in a 
high number of cells which in addition had a better redifferentiation capacity than 
cells expanded in medium with 10% serum. 
.
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Introduction 
Surgical repair and reconstruction of cartilage defects in articular joints as well as 
the head and neck area require extra cartilage. Often the amount of donor site 
cartilage is limited. The expansion of donor site cartilage using tissue-
engineering techniques could be a possibility to solve this problem. Cells are 
generally isolated from the tissue and expanded using monolayer culture. 
Standard culture medium consists of 10% serum. A culture medium without 
serum is preferable because of the risk of transmitting disease. Furthermore, a 
SFM (Serum-Free Medium) would exclude the variation between serum batches. 
Cell expansion in SFM should at least be comparable to expansion in medium 
supplemented with 10% FCS (Fetal Calf Serum). 
During expansion the cells lose their phenotype and become more fibroblast-like, 
producing less GAG (GlycosAminoGlycan)and they change collagen type II 
production to collagen type I 4, 38, 210 . After sufficient multiplication the 
dedifferentiated cells should be stimulated to regain their specific phenotype. 
Besides obtaining sufficient chondrocyte proliferation, this is essential in order to 
engineer a functional piece of cartilage. 
 In earlier publications FGF2 (Fibroblast Growth Factor 2) was added to medium 
with serum to stimulate chondrocyte proliferation 2, 32, 166. Sometimes, very high 
concentrations (up to 100 ng/ml) were used. Furthermore, recent publications 
showed that supplemention of 5 ng/ml FGF2 to SCM (Serum-Containing 
Medium) promoted redifferentiation capacity 127. In the present study we 
composed a SFM supplemented with FGF2 for expansion of human auricular 
chondrocytes. To evaluate redifferentiation capacity after expansion in 
monolayer, the chondrocytes were cultured in a three dimensional environment, 
i.e. alginate beads in SFM supplemented with IGF1 (Insulin-like Growth Factor 
1) and TGFß-2 (Transforming Growth Factor β-2) 201, 215. 
 
 
Materials and methods 
Cartilage 
Human ear cartilage was obtained from three children (aged 5-10) during 
protruding ear correction surgery after informed consent. No ‘extra’ ear cartilage 
was harvested for this study. The perichondrium was carefully dissected from the 
cartilage and the cartilage was sliced into small pieces and washed several times 
in physiological saline. A two-step digestion protocol was used. First the 
cartilage was pre-incubated in pronase E (2 mg/ml; Sigma, St Louis, Mo.) for 
two hours, followed by overnight digestion in collagenase B (1.5 mg/ml; 
Boehringer Mannheim, Germany). The chondrocytes were filtered using a 
100 µm filter to remove small parts of undigested cartilage. Cell viability was 
tested using trypan blue staining. No significant cell death was noted. 
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Expansion culture 
Chondrocytes were seeded onto culture flasks at a density of 4·104 cells/cm2. 
Four different types of expansion media were prepared. Dulbecco’s modified 
eagle medium (Life Technologies, Breda, the Netherlands; Glutamax-I) was 
supplemented with either 10% FCS, ITS+ (1:100; Becton Dickinson, Insulin, 
Transferrin, selenious acid, bovine serum albumin (1.25 mg/ml final 
concentration in medium), linoleic acid), ITS+ with 5 ng/ml FGF2 (recombinant 
human, Instruchemie, Hilversum, the Netherlands) or ITS+ with 100 ng/ml 
FGF2. The SCM will be referred to as SCM and the SFM as SFM + 
supplementations. Bacterial and fungal growth was inhibited by using 
gentamycine (50 µg/ml; Life Technologies) and fungizone (1.5 µg/ml; Life 
Technologies). At subconfluency chondrocytes were trypsinized using trypsin-
EDTA (Life Technologies). At the start of each new passage, chondrocytes in the 
serum-free conditions were cultured in 10%  FCS for one day to promote cell 
adhesion onto the culture flask. Medium was changed every other day. Cells 
were expanded for four passages. 
 
Redifferentiation culture 
After the fourth passage the chondrocytes from the four conditions were 
encapsulated separately in alginate beads to enhance cell redifferentiation 12. The 
cells were suspended in sterile 1.2% alginate in saline (Keltone LV, Kelco, 
Chicago, Ill.) at a density of 4·106 cells/ml. This suspension was slowly dropped 
in a 102 mM CaCl2 solution using a 23-gauge needle, creating gelled alginate 
beads. After 10 minutes in the CaCl2 solution the beads were washed three times 
with physiological saline.  
DMEM was supplemented with ITS+, 10 ng/ml IGF1 (recombinant human, 
Boehringer Mannheim, Germany), 10 ng/ml TGFß-2 (recombinant human, R&D 
systems, Abingdon, UK) and 0.1 µg/ml hydrocortisone (Becton Dickinson 
Labware); reffered to as SFM+IGF1/TGFß-2. This condition is described before 
to induce rediffferentiation 201, 215. As control, alginate beads were cultured in 
DMEM with 10% FCS, shown before to induce little redifferentiation of 
chondrocytes 32, 201. L-ascorbic acid (25 µg/ml) was freshly added. The beads 
were cultured for 21 days in a 24-wells plate. Each well contained 10 beads and 
50 µl medium per bead was added. The medium was changed every other day. 
 
Biochemical analysis 
Alginate beads were dissolved by 150 µl of 55 mM sodium citrate in 150 mM 
sodium chloride per bead. The samples were divided in two parts to determine 
DNA content and GAG amount. 
To determine the amount of DNA Papain (Sigma, St Louis, MO) was added to 
the samples (final concentration 125 µg/ml) and the samples were incubated 
overnight at 60 °C. Using Hoechst 33258 dye the amount of DNA per sample 
was measured with a fluorometer (Perkin-Elmer LS-2B) at 440 nm. The emission 
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of the samples was compared to the emission of a standard (calf thymus DNA; 
Sigma). 
GAG content was measured using the dimethylmethylene blue assay 40. To 
extract the GAG GuHCl was added to the samples at a final concentration of 4 M 
and incubated at 4 °C for 48 hours on a shaker. Using a microplate reader the 
ratio of absorption at 540 nm and absorption at 595 nm was measured. The 
amount of GAG was calculated using a standard of chondroitin sulphate C 
(shark; Sigma). 
For each sample the amount of GAG was divided by the amount of DNA. 
 
Immunohistochemistry 
Alginate beads were dissolved in sodium citrate. Cytospins were prepared and 
stored at -80 °C. The cytospins were stained for collagen type I, collagen type II, 
elastin and 11-fibrau. 
 
Collagen staining 
The cytospins were fixed in acetone and treated by 1% hyaluronidase (Sigma) for 
20 minutes. The next steps included pre-incubation with normal goat serum 
followed by incubation with monoclonal antibodies against procollagen type I 
and collagen type II (1:100 M38 and 1:100 II-II6B3 respectively; Developmental 
Studies Hybridoma Bank). Fab-fragments against mouse conjugated with 
alkaline phosphatase (GAMAP; Immunotech, Marseille, France, 1:100) were 
added. Next, mouse monoclonal alkaline phosphate anti-alkaline phosphatase 
(APAAP; Dakopatts, Copenhagen, Denmark; 1:100) was added. A red signal in 
positive cells was obtained by incubation with a new fuchsin substrate (Chroma, 
Kongen, Germany), demonstrating alkaline phosphate activity. 
 
Elasin staining 
The cytospins were fixed in formaline at 4 °C overnight. The next day the 
cytospins were treated with 0.1% trypsin for 15 minutes at 37 °C. 
After pre-incubation with 10% normal goat serum the cytospins were incubated 
with monoclonal antibodies against elastin (BA4 1:50, Sigma). Next, goat Fab-
fragments against mouse conjugated with boitine (1:50, Vector Laboratories, 
Burlingame, CA) were used, followed by mouse monoclonal biotine anti-alkaline 
phosphatase (1:50, Vector Laboratories, Burlingame, CA). New fuchsin substrate 
was used to demonstrate positive cells. 
 
11-fibrau 
Monoclonal antibody 11-fibrau binds a 112 kDa protein on the cell surface of 
fibroblasts. This protein is absent on differentiated chondrocytes, but is expressed 
by dedifferentiated chondrocytes200. 
The cytospins were fixed in acetone. Next, the cytospins were washed and pre-
incubated with 10% normal goat serum. This was followed by incubation with 
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the 11-fibrau antibody (1:400, Imgen, distributed by ITK diagnostics, Uithoorn 
the Netherlands) for two hours. Fab-fragments against mouse conjugated with 
alkaline phosphatase (1:100) were added for 30 minutes. Next, mouse 
monoclonal alkaline phosphate anti-alkaline phosphatase (1:100) was added for 
30 minutes. Incubation with a new fuchsin substrate demonstrated alkaline 
phosphate activity. 
Controls for the four staining procedures were made by following the same 
staining routine but by omitting the first antibody. 
The percentage of positive cells for each cytospin was determined by randomly 
selecting and counting 300 cells.  
 
Data analysis 
For each donor, three samples of each experimental group are used for analysis 
of GAG/DNA and one sample is used to prepare cytospins. Each sample 
contained three beads. Mean and standard deviations of three donors were 
presented. When data of  less than three donors were used this is indicated. 
Differences among experimental groups were analysed using the Mann-Whitney 
test. A p-value < 0.05 is considered to indicate a statistically significant 
difference. 
 
 
Results 
Cell expansion 
Cells cultured in SFM with no growth factors, did not expand. The addition of 
5 ng/ml FGF2  to this SFM increased the expansion to 1.7 times (SD = 0.67), but 
this was still less than expansion in SCM. Expansion in SFM supplemented with 
100 ng/ml FGF2  appeared always higher than expansion in medium with 10% 
FCS. In average 2.5 times as many cells were obtained by replacement of 10% 
FCS by ITS+ and 100 ng/ml FGF2 . The time to reach passage four was not 
significantly different for these conditions. Cells cultured with 100 ng/ml FGF2  
remained a polygonal shape for longer period of time in monolayer culture.  
 
Chondrocyte Redifferentiation 
Alginate culture in SCM showed poor chondrocyte redifferentiation of expanded 
chondrocytes, independent of the expansion medium used. Collagen type I 
expression was high and both GAG/DNA production and collagen type II 
expression were low (Figure III-1 and Figure III-2 next page). Alginate culture in 
SFM+IGF1/TGFß-2 showed redifferentiation for chondrocytes expanded in 
either SCM or SFM supplemented with FGF2  (both 5 and 100 ng/ml); 
Production of GAG/DNA showed a 10-fold increase (p=0.01) and collagen 
type II expression increased from virtually 0% to 80-90%. 
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Figure III-1  The amount of glycosaminoglycan per DNA (GAG/DNA) produced by 
chondrocytes after redifferentiation culture in alginate. The three bars on the left side of 
the figure represent chondrocytes expanded in SCM and the three bars on the right side 
represent chondrocytes expanded in SFM + 100 ng/ml FGF2. The star represents 
statistical significant difference of GAG/DNA to T=0 and SCM.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-2  The number of cells positive for collagen type I and II afterredifferentition 
culture in alginate. The three bars on the left side of the figure represent chondrocytes 
expanded in SCM and the three bars on the right side represent chondrocytes expanded 
in SFM + 100 ng/ml FGF2. A star indicates a statistical significant difference between 
the two conditions compared. Only comparisons important for this study were 
submitted to statistical analyses in this figure. 
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 Chondrocytes expanded in SFM alone were not redifferentiated, showing high 
collagen type I expression and both low collagen type II expression and 
GAG/DNA production.  
Elastin expression increased from minimal amounts after alginate culture in SCM 
upto 22% when SFM+IGF1/TGFß-2 had been used. No differences were found 
between cells expanded in different types of medium.  
Because expansion in both SFM alone and  SFM+5 ng/ml FGF2  resulted in a 
very low number of cells, these conditions are considered  non-relevant for 
clinical application. Furthermore, insufficient amount of cells were obtained to 
perform redifferentiation cultures of all experiments. Therefore only the results 
for expansion in SCM and expansion in SFM+100 ng/ml FGF2  are further 
evaluated using 11-fibrau. 
After expansion in medium with serum, most cells were positive for 11-fibrau 
(Figure III-3, opposite page). 
 Redifferentiation in SFM+IGF1/TGFß-2 slightly but significantly reduced the 
amount of 11-fibrau positive cells. When cells after expansion in SFM with 
100 ng/ml FGF2  were cultured in alginate with SCM, the number of 11-fibrau 
positive cells was lower. Moreover, culture in alginate in SFM+IGF1/TGFß-2 
almost completely removed the epitope for 11-fibrau, indicating these cells 
expressed chondrocyte phenotype. 
 
 
Discussion 
Expansion cultures should be safe, reproducible and fast in order to introduce 
tissue-engineered cartilage in clinical practice. Using SFM supplemented with 
specific growth factors these three conditions are met. Basic FGF2 in a 
concentration of 100 ng/ml added to expansion culture has been shown to 
stimulate chondrocyte expansion in monolayer and to enhance the capacity to 
express the cartilage phenotype. Both high expansion numbers and good 
redifferentiation are essential for cartilage tissue engineering. Expansion in 
SFM+100 ng/ml FGF2  showed highest multiplication.  
After three weeks of redifferentiation in alginate culture, immunohistochemical 
staining showed chondrocytes expressing mainly collagen type I when SCM had 
been used for redifferentiation culture. Evenmore, when expansion had been 
performed in the presence of serum, collagen type II and the ratio collagen 
type II / collagen type I was overall lowest. This is indicative for poor 
redifferentiation. Yaeger et al. and van Osch et al. showed a positive synergistic 
effect of IGF1 and TGFß-2 in SFM on collagen type II expression and GAG 
production during redifferentiation culture of articular and auricular chondrocytes 
respectively. Based on these results we supplemented our SFM with 10 ng/ml 
IGF1 and 10 ng/ml TGFß-2. Subsequently, collagen type II expression and 
GAG/DNA production increased dramatically for chondrocytes expanded in both 
SCM and SFM+100 ng/ml FGF2 to the same amount. 
Chapter III 
 
 29
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure III-3   The results of the immunohistochemical staining with 11-fibrau (a 
fibroblast membrane marker) are presented of cells redifferentiated in alginate. The 
three bars on the left side of the figure represent chondrocytes expanded in SCM and 
the three bars on the right side represent chondrocytes expanded in SFM+100 ng/ml 
FGF2. A star indicates a statistical significant difference between the two condition 
compared. When chondrocytes had been expanded in SFM+100 ng/ml FGF2 and 
redifferentiated in SFM+IGF1/TGFß-2 almost 95% of the chondrocytes were negative 
for 11-fibrau, indicating superior redifferentiation compared to the other conditions.  
 
 
Van Osch et al. showed that 11-fibrau is a useful antibody to mark the state of 
dedifferentiation for in vitro expanded chondrocytes 200 . Fibroblast-like 
chondrocytes stain positive when 11-fibrau antibody is used, confirming a 
dedifferentiated phenotype. Immunohistochemical staining with 11-fibrau on 
chondrocytes expanded in SCM and ‘redifferentiated’ in in SFM+IGF1/TGFß-2 
still showed many positive cells, indicating cells were not completely 
redifferentiated in spite of the high number of collagen type II positive cells. 
However, cells expanded in SFM+100 ng/ml FGF2 showed an almost complete 
absence of 11-fibrau staining when cultured in alginate in SFM+IGF1/TGFß-2, 
indicating better re-expression of the chondrocyte phenotype. These data 
implicate the usefulness of assessing more parameters than collagen type I and II 
expression when evaluating chondrocyte differentiation stage. The use of 
antibody 11-fibrau provides additional information on chondrocyte 
differentiation stage. 
What mechanism(s) is(are) responsible for the effect of FGF2 on expression of 
chondrocyte phenotype is not fully clear yet. Recently, a growing number of 
studies report a relation between the group of FGF2, Sox9 and chondrocyte 
matrix production 9, 31, 143. Sox9 is a transcription factor, which is responsible for 
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the differentiation of mesenchymal stem cells to chondrocytes. Also, Sox9 
promotes upregulation of several chondrocyte-specific marker genes including 
the genes for collagen type II and aggrecan. FGF2, including FGF2, can enhance 
the expression of Sox9. Addition of FGF2 to expansion cultures might slow 
down the dedifferentiation process or enhance preservation of redifferentiation 
capacity.  
Next to collagen type II, elastin is an important extracellular matrix component 
of elastic cartilage. Elastin production during the primary differentiation of 
mesenchymal stem cells to ear chondrocytes is temporally linked to the 
expression of collagen type II and proteoglycans production. Elastin expression 
during redifferentiation culture might therefore be an indicator of 
redifferentiation of auricular chondrocytes. We could demonstrate a low 
percentage of cells positive for elastin/tropoelastin when cells were 
redifferentiated in SFM+IGF1/TGFß-2. This low percentage could be due to the 
fact that elastin is produced slowly by chondrocytes in culture 110. Moreover, we 
can not exclude the possibility that our redifferentiation medium is not optimal 
for re-expression of elastin. 
 
Tissue engineered cartilage without the presence of bovine serum is safer in 
clinical use.  
However, it should be noted again that after each passage during cell expansion 
chondrocytes had to be cultured with serum containing media for one day to 
promote cell adhesion onto the culture flask. Also, the ITS+ used for the SFM 
contains BSA (Bovine Serum Albumin), mainly to serve as a carrier for linoleic 
acid and to bind growth factors. In future studies autologous serum could be used 
for cell adhesion because only a relatively small amount of serum is needed and 
HSA (Human Serum Albumin) could be supplemented to ITS+ to replace BSA.  
 
 In this study ear chondrocytes from children were used. Cartilage tissue 
engineering of immature donors could be used to treat microtia or traumatic 
defects in children. However, cartilage tissue engineering will also be used for 
mature patients.  Several publications on culturing young versus adult 
chondrocytes have shown that donor age can be an important factor in 
redifferentiation capacity and responds to growth factors 107, 201. Therefore, 
chondrocytes derived from adult tissue should be tested to detemine whether 
similar results can be obtained as with immature chondrocytes. 
 
Finally, we can say that we have made significant progression in excluding 
bovine serum from the cartilage tissue engineering culture system. Futhermore, 
expansion in SFM with 100 ng/ml FGF2 promotes multiplication and re-
expression of chondrocyte phenotype compared to expansion in medium with 
10% serum. This has several advantages. First, a higher number of cells gives 
larger pieces of tissue engineered cartilage. Second, superior redifferentiation 
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should give better quality extracellular matrix and hence a more functional piece 
of engineered cartilage.  
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Abstract 
To treat a cartilage defect with tissue engineering techniques, multiplication of 
donor cells is essential. However, during this multiplication in monolayer 
expansion culture chondrocytes will lose their phenotype and produce matrix of 
inferior quality (dedifferentiation). Dedifferentiation occurs more extensively by 
low seeding densities and passaging. To obtain cartilage of good quality it is 
important that the multiplicated cells regain their cartilaginous phenotype 
(redifferentiation capacity). A gold standard for the multiplication of 
chondrocytes in monolayer, with respect to seeding density and passaging is 
lacking.  In numerous studies available, various cell densities have been used 
making comparison of the results of these studies difficult. Therefore, we 
performed a comparative study to gain insight in the effect of seeding density and 
passaging on the capacity of the cells to redifferentiate. From the resulting data 
we will deduce the seeding density in monolayer culture for which cell expansion 
is both sufficient and fast, whereas the cells retain a capacity to redifferentiate. 
As a guideline we calculated that a minimum of 20 times multiplication is needed 
to fill an average cartilage defect of 4 cm2 with the amount of donor 
chondrocytes we obtained. For this study we used isolated ear chondrocytes from 
five children. Four different seeding densities in monolayer culture were used, 
ranging from 3500 cells/cm2 to 30,000 cells/cm2. The cells were cultured for 
4 passages. The capacity of the expanded chondrocytes to redifferentiate 
(redifferentiation capacity) was studied after an additional three weeks culture in 
alginate beads and was assessed by GAG production and immunohistochemical 
stainings for collagen type I, collagen type II, elastin and a fibroblast marker (11-
fibrau). In general we found that both passaging and decreasing seeding density 
yielded an increase of expanded chondrocytes, but at the same time decreased the 
redifferentiation capacity. Further analyzing our data with the proposed guideline 
we found that with lower seeding densities sufficient multiplication (20 times) 
was reached in less time and with less passaging than at higher seeding densities. 
Importantly, the redifferentiation capacity of these chondrocytes was preserved. 
It was equal or might even be better than chondrocytes multiplicated 20 times at 
higher seeding densities, which used more time and more passages in monolayer 
culture. Thus, for cartilage tissue engineering purposes we propose that 
expansion culture with low seeding densities is preferable.  
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Introduction 
The treatment of traumatic or congenital cartilage defects is limited by several 
factors. First, cartilage has no or little intrinsic repair mechanisms. Furthermore, 
the amount of cartilage available for autologous transplantation is limited. 
However, during the last 15 years cartilage tissue engineering techniques have 
been studied to overcome these problems. With these techniques a relatively 
small amount of donor cells, either chondrocytes or progenitor cells, are 
expanded in vitro until sufficient cells are obtained. Currently, expansion using 
monolayer culture is most widely used.  However, it is well known that in vitro 
multiplication of chondrocytes in monolayer results in dedifferentiation of these 
cells 59, 209, 210. They lose their specific phenotype and become more fibroblast-
like. The production of the specific cartilage matrix components collagen type II 
and aggrecan is gradually shifted toward collagen type I and small proteoglycan 
112, 211. To re-express the differentiated phenotype (redifferentiation) a three 
dimensional environment, like a gel 10, 12, a pellet 73 or a 3D scaffold 45 in which 
the expanded chondrocytes can obtain a spherical configuration, is essential. 
However, studies showed that many of these redifferentiated chondrocytes still 
produce collagen type I and small proteoglycans to some extent indicating a not 
fully restored cartilage phenotype 73, 116. To enhance chondrocyte 
redifferentiation changes can be made in either the redifferentiation culture itself 
or in the expansion culture. In this study we focussed on the expansion culture. 
Since the early 1960’s it has been known that dedifferentiation in monolayer is 
enhanced by low seeding densities, passaging and ongoing multiplication. 
Therefore, high initial seeding densities (30,000 cells/cm2 and higher) are being 
used to reduce dedifferentiation. However, expansion in high seeding density 
cultures often fail to produce sufficient chondrocytes, even after several passages. 
Lower seeding densities may increase cell yield but bear the risk of decreased 
redifferentiation capacity. Although much research is performed, there is no gold 
standard for cell density in monolayer culture to expand cell number for cartilage 
tissue engineering purposes. Various seeding densities have been used, making 
comparison of the numerous results impossible. Therefore, we performed several 
experiments to study the relations between the seeding density in monolayer, the 
number of passages in monolayer and subsequent chondrocyte redifferentiation 
capacity in more detail.  From the results we hoped to find a seeding density for 
which cell expansion is both sufficient and fast whereas the cells retain the 
capacity to redifferentiate. As a guideline we presumed a cartilage defect of the 
human nasal septum or an articular joint of 5 mm thickness and with an area of 
4 cm2. We also presumed the possibility to harvest 2·106 donor chondrocytes 
from the biopsy 116 and that the minimal concentration to generate new cartilage 
in vivo is 20·106 cells/cm3  158. To treat our presumed cartilage defect the donor 
cells have to be multiplied at least 20 times. Isolated ear chondrocytes from 
children were expanded in monolayer using four different seeding densities 
ranging from 3500 cells/cm2 to 30,000 cells/cm2. At different passages the 
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chondrocytes were encapsulated in alginate to evaluate redifferentiation capacity. 
By correlating seeding density and number of passages to the resulting expansion 
and redifferentiation capacity we provide a scientific base for the choice of 
seeding density of human ear chondrocytes in monolayer for cartilage tissue 
engineering. 
 
 
Materials and Methods  
Two experiments were performed with five separate donors. In each experiment 
chondrocytes were expanded using monolayer culture. After expansion the 
chondrocytes were encapsulated in alginate to promote redifferentiation. A brief 
overview of the separate experiments is given below. 
 
Experiment 1: seeding densities 
Cells from two donors (aged 6 and 12, respectively donor I and donor II) were 
used. Freshly isolated chondrocytes were seeded in monolayer culture in four 
different densities; 3500 cells/cm2, 7500 cells/cm2, 15,000 cells/cm2 and 
30,000 cells/cm2. The chondrocytes were expanded until passage 4. A culture of 
three weeks in alginate was performed with P4 chondrocytes from donor I and 
with both P2 and P4 chondrocytes from donor II.  
 
Experiment 2: passaging 
Cells from donor II and three additional donors (aged 7,11 and 7, respectively 
donor III, IV and V) were seeded in monolayer in a density of 7500 cells/cm2. At 
each passage (1,2,3 and 4) part of the expanded cells were encapsulated in 
alginate and a redifferentiation culture was performed. The remaining cells were 
seeded at the initial density in monolayer again. After passage four the expansion 
culture was stopped. 
 
Chondrocyte isolation 
The pieces of cartilage were resected from five children (aged 6-12) during 
protruding ear corrections and were used by informed consent. Perichondrium 
was removed in order to prevent any contamination with chondrogenic cells and 
the cartilage was digested using 2 mg/ml pronase (Sigma, St Louis, Mo) with 
saline for 1.5 hours, followed by overnight digestion in 2 mg/ml collagenase B 
(Boehringer Mannheim, Germany) in Dulbecco’s modified eagle medium (Life 
Technologies, Breda, the Netherlands; Glutamax-I) with 10% FCS (Fetal Calf 
Serum). The next day the chondrocytes were washed three times in physiological 
saline and cell viability was tested using trypan blue staining. Cell yield was 
9000-40,000 cells/mg prepared cartilage. Next, the chondrocytes were seeded in 
monolayer at different densities.  
 
Chapter IV 
 
 37
Expansion culture 
Four different seeding densities were used: 3500 cells/cm2, 7500 cells/cm2, 
15,000 cells/cm2 and 30,000 cells/cm2. The chondrocytes were expanded in 
culture flasks (either 25 cm2 (3 ml medium) or 75 cm2 (10 ml medium)) using 
DMEM with  
10% FCS,gentamycine (50 µg/ml; Life Technologies) and fungizone (1.5 µg/ml; 
Life Technologies). At confluency the cells were detached from the culture flask 
using trypsin-EDTA (Life Technologies). Next, the cells were counted using a 
haemacytometer to determine the expansion. The remaining cells were either 
seeded in new culture flasks at the same density as before and/or encapsulated in 
alginate. At passage four the cell expansion culture was stopped.  
 
Alginate culture 
Alginate culture was performed to promote chondrocyte redifferentiation 12. 
Briefly, the expanded chondrocytes were suspended in 1.2% alginate in saline 
(4·106 cells/ml). Using a 23-gauge needle the suspension was carefully dropped 
in CaCl2 (102 mM), creating gelled beads. After 10 minutes in CaCl2 the beads 
were washed three times with physiological saline. The alginate beads were 
cultured in a 24-wells plate with twelve beads per well. A defined SFM (Serum-
Free Medium) was used to stimulate redifferentiation 116, 201, 215: DMEM 
supplemented with ITS+ (1:100; Becton Dickinson, Insulin, transferrin, selenious 
acid, bovine serum albumin {1.25 mg/ml final concentration in medium}, 
linoleic acid), 10 ng/ml IGF1 (Insulin-like Growth Factor 1, recombinant human, 
Boehringer Mannheim, Germany), 10 ng/ml TGFß-2 (Transforming Growth 
Factor β-2, recombinant human, R&D systems, Abington, UK) and L-ascorbic 
acid 2-phosphate (25 µg/ml, freshly added). The culture medium was changed 
every other day and 50 µl medium was used per bead. After three weeks the 
beads were harvested and stored at –18 °C until further biochemical and 
immunohistochemical analyses. 
 
Biochemical analysis 
Each sample contained three alginate beads and for each condition three samples 
were analyzed. Alginate beads were dissolved by 150 µl of 55 mM sodium 
citrate in 150 mM sodium chloride per bead. After the samples were dissolved 
they were divided in two parts to determine DNA content and GAG 
(GlycosAminoGlycan) amount. 
To determine the amount of DNA Papain (Sigma, St Louis, MO) was added to 
the samples (final concentration 125 µg/ml) and the samples were incubated 
overnight at 60 oC. The amount of DNA per sample was measured with Hoechst 
33258 dye using a fluorometer (Perkin-Elmer LS-2B) at 440 nm Calf thymus 
DNA( Sigma) was used as a standard. 
GAG content was measured using the dimethylmethylene blue assay 41. To 
extract the GAG, Guanidine HCl was added to the samples at a final 
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concentration of 4 M and incubated at 4 °C for 48 hours on a shaker. Using a 
microplate reader the ratio of absorption at 540 nm and absorption at 595 nm was 
measured. The amount of GAG was calculated using a standard of chondroitin 
sulfate C (shark; Sigma). 
For each sample the amount of GAG was related to the amount of DNA. 
 
Immunohistochemistry 
A sample of 3 alginate beads were dissolved in sodium citrate. Cytospins were 
prepared and stored at -80 °C. The cytospins were stained for collagen type I, 
collagen type II, elastin and 11-fibrau. 
 
Collagen staining 
The cytospins were fixed in acetone and treated by 1% hyaluronidase (Sigma) for 
20 minutes. The next steps included pre-incubation with normal goat serum 
followed by incubation with monoclonal antibodies against procollagen type I 
and collagen type II (1:100 M38 and 1:100 II-II6B3 respectively; Developmental 
Studies Hybridoma Bank) for 2 hours. Fab-fragments against mouse conjugated 
with alkaline phosphatase (GAMAP; Immunotech, Marseille, France, 1:100) 
were added. Next, mouse monoclonal alkaline phosphate anti-alkaline 
phosphatase (APAAP; Dakopatts, Copenhagen, Denmark; 1:100) was added. A 
red signal in positive cells was obtained by incubation with a new fuchsin 
substrate (Chroma, Kongen, Germany). 
 
Elastin staining 
The cytospins were fixed in formalin at 4 °C overnight. The next day the 
cytospins were treated with 0.1% trypsin for 15 minutes at 37 °C. After pre-
incubation with 10% normal goat serum the cytospins were incubated with 
monoclonal antibodies against elastin (BA4 1:50, Sigma) for 2 hours. Next, goat 
Fab-fragments against mouse conjugated with biotin (1:50, Vector Laboratories, 
Burlingame, CA) were used, followed by mouse monoclonal anti-biotin alkaline 
phosphatase (1:50, Vector Laboratories, Burlingame, CA). New fuchsin substrate 
was used to demonstrate positive cells. 
 
11-fibrau 
Monoclonal antibody 11-fibrau binds a 112 kDa protein on the cell surface of 
fibroblasts. This protein is absent on differentiated chondrocytes, but is expressed 
by dedifferentiated chondrocytes 200. 
The cytospins were fixed in acetone. Next, the cytospins were washed and pre-
incubated with 10% normal goat serum. This was followed by incubation with 
the 11-fibrau antibody (1:400, 11-fibrau = SM1399, Imgen, distributed by ITK 
diagnostics, Uithoorn, the Netherlands) for two hours. Fab-fragments against 
mouse conjugated with alkaline phosphatase (1:100) were followed by mouse 
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monoclonal alkaline phosphate anti-alkaline phosphatase (1:100) and a new 
fuchsin substrate.  
Controls for the staining procedures were made by following the same staining 
routine but by omitting the first antibody. The percentage of positive cells for 
each cytospin was determined by randomly selecting and counting 3 times 
100 cells.  
 
Data Analysis 
For each donor, three samples of three alginate beads were used for each 
experimental group to analyze GAG/DNA, and one sample was used to prepare 
cytospins. Mean and standard deviations of five donors are presented. 
Differences among experimental groups were analyzed using the Wilcoxon’s 
rank test and the Spearman’s correlation coefficient (rs) for non-parametric 
analysis. A p-value < 0.05 was considered to indicate a statistically significant 
difference.  
The average saturation density of 4 passages was calculated by taking fourth root 
of the total expansion after four passages of a certain seeding density in 
monolayer and multiplying this with the seeding density. 
 
 
Results 
Experiment 1: seeding density 
For both donors from experiment 1 total expansion after four passages increased 
when the seeding density was decreased from 30,000 cells/cm2 to 3500 cells/cm2 
(Table IV-1 page 41, correlation coefficient = 0.97, p < 0.001). In the 
introduction we hypothesized that minimal 20 times multiplication is needed for 
cartilage tissue engineering. For the lower seeding densities (3500 cells/cm2 and 
7500 cells/cm2) the required 20 times multiplication was reached after passage 2 
or 3 within 3-4 weeks. With higher seeding densities multiplication was 
insufficient after four passages. A remarkable observation was that donor I had a 
much higher cell yield after multiplication than donor II. For donor I the number 
of chondrocytes harvested from a culture flask at confluency (saturation density) 
was much higher (Table IV-2 page 42). The saturation density was fairly 
constant for each donor regardless the amount of chondrocytes seeded initially 
(Table IV-2 page 42).  
With decreasing seeding density and thus increasing total expansion, both 
GAG/DNA production and collagen type II expression after three weeks 
redifferentiation culture were decreased (Table IV-1 page 41). Collagen type I, a 
marker of chondrocyte dedifferentiation, was always expressed after 
redifferentiation culture. However, it was variable and did not show any 
correlation with the seeding density used during expansion. The 11-fibrau 
staining, another dedifferentiation marker, also showed that chondrocytes after 
redifferentiation culture were still not fully redifferentiated. No correlation 
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between seeding density and the amount of 11-fibrau positive cells was present. 
The third important matrix component of ear cartilage is elastin. However, elastin 
expression after redifferentiation culture was low, ranging from 0.6 % to 6 % 
positive cells (data not shown).  
 
Experiment 2: passaging 
In experiment 2, chondrocytes from four donors were expanded at 7500 cells/cm2 
and after each passage a redifferentiation culture in alginate was performed. 
Passaging and the resulting increased expansion were correlated with a decrease 
in GAG/DNA production during subsequent redifferentiation culture (p = 0.040, 
Table IV-3 page 42 and Figure IV-1 page 43). For all donors except donor V, the 
collagen type II expression after redifferentiation decreased with higher passage 
number. Comparable to experiment I, collagen type I expression was variable 
and not correlated with passaging and resulting expansion. The amount of 11-
fibrau positive chondrocytes after redifferentiation culture tend to increase with 
higher passage number. Cells of donor I and III were dividing rapidly and had a 
high saturation density in monolayer (the amount of cells at confluency). These 
cells reached sufficient multiplication for cartilage tissue engineering (20 times) 
in the second passage. Except for donor IV, sufficient multiplication for cartilage 
tissue engineering (20 times) was reached before passage three. Remarkably, the 
subsequent redifferentiation culture after 20 times multiplication showed that 
GAG production and collagen type II expression were comparable to 
chondrocytes expanded at high seeding density for 4 passages, that had not 
multiplied enough yet (experiment I). 
 
 
Discussion 
The expansion of isolated donor chondrocytes is an important step in cartilage 
tissue engineering. Without a sufficient number of cells an engineered construct 
will definitely fail. To obtain a clinical application, expansion culture should 
yield large amounts of cells in a short period of time. Secondly, these expanded 
chondrocytes should preferably express or at least be able to re-express their 
chondrocyte phenotype (redifferentiation capacity) in order to produce a 
functional extracellular matrix. Thus, the number of cells and the 
redifferentiation capacity are important outcome parameters in cartilage tissue 
engineering. The seeding density used in monolayer culture has been known to 
be a powerful factor that can influence both outcome parameters. In the present 
study we used different seeding densities in monolayer to multiplicate human ear 
chondrocytes and study the effects on total expansion and subsequent 
redifferentiation capacity. Our results are consistent with previous publications 
and the generally accepted opinion that both low (text continues on page 43)  
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 Average Saturation Density 
at seeding densities of 
 3500 cells/cm2 7500 cells/cm2 15,000 cells/cm2 30,000cells/cm2 
Donor I 43,000 46,015 45,343 46,347 
Donor II 28,176 24,344 26,872 33,581 
Donor III  41,920   
Donor IV  20,697   
Donor V  28,752   
 
 
Table IV-2   The average saturation densities from passage 1 to passage 4 are shown for all 
experiments. Note that the average saturation density was donor-dependent and independent of 
seeding density or passage number. 
 
 
 
Passage 
Multiplication 
factor (cumulative) 
µgGAG/µgDNA 
(value ± SD) 
%Collagen type 
II positive cells 
%Collagen type 
I positive cells 
% 11-Fibrau 
positive cells 
Donor I 
P1 6.3 NA NA NA NA 
P2 4.3 (27) NA NA NA NA 
P3 8.0 (217) NA NA NA NA 
P4 6.6 (1417) 29.1 ± 9.5 30 81 78 
Donor II 
P1 3.2 NA NA NA NA 
P2 2.3 (7.4) 30.9 ± 5.2 34 23 95 
P3 3.3 (24) 33.7 ± 2.9 39 14 84 
P4 4.7 (111) 19.6 ± 0.9 25 16 100 
Donor III 
P1 7.3 45.3 ± 6.4 65 34 44 
P2 5.4 (39) 33.5 ± 2.5 48 15 83 
P3 4.5 (177) 28.5 ± 5.2 20 43 49 
P4 5.5 (976) 12.4 ± 0.8 7 37 84 
Donor IV 
P1 2.3 45.8 ± 1.4 42 20 70 
P2 2.0 (4.6) 10.8 ± 0.1 22 32 90 
P3 3.5 (16) 12.0 ± 0.3 26 29 95 
P4 3.6 (58) 12.2 ± 0.6 14 19 100 
Donor V 
P1 2.8 8.0 ± 0.5 26 11 67 
P2 4.0 (11) 15.8 ± 1.3 49 25 100 
P3 4.2 (47) 9.4 ± 1.4 46 38 NA 
P4 4.6 (216) 13.2 ± 3.2 47 18 100 
Statistics 
rs 0.884 -0.311 -0.488 0.066 0.612 
p-value <0.001 0.040 0.065 0.814 0.020 
 
 NA = no data available 
 
Table IV-3   Expansion and redifferentiation capacity of chondrocytes seeded at 7500 cells/cm2 
from passage and p-values are determined for correlation between passaging and subsequent 
expansion or redifferentiation capacity parameters.
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Figure IV-1  The relation between cell passage number and cell redifferentiation parameters. 
The average amount of µgGAG/µgDNA, the average percentage of cells positive for collagen 
type II and 11-fibrau after redifferentiation culture are shown for P1 to P4 chondrocytes 
expanded at a seeding density of 7500 cells/cm2 (average calculated from donor II, III, IV and 
V). Both the Spearman’s correlation coefficients (rs) and a line drawn between the averages 
indicate a relation between passaging from P1 to P4 and a subsequent redifferentiation capacity. 
 
 
 
 
seeding densities and ongoing passaging promote expansion but also decrease 
redifferentiation capacity 55, 59, 112, 211. Total cell expansion increased dramatically 
with lower seeding densities, with up to 2500-4000 times more multiplication 
with a seeding density of 3500 cells/cm2 compared to 30,000 cells/cm2. However, 
with this increase in total expansion the redifferentiation capacity after alginate 
culture, indicated by GAG production and collagen type II expression, decreased 
significantly. Several mechanisms have been proposed by which lower seeding 
densities result in more dedifferentiation. Firstly, cells seeded at lower density 
have to multiply more until confluency is reached. Furthermore, with lower 
seeding density the cell-cell contact inhibition will be less. This has been shown 
to inhibit chondrogenic differentiation in chick mesendermal cells 209. Moreover, 
secreted factors by the chondrocytes that condition the medium can have a role in 
stabilizing phenotype 59, 175. These factors will have lower concentrations in low 
seeding density cultures. Another proposed mechanism of dedifferentiation is the 
changing cell shape during monolayer culture. Changes in cell shape are thought 
to be a (morphologically visible) result of changes in microfilament organization 
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that have been suggested to have a direct effect on chondrogenic phenotype in 
vitro 10, 16, 63, 108, 114.  
With the correlation’s we found between seeding density, total multiplication and 
subsequent redifferentiation capacity we tried to deduce a pathway to 
multiplicate chondrocytes in monolayer culture for which the resulting total 
expansion, culture time and redifferentiation capacity is adequate for clinical 
purposes. In theory two different pathways can be chosen to obtain an adequate 
number of cells. Expansion culture with high seeding densities (30,000 cells/cm2 
and 15,000 cells/cm2) could have the advantage of a better-retained phenotype, 
whereas more time in culture and more passages would be needed. On the 
contrary, expansion with low seeding densities (3500 cells/cm2 and 
7500 cells/cm2) would need less time and less passages to reach an adequate 
number of cells. However, loss of phenotype would be more prevalent. As a 
guideline to find the optimal pathway we presumed a cartilage defect of 4 cm2 
area and 5 mm thickness. To treat such a cartilage defect with the required 
minimal of 20·106 cells/ml 158, we need 40·106 cells. The donor cartilage we used 
yielded a minimum of 2·106  chondrocytes after digestion. Thus, with 2·106 donor 
cells from a biopsy a minimum of 20 times multiplication is needed. By using 
low seeding densities of 3500 cells/cm2 or 7500 cells/cm2 20 times multiplication 
was reached between passage 2 and passage 3 for most donors (< 28 days). 
Chondrocytes seeded at a density of 15,000 cells/cm2 and 30,000 cells/cm2 only 
rarely reached 20 times multiplication after 4 passages. Therefore, the 
redifferentiation capacity of both groups cannot be compared directly. However, 
when for example the results from donor I are extrapolated, chondrocytes seeded 
at 30,000 cells/cm2 would have reached a sufficient number of cells at passage 7 
taking 49 days. After such prolonged expansion culture the redifferentiation 
capacity is equal or even lower than chondrocytes expanded at lower seeding 
densities. Thus, for a clinically relevant amount of multiplication the advantages 
of using low seeding densities, less time in culture and fewer passages needed are 
in balance with or will even outweigh the negative effects of low seeding 
densities on differentiation level. The advantage of using fewer passages could 
have several grounds. Holtzer et al. showed by using labeled globulin that up to 
20% of chondrocytes can be injured after trypsinisation and are probably lost 59. 
Also, the whole purpose of passaging is seeding the chondrocytes in a lower 
density again, with the previously mentioned negative effects on phenotype.  
Further analyzing the data shows that the correlation between higher 
multiplication (by decreasing seeding density or continued passaging) and 
decreased capacity applies for each donor individually, but it does not apply 
when results between donors are compared. The number of cells per unit of area 
at confluency was donor dependent and independent of initial seeding density 
(Table IV-2 page 42). The number of cells per unit of area at confluency was 
previously reported by Kolettas to be approximately 10,000 cell/cm2 for human 
articular chondrocytes and was referred to as the saturation density 90. In our 
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experiment with human ear chondrocytes the saturation density ranged from 
approx. 21,000 cell/cm2 to 46,000 cells/cm2 for the different donors. Higher 
67saturation density resulted in higher total expansion. However, higher 
saturation density and hence higher total expansion did not result in a lower 
redifferentiation capacity. On the contrary, expansion culture with a chondrocyte 
population with high saturation density took less time, less passaging and showed 
a better preserved redifferentiation capacity.  Again, less time in culture, less 
passaging, or a combination of these, seems beneficial for cellular performance 
in redifferentiation culture. For example, comparing donor III with donor IV. The 
mean saturation density for donor III was 41,920 cell/cm2 and for donor IV 
20,697 cells/cm2. When chondrocytes from both donors had to be expanded 
20 times, the chondrocytes from donor III reached this number at passage 2, 
while chondrocytes from donor IV reached 20 times multiplication between 
passage 3 and 4. Furthermore, chondrocytes of donor III showed a better 
redifferentiation capacity, GAG/DNA production was higher (p = 0.05) and more 
cells were positive for collagen type II (48% versus 26%). We assume that the 
relatively large variation between the saturation densities of the different donors 
could be due to differences in internal biological activity (other than donor age, 
which did not correlate with the results) or due to the presence of subpopulations 
of cells in monolayer. Although the perichondrium was dissected from the donor 
cartilage before digestion, we can not exclude that a small amount of 
perichondrium cells was included in expansion culture. The perichondrium has 
been known to contain cells that have chondrogenic progenitor potentials 191, 199. 
Expansion of these cells could result in a relative overgrowth. Furthermore, 
cartilage itself has different subpopulations. Several reports have stated the 
possibility that chondrocytes from the superficial layer also show progenitor 
potentials 5, 194 . The progenitor cells might expand better and retain better 
capacity to express the cartilage phenotype. Other factors that influence 
saturation density total expansion and redifferentiation were excluded as much as 
possible. Interobserver variability was ruled out as one person performed 
culturing and decided when cultures were confluent. Furthermore, for all 
expansion cultures one serum-batch was used. Finally, correcting protruding ears 
is an elective operation; therefore all the obtained cartilage for the experiments 
was of patients in normal health. 
Ear cartilage could prove to be a useful source of chondrocytes for articular 
cartilage tissue engineering. It has the advantage of a high cell yield and it is 
metabolically very active, although elastin production in vitro has been 
demonstrated to be poor 57, 116, 159, 165. Furthermore, ear cartilage is easier to 
harvest than autologous articular cartilage and relatively large pieces can be 
harvested without cosmetic problems. Finally, harvesting ear cartilage seldomly 
causes large donor site morbidity 46.  
Although we have used young ear chondrocytes for our experiments we do not 
anticipate that using adult ear chondrocytes will show a completely different 
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relationship between seeding density, passaging and redifferentiation capacity. 
We do hypothesize that using lower seeding densities in monolayer for adult 
chondrocytes also would be advantageous. Details of growth rate, saturation 
densities of adult ear chondrocytes in monolayer, as well as a possible worse 
redifferentiation capacity, have to be investigated. Also, for our experiments we 
have used DMEM with 10% FCS. Recently, a growing number of reports show 
that using a (serum-free) medium supplemented with growth factors enhances 
cell yield during expansion cultures 116, 127. Concurrently, these defined expansion 
media promote redifferentiation capacity 73, 127. We previously published data in 
which SFM with high concentration FGF2 (Fibroblast Growth Factor 2) was 
used for expansion of young ear chondrocytes seeded at 40,000 cells/cm2 in 
monolayer 116. Although total multiplication was only slightly increased, 
redifferentiation capacity increased significantly compared to chondrocytes 
expanded in 10% FCS. Future experiments will indicate whether FGF2 also 
enhances the lower redifferentiation capacity of chondrocytes expanded at low 
seeding densities. 
 
In summary, we show a relationship between initial seeding density, passaging 
and the subsequent redifferentiation capacity of human ear chondrocytes in 
monolayer culture. For cartilage tissue engineering purposes we propose that 
expansion culture with low seeding densities is preferable. This will result in an 
adequate number of cells, using less time and fewer passages than expansion 
culture with high seeding densities. Importantly, the redifferentiation capacity of 
these cells is preserved. 
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Fibroblast Growth Factor 2 in serum-free medium 
is a potent mitogen and reduces dedifferentiation of 
human ear chondrocytes in monolayer culture 
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Abstract 
The loss of the differentiated phenotype (dedifferentiation) during the expansion 
culture of donor chondrocytes remains a large problem in cartilage tissue 
engineering. Dedifferentiated chondrocytes produce other matrix components 
and therefore the tissue produced will be of less suitable quality. Previously, the 
addition of FGF2 to a SCM (Serum-Containing Medium) during expansion 
culture was shown to have positive effects on the phenotype of articular 
chondrocytes. In the present study we focused on a more defined, SFM (Serum-
Free Medium), to expand chondrocytes in monolayer culture for the purpose of 
cartilage tissue engineering. Adult human ear chondrocytes were expanded in 
SFM supplemented with 100 ng/ml FGF2. Expansion culture in a conventional 
SCM (10% fetal calf serum) served as control. The cell yield during expansion 
culture in SFM with FGF2 was significantly higher compared to SCM. In 
addition, chondrocytes expanded in the SFM with FGF2 expressed a more 
differentiated phenotype at the end of monolayer culture, as indicated by higher 
gene expression ratios of collagen type II to collagen type I and aggrecan to 
versican. Also, a higher gene expression of Sox9 was found. Next, suspension in 
alginate and subsequent culture in vitro or subcutaneous implantation in nude 
mice was used to evaluate the capacity of the chondrocytes, expanded in either 
medium, to re-express the differentiated phenotype (redifferentiation) and to 
form cartilage. The observed beneficial effects of the SFM with FGF2 on the 
chondrocyte phenotype at the end of monolayer culture were sustained on both 
transcriptional and extracellular level throughout both redifferentiation methods. 
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Introduction 
Cartilage has limited intrinsic repair mechanisms. Therefore, cartilage defects 
beyond a certain magnitude will not heal spontaneously and can lead to 
significant joint morbidity 64, 180. During the last 15 years new techniques, 
grouped under the name of tissue engineering, are being developed to treat 
cartilage defects using culture- expanded donor cells. Classically, 2D-monolayer 
culture on a plastic surface with serum-supplemented medium is used for 
expansion culture. A serious side effect of monolayer expansion culture is loss of 
chondrocyte phenotype (dedifferentiation) 1, 59, 208. During monolayer culture 
chondrocytes spread onto the culture flask and expression gradually shifts from 
collagen type II and aggrecan to collagen type I and versican, molecules 
characteristic for a more fibroblast-like phenotype 208. In an attempt to improve 
the quality of tissue engineered cartilage by culture-expanded chondrocytes, 
various expansion media supplemented with growth factors were recently 
developed 32, 73, 116, 126, 127, 154, 159, 178, 195. The most widely used growth factor for 
this purpose is FGF2 (Fibroblast Growth Factor 2). Previous studies showed that 
addition of FGF2 to the conventional SCM (Serum-Containing Medium) 
increased both cell yield during monolayer expansion culture and the capacity of 
expanded chondrocytes to re-express cartilage specific molecules during 
subsequent 3D culture in vitro 126, 127. Controversially, it was shown in these 
studies that FGF2 increased dedifferentiation during monolayer culture 73, 127. 
Most studies with growth factors were performed in the presence of serum. 
Addition of growth factors to serum-supplemented media could influence the 
actions of the growth factors due to possible interacting factors in the serum 202. 
Also, large variations in bioactivity can exist between different serum batches, 
making the reproducibility of results difficult 215. In a previous study we were 
able to multiply immature ear chondrocytes in a defined SFM (Serum-Free 
Medium) with FGF2 and thereby enhancing the quality of the matrix generated 
lateron in 3D tissue formation, compared to chondrocytes multiplied in medium 
with 10% serum 116. However, in that study we used high cell densities in 
monolayer (40,000 cells/cm2), which limited cell multiplication. The aim of the 
present study is to evaluate and further elucidate the effects of SFM with FGF2 
on cell expansion and redifferentiation capacity of human adult chondrocytes. 
Therefore, adult human ear chondrocytes were expanded in monolayer culture in 
either defined SFM with 100 ng/ml FGF2 (SFM+FGF2) or conventional SCM 
without additional growth factors. Next, the ability of expanded chondrocytes to 
re-express the differentiated phenotype (redifferentiation) and to form cartilage 
was assessed via suspension in an alginate gel. The alginate-cell suspension was 
either cultured in vitro or implanted subcutaneously in nude mice after seeding 
into a biomaterial. Quantitative RT-PCR technique was used in combination with 
biochemical assays and histology to analyze the effects of our experimental 
medium with FGF2 on cellular phenotype at different stages of the process and 
the quality of extracellular matrix produced.  
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Materials and Methods 
Chondrocyte expansion 
Pieces of ear cartilage from three adults (resp. 18, 43 and 46 years old) , obtained 
as leftover material from patients undergoing reconstructive surgery of the nose 
using ear cartilage, was used. The perichondrium was removed and cartilage was 
digested  for 1.5 hours with  pronase (Sigma, St Louis, Mo) followed by 
overnight digestion with collagenase B (Boehringer Mannheim, Germany). 
Chondrocytes were seeded in monolayer using two different densities: 
7500 cells/cm2 and 15,000 cells/cm2. Expansion culture was performed using 
either a SFM (SFM) or serum-containing control medium, thus creating four 
different conditions (Figure V-1 next page). SFM was composed of DMEM 
(Dulbecco’s modified eagle medium, Life Technologies, Breda, the Netherlands; 
Glutamax-I) supplemented with ITS+ (1:100; Becton Dickinson, insulin, 
transferrin, selenious acid, bovine serum albumin, linoleic acid) and 100 ng/ml 
FGF2 (recombinant human, Instruchemie, Hilversum, The Netherlands). Control 
medium consisted of DMEM with 10% heat-inactivated FCS (Fetal Calf Serum). 
Gentamycine (50 µg/ml; Life Technologies) and fungizone (1.5 µg/ml; Life 
Technologies) were added to prevent microbial growth. Chondrocytes in the 
serum-free conditions were cultured in 10% FCS for one day to promote cell 
adhesion in the culture flasks and to ensure that cell adhesion was not influenced 
by the experimental medium. At subconfluency the cells were detached from 
culture flasks using trypsin-EDTA (Life Technologies) and cell multiplication 
from seeding till trypsin treatment is determined. At the start of each new 
passage, chondrocytes were again seeded at their original seeding density of 
either 7500 cells/cm2 or 15,000 cells/cm2 and the serum-free conditions were 
cultured for one day in 10% FCS. Medium was changed two times a week. 
Expansion culture was stopped after the third passage (25 days for SCM and 
28 days for SFM+FGF2) and cells were suspended in alginate for 
redifferentiation culture. 
 
In vitro redifferentiation culture 
To promote redifferentiation, expanded chondrocytes were suspended in 1.2% 
alginate in physiological saline (4·106 cells/ml) 12. Beads were prepared and 
cultured in a 24-wells plate with twelve beads per well in a defined SFM to 
stimulate redifferentiation 116 , 201, 215 : DMEM supplemented with ITS+, 10 ng/ml 
IGF1 (Insulin-like Growth Factor 1, recombinant human, Boehringer 
Mannheim,Germany), 10 ng/ml TGFß-2 (Transforming Growth Factor β-2, 
recombinant human, R&D systems, Abington, UK) and L-ascorbic acid 
2−phosphate (25 µg/ml, freshly added). Culture medium (50 µl was used per 
bead) was changed every other day. After three weeks beads were harvested. Part 
was used immediately for RNA extration, the rest was stored at –20 °C until 
further biochemical and immunohistochemical analyses (Figure V-1 next page). 
Chapter V 
 
 51
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure V-1   A schematic overview of the experiments:  
A= Chondrocytes from each donor were culture-expanded in monolayer using four different 
conditions. (1) Serum-containing medium (SCM) at a seeding density of 7500 cells/cm2, (2) 
Serum-containing medium at 15,000 cells/cm2, (3) serum-free medium with FGF2 
(SFM+FGF2) at 7500 cells/cm2 and (4) serum-free medium with FGF2 at 15000 cells/cm2. 
After expansion culture the chondrocytes were suspended in alginate and cultured in vitro 
(alginate beads) or in vivo (subcutaneous implantation in nude mice). 
* Condition seeded at 15,000 cells/cm2 in SCM failed to generate sufficient cells to  
   perform experiments in nude mice.  
B= An overview to underscore significant time points during the experiments. Gene expression 
profiles were assessed at the end of monolayer culture, the end of three weeks in vitro 
redifferentiation culture and after 8 weeks subcutaneous implantation in nude mice. Alongside, 
the amount and quality of the extracellular matrix produced during either redifferentiation 
method was also assessed at these end points. 
 
 
In vivo redifferentiation 
Expanded chondrocytes were suspended in 1.8% alginate at a concentration of 
20·106 cells/ml 149. Demineralized trabecular bone matrix (DBM, bovine collagen 
type I, Osteovit, Braun, Oss, The Netherlands), cut into cores of 3 mm height and 
8 mm diameter, were impregnated with alginate-cell suspension for 15 minutes 
and put into 102 mM CaCl2 for 20 minutes allowing the alginate to gel. 
1 SCM at 7500 cells/cm2                         2 SCM at 15000 cells/cm2                       3 SFM+FGF2 at 7500 cells/cm2                       4 SFM+FGF2 at 15000 cells/cm2
In Vitro           In Vivo
Alginate Beads         Nude Mice
In Vitro           *
Alginate Beads         
In Vitro           In Vivo
Alginate Beads         Nude Mice
In Vitro           In Vivo
Alginate Beads         Nude Mice
25-28 days monolayer expansion culture
3  weeks in vitro redifferentiation
8  weeks in vivo redifferentiationAssessment of gene expressions 
Assessment of gene expressions and 
biochemical/immunohistochemical  assays
Assessment of gene expressions and 
biochemical/immunohistochemical  assays
Expansion:
Redifferentiation:
Ear Chondrocytes
A
B
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Subsequently, the constructs were washed two times in plain DMEM. As an in-
vivo redifferentiation model the constructs were implanted subcutaneously in six 
nude mice (male, SWISS Nu/Nu, Charles River). Approval for this animal 
experiment was obtained from the local ethical committee (116-02-01). Four 
pockets were created subcutaneously; one pocket near each limb. For each 
condition two construct were implanted, one in the pocket close to the forelimb 
and one close to the hindlimb. In total four constructs were implanted per mouse. 
The six mice were housed in two filter-top cages. Mice were sacrificed using 
cervical dislocation eight weeks after implantation and the constructs were 
harvested (Figure V-1 previous page). Each construct was divided into four equal 
parts; one part for paraffin embedding was fixed in formaline, the other three 
parts, one for biochemical assays, one for cryo-sectioning and one part for RNA 
isolation were stored at –80 °C. Due to insufficient cell yield during expansion 
culture, the condition 15,000 cells/cm2 in combination with SCM was not used 
for in vivo alginate experiments.   
 
Biochemical analysis 
Alginate Beads 
Each sample contained three alginate beads and for each condition three samples 
were analyzed. Alginate beads were dissolved in 150 µl of 55 mM sodium citrate 
in 150 mM sodium chloride per bead and divided into two parts to determine 
DNA content and GAG (GlycosAminoGlycan) amount. 
The amount of DNA was determined fluorometrically with Hoechst 33258 dye, 
after papain digestion (final concentration 125 µg/ml; Sigma, St Louis, MO) 
using calf thymus DNA (Sigma) as a standard. GAG was determined after 
extraction in 4 M Guanidine HCl using dimethylmethylene blue assay 41. 
Absorption ratio’s at 540 nm and at 595 nm were measured and the amount of 
GAG was calculated using a standard of chondroitin sulfate C (shark; Sigma). 
 
Alginate/DBM contructs 
Samples were weighted and a Proteinase K digestion was used to digest the 
samples overnight at 56 °C. The reaction buffer contained TRIS EDTA 
(pH = 7.6) with 0.19 mg/ml iodoacetamide (ICN Biomedical, Ohio, USA), 
10 µg/ml Pepstatin A (ICN Biomedicals, Ohio, USA) and 1 mg/ml Proteinase K 
(Boehringer Mannheim, Germany). The next day the samples were heated to 
100 oC for 10 minutes in order to inactivate proteinase K. Next, the amount of 
GAG and DNA was measured as described above under Alginate beads.  
 
Immunohistochemistry 
Alginate Beads 
Three alginate beads per condition were dissolved in sodium citrate and 
cytospins were made which were stained for collagen type I, collagen type II and 
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elastin. The percentage of positive cells for each cytospin was determined by 
randomly selecting and counting three times 100 cells. Controls for the staining 
procedures were made by following the same staining routine but by omitting the 
first antibody. For collagen staining the cytospins were fixed in acetone and 
treated with 1% hyaluronidase (Sigma). For elastin staining the cytospins were 
fixed in formalin and treated with 0.1% trypsin. Sections were incubated with 
monoclonal antibodies against procollagen type I, collagen type II (1:100 M38 
and 1:100 II-II6B3 respectively; Developmental Studies Hybridoma Bank) or 
elastin (BA4 1:50, Sigma) for two hours. Finally, alkaline phosphatase 
conjugated antibodies in combination with a new fuchsin substrate (Chroma, 
Kongen, Germany) were used to obtain a red signal in positive cells. 
 
Alginate/DBM constructs 
Alkaline phosphatase conjugated anti-mouse Fab-fragments (GAMAP, 1:400) 
were coupled overnight with monoclonal anti-collagen type II (1:100 II-II6B3) or 
anti-elastin (1:1000 BA-4) antibodies. Two hours before staining 0.1% normal 
mouse serum was added. Paraffin embedded histological slices were 
deparaffinised using xyleen and alcohol. For collagen staining, the sections were 
incubated with 1 mg/ml pronase and subsequently with hyaluronidase. For elastin 
staining the sections were incubated with trypsin. Next, the sectons were 
incubated with the conjugated antibody for two hours. Subsequent steps were 
identical to the immunohistochemical staining on cytospins. 
 
Quantification of gene expression 
Isolation of total RNA 
Cells in monolayer were rinsed with phosphate-buffered saline, homogenized in 
RNA-BeeTM  (TEL-TEST, Inc; Friendswood, TX, USA) by scraping and stored 
at –80 °C. Alginate beads were dissolved in ice-cold sodium citrate/EDTA 
buffer. Cell pellets were suspended in RNA-BeeTM and stored at –80 °C. 
Alginate/DBM constructs were snap frozen in Liquid nitrogen, disrupted for one 
minute at 47 Hz in a Micro-Dismembrator-S (B. Braun Biotech International 
GmbH, Melsungen, Germany), then homogenized in RNA-BeeTM and frozen at  
–80 °C. 
RNA was precipitated with 2-propanol and purified with lithium chloride (cells) 
or RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany) (alginate/DBM 
constructs). 
 
Reverse transcriptase 
Quantities and purity of extracted total RNA were determined 
spectrophotometrically at 260  and 280 nm. Ratios between 1.7 and 2.0 indicated 
reasonable purity. Total RNA was quantified using RibogreenTM reagent (R-
11490, Molecular Probes Europe BV, Leiden, The Netherlands) prior to cDNA 
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synthesis using RevertAidTM First Strand cDNA Synthesis Kit (#1622, MBI 
Fermentas, Germany). 
 
Primer and probe design and TaqMan® assay 
All Taqman assays were performed in triplicates in 96-well optical plates using 
qPCRTM Core Kit (#RT-QP73-05; Eurogentec Nederland B.V., Maastricht, 
Nederland B.V.). Oligonucleotide sequences and assay concentrations for COLI, 
COLII, COL10, CSPG2 (versican), and GAPDH were adopted from 124. The 
other primers and probes were designed using PrimerExpress1.5 software 
(Applied Biosystems, Foster City, CA, USA) the way that the probe binds to 
separate exons to avoid false positive results arising from amplification of 
contaminating genomic DNA. Specificity of primer sets was checked by 
BLASTN search and gel electrophoretic analysis of amplicons after reverse 
transcription PCR. Gene expression was quantified relatively using the 2-∆∆CT 
formula from ABI Prism 7700 Sequence Detection System user bulletin #2 . The 
amount of target was normalized to endogenous GAPDH expression, with the 
efficiencies amplification of the targets and that of the reference being 
approximately equal. Primer and probe nucleotide sequences for gene 
amplification were as follows:  
 
 
 
Data Analysis 
Differences in multiplication, GAG production, DNA content, the percentages of 
positive cells on cytospins and relative gene expression, among experimental 
groups were analyzed using the Mann-Whitney U test for non-parametric nalysis. 
A p-value < 0.05 was considered to indicate a statistically significant difference. 
 Access. No. Primers  
and position (5’-3’) 
Probe (FAM)  
(5’-3’) 
AGC1 NM_001135 Forward  1066 GGCTACCCCGACCCCTC 
Reverse   TCCACAAAGTCTTCACCTCTGTGT 1127 
TCCCGCTACGACGCCATCTGC 
ALPL NM_000478 Forward  1074 GACCCTTGACCCCCACAAT 
Reverse  GCTCGTACTGCATGTCCCCT 1122 
TGGACTACCTATTGGGTCTCTTCGAGCCA 
ELN NM_000501 Forward  927 AGCCGCTAAGGCAGCCA 
Reverse  ACCAACTACTCCCGGGCC 988 
TATGGAGCTGCTGCAGGCTTAGTGCC 
Sox9 NM_000346 Forward  765 CAACGCCGAGCTCAGCA 
Reverse  TCCACGAAGGGCCGC 825 
TGGGCAAGCTCTGGAGACTTCTGAACG 
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Results 
Monolayer expansion culture 
On average four times more proliferation was observed with SFM with FGF2 
(SFM+FGF2) compared to SCM (Figure V-2 next page). The highest number of 
cells was found with 7500 cells/cm2 in SFM+FGF2, where at least 7 doublings 
had occurred after 3 passages. In all conditions, Q-RT-PCR data obtained from 
chondrocytes at the end of monolayer culture showed a very low expression of 
aggrecan and collagen type II, which is typical for chondrocyte dedifferentiation 
(Figure V-3A page 58). The degree of dedifferentiation can be assessed by the 
ratios of expressed collagen type II to collagen type I and aggrecan to versican 
(COL2/COL1 and AGC/VERS).  At the end monolayer culture, for chondrocytes 
expanded in SFM+FGF2 both ratios were higher than for chondrocytes expanded 
in SCM, indicating less dedifferentiation. For collagen this was the result of 
significant lower collagen type I expression in chondrocytes expanded in 
SFM+FGF2 compared to SCM. On the proteoglycan level however, the higher 
ratio of differentiation was caused by a combination of higher aggrecan 
expression and lower versican expression. Expression of Sox9 was 3-5 times 
higher in chondrocytes expanded in SFM+FGF2, whereas elastin was 
significantly lower expressed compared to chondrocytes expanded in SCM 
(Table V-1 next page). 
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 * = a statistical significant increase in total multiplication compared to SCM at similar seeding 
       density. 
 7500SCM = expansion in serum-containing medium at 7500 cells/cm2. 
 15000SCM = expansion in serum-containing medium at 15,000 cells/cm2. 
  7500SFM+FGF2 = expansion in serum-free medium with FGF2 at 7500 cells/cm2. 
  15000SFM+FGF2 = expansion in serum-free medium with FGF2 at 15,000 cells/cm2. 
 
Figure V-2   Total chondrocyte multiplication after three passages in monolayer for each of the 
four conditions used. Averages ± SD of three donors are shown 
 
 
 
* = a significant higher expression compared to either SCM or SFM+FGF2 at the same seeding density. 
# = a significant difference in gene expression between 7500 SCM and 15,000 SFM+FGF2. 
7500 SCM = expansion in serum-containing medium at 7500 cells/cm2. 
15000 SCM = expansion in serum-containing medium at 15,000 cells/cm2. 
7500 SFM+FGF2 = expansion in serum-free medium with FGF2 at 7500 cells/cm2. 
 15000SFM+FGF2 = expansion in serum-free medium with FGF2 at 15,000 cells/cm2. 
 
Table V-1   .For the four conditions used during expansion culture the expression of typical 
genes is shown at harvesting from the monolayer culture, in vitro redifferentiation culture and 
the in vivo implantation in nude mice (in vivo alginate). Averages ± SD of three donors are 
shown with expression levels normalized to GADPH. 
Monolayer Sox9 Elastin Alkaline Phosphatase Collagen type X 
7500   SCM 6.1*10-3±1.4*10-3 0.09±0.03 * # 270*10-6±24*10-6 * # 3.3*10-7±2.1*10-7 
15000 SCM 8.6*10-3±3.7*10-3 0.06±0.03 * 340*10-6±20*10-6 * 1.6*10-7±0.59*10-7 
7500   SFM+FGF2 0.04±2.6*10-3  * 0.01±3.5*10-3 0.57*10-6±0.39*10-6 2.3*10-7±0.92*10-7 
15000 SFM+FGF2 0.03±0.01  * # 0.01±3.7*10-3 2.9*10-6±2.9*10-6 9.0*10-7±13*10-7 
In Vitro     
7500   SCM 0.14±0.02 1.17±1.02 220*10-4±240*10-4 * # 0.07±0.06 * # 
15000 SCM 0.10±0.03 0.50±0.19 130*10-4±68*10-4 * 0.04±0.02  
7500   SFM+FGF2 0.11±0.04 0.96±0.48 4.1*10-4±4.3*10-4 0.01±2.1*10-3 
15000 SFM+FGF2 0.08±0.04 0.85±0.20 6.5*10-4±2.2*10-4 0.02±0.01 
In Vivo     
7500   SCM 0.55±0.31 10.5±4.9 15*10-4±6.1*10-4 2.1*10-4±1.5*10-4 
7500   SFM+FGF2 0.78±0.21 6.3±3.4 8.2*10-4±6.1*10-4 5.4*10-4±3.1*10-4 
15000 SFM+FGF2 0.76±0.15 8.4±2.3 7.9*10-4±3.1*10-3 5.4*10-4±3.9*10-4 
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In vitro redifferentiation culture 
At the end of three weeks redifferentiation culture in 1.2 % alginate beads gene 
expressions were upregulated compared to the monolayer culture, except for 
versican (Figure V-3B page 59). The higher expression ratio of COL2/COL1 
observed at the end of monolayer culture in chondrocytes expanded in 
SFM+FGF2 compared to SCM was sustained, again due to a lower collagen 
type I expression. This was confirmed by immunohistochemical staining for 
collagen type I on cytospins, which showed a similar pattern (Figure V-4 page 
61). However, in contrast to gene expression, collagen type II was also 
significant higher expressed on cytospins when SFM+FGF2 had been used 
during expansion culture. The gene expression ratio of AGC/VERS at the end of 
the in vitro redifferentiation culture was not significantly different between either 
expansion medium used (Figure V-3B page 59). Also, on the extracellular matrix 
level no significant differences were found in total sulfated GAG (Figure V-5 
page 61). Sox9 gene expression levels were similar in the four conditions (Table 
V-1 page 56). Although elastin gene expression was considerate (Table V-1 page 
56), only a maximum of 20% of the chondrocytes were positive for elastin on 
cytospins, showing no significant difference between expansion medium or 
seeding density used (data not shown). 
 
 In vivo redifferentiation 
At harvesting after eight weeks the constructs had a cartilage-like macroscopical 
appearance. The biochemical assays on GAG and DNA showed that 
chondrocytes which had been expanded in SFM+FGF2 produced more GAG per 
milligram tissue than constructs with cells expanded in SCM (Figure V-6 page 
62). Histological methods revealed cartilage-like tissue, which was more positive 
for collagen type II when SFM+FGF2 had been used during expansion culture 
(Figure V-7 page 62). Higher expression ratios of COL2/COL1 were found for 
chondrocytes expanded in SFM+FGF2 with a similar AGC/VERS ratio in all 
conditions (Figure V-3C page 60). Elastin expression levels were similar in all 
conditions. However, immunohistochemical staining for elastin was only faintly 
positive, with highest staining in constructs initially seeded with chondrocytes 
expanded in SCM. Expression of chondrocyte hypertrophy markers, such as 
alkaline phosphatase and collagen type X, was low with no significant 
differences between the conditions (Table V-1 page 56).  
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* = statistically significant higher gene expression compared to expansion culture in serum-containing 
      medium (SCM) at the same seeding density. 
# =  significant difference in gene expression between 7500SCM and 15000SFM+FGF2. 
7500SCM = expansion in serum-containing medium at 7500 cells/cm2. 
15000SCM = expansion in serum-containing medium at 15,000 cells/cm2. 
7500SFM+FGF2 = expansion in serum-free medium with FGF2 at 7500 cells/cm2. 
15000SFM+FGF2 = expansion in serum-free medium with FGF2 at 15,000 cells/cm2. 
 
Figure V-3A.  Gene expression after monolayer only. In the upper four frames, the expressions of 
four typical genes (aggrecan, versican, collagen type II and collagen type I) is shown, normalized to 
GAPDH.  In the lower frame, the ratios of differentiation, i.e. the expression of the ‘differentiated’ 
gene divided by the expression of the ‘dedifferentiated’ gene are plotted. The left y-axis represent the 
ratios of differentiation on the proteoglycan level (filled bars), whereas the right y-axis represent the 
ratios of differentiation on the collagen level (shaded bars). Averages ± SD of 3 donors are presented. 
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Figure V-3B  Gene expression after monolayer (Figure V-3A) and subsequent 
redifferentiation culture in vitro. In the upper four frames, the expressions of four typical genes 
(aggrecan, versican, collagen type II and collagen type I) is shown, normalized to GAPDH.  In the 
lower frame, the ratios of differentiation, i.e. the expression of the ‘differentiated’ gene divided by the 
expression of the ‘dedifferentiated’ gene are plotted. The left y-axis represent the ratios of 
differentiation on the proteoglycan level (filled bars), whereas the right y-axis represent the ratios of 
differentiation on the collagen level (shaded bars). Averages ± SD of 3 donors are presented. For 
further explanation see preceding Figure V-3A  
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Figure V-3C   Gene expression after monolayer and subsequent redifferentiation culture in vivo. In 
the upper four frames, the expressions of four typical genes (aggrecan, versican, collagen type II and 
collagen type I) is shown, normalized to GAPDH.  In the lower frame, the ratios of differentiation, i.e. 
the expression of the ‘differentiated’ gene divided by the expression of the ‘dedifferentiated’ gene are 
plotted. The left y-axis represent the ratios of differentiation on the proteoglycan level (filled bars), 
whereas the right y-axis represent the ratios of differentiation on the collagen level (shaded bars). 
Averages ± SD of 3 donors are presented. For further explanation see Figure V-3A page 58. 
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7500SCM = expansion in serum-containing medium at 7500 cells/cm2.  
15000SCM = expansion in serum-containing medium at 15,000 cells/cm2.  
7500SFM+FGF2 = expansion in serum-free medium with FGF2 at 7500 cells/cm2.  
15000SFM+FGF2 = expansion in serum-free medium with FGF2 at 15,000 cells/cm2. 
 
Figure V-4   The percentage of collagen type I and II positive chondrocytes on cytospins made 
from the in vitro suspension culture. Compared to expansion in serum-containing medium 
(SCM), the percentage of cells which were positive for collagen type I was significantly lower 
and for collagen type II significantly higher when chondrocytes had been expanded in a serum-
free medium with 100 ng/ml FGF2 (SFM+FGF2). Averages ± sd of three donors are presented. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7500SCM = expansion in serum-containing medium at 7500 cells/cm2.  
15000SCM = expansion in serum-containing medium at 15,000 cells/cm2.  
7500SFM+FGF2 = expansion in serum-free medium with FGF2 at 7500 cells/cm2.  
15000SFM+FGF2 = expansion in serum-free medium with FGF2 at 15,000 cells/cm2. 
 
Figure V-5   The amount of glycosaminoglycan (GAG) produced during the three 
weeks in vitro alginate culture. Averages ± SD of 3 donors are presented. No significant 
difference was found between the conditions used during expansion culture. 
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7500SCM = expansion in serum-containing medium at 7500 cells/cm2.  
15000SCM = expansion in serum-containing medium at 15,000 cells/cm2.  
7500SFM+FGF2 = expansion in serum-free medium with FGF2 at 7500 cells/cm2.  
15000SFM+FGF2 = expansion in serum-free medium with FGF2 at 15,000 cells/cm2. 
 
Figure V-6   The amount of glycosaminoglycan (GAG) per mg tissue for the alginate/DBM 
constructs, harvested 8 weeks after subcutaneous implantation in nude mice. Averages ± sd of 
constructs of 3 donors are presented. The star represents a statistical significant higher GAG/mg 
tissue in the constructs with chondrocytes expanded with SFM+FGF2 at 15,000 cells/cm2 
compared to constructs with chondrocytes expanded in SCM at 7500 cells/cm2. Due to an 
insufficient number of cells the condition ‘15000SCM’ was not included in the in vivo 
redifferentiation experiments. 
 
 
 
 
Figure V-7   Collagen type II staining on histological slices from the constructs 
harvested from the nude mice. A: Slice from a demineralized bone matrix core initially 
filled with chondrocytes solved in alginate after expansion  in serum-containing 
medium at 7500 cells/cm2. B: Slice from a demineralized bone matrix core initially 
filled with chondrocytes solved in alginate after expansion in serum-free medium with 
FGF2 at 15,000 cells/cm2. 
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Discussion 
Reducing chondrocyte dedifferentiation during monolayer culture offers a major 
challenge in cartilage tissue engineering. In the present study we found that 
expansion of chondrocytes in a defined SFM with a high concentration of FGF2 
reduced dedifferentiation and subsequently favored chondrogenic expression 
during in vitro or in vivo redifferentiation methods. Alongside, total cell yield 
after three passages in monolayer was significantly enhanced when SFM+FGF2 
had been used instead of SCM. This increase in cell yield could have 
underestimated the actions of FGF2 on the cellular phenotype, because the 
process of dedifferentiation during monolayer is enhanced by higher 
multiplication itself 115, 208, 211. We have anticipated this, as we expected a 
difference in cell yield between both media, by using two different seeding 
densities in monolayer. Total cell yield decreased by doubling the seeding 
density in the SFM+FGF2 condition, resulting in a non-significant difference in 
cell yield between expansion in SFM+FGF2 at 15,000 cells/cm2 and SCM at 
7500 cells/cm2. Comparison of the data of these two conditions is thus less 
influenced by differences in cell yield (Figure V-3A,B,C pages 58, 59 en 60 and 
Table V-1 page 56). 
Cellular phenotype was assessed by the ratios of mRNA’s of COL2/COL1 and 
AGC/VERS, termed ratios of differentiation. These ratios of differentiation have 
been demonstrated to decrease with time in monolayer culture 109,110. Our study 
shows that the ratios of COL2/COL1 and AGC/VERS are higher after monolayer 
culture with FGF2 than with 10% FCS. This is mainly due to the lower 
expression of collagen type I and versican. The possible mechanism for this is 
assumed as the result of reduction of the dedifferentiation process by FGF2. 
However, it is possible that it is due to differential effects of FGF2 on 
proliferation of selective populations in the primary cells, stimulating 
proliferation of the cells which express collagen type II or suppressing 
proliferation of the cells, which express collagen type I.  Independent of what the 
mechanism is, we conclude that the cells harvested after expansion in SFM+FGF 
medium have a less dedifferentiated phenotype. This is in contrast with previous 
studies by Jakob et al. and Martin et al. 73, 126, in which FGF2 was supplemented 
to a SCM. These studies showed that FGF2 increased proliferation but decreased 
gene expression ratios of COL2/COL1 and AGC/VERS during the first two 
passages in monolayer culture of human articular chondrocytes. Although 
expression of collagen type I was reduced by FGF2, which is similar to our 
results, the lower ratio COL2/COL1 must imply that expression of collagen type 
II was significantly downregulated as compared to SCM alone. It was 
hypothesized that FGF2 promoted the chondrocytes to dedifferentiate towards a 
more precursor-like state from which both the ability to multiply and to 
redifferentiate was enhanced, given the right stimuli. The discrepancy in 
expression patterns after monolayer culture between our study and the studies by 
Jakob et al. 73 and Martin et al. 126 may have several reasons. First, these authors 
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might not have accounted for the higher multiplication rates observed in the 
condition supplemented with FGF2, which could have increased dedifferentiation 
during monolayer culture. Furthermore, our experiments were performed with 
ear chondrocytes, which could respond differently to growth factors than 
articular chondrocytes. Finally, a serum-supplemented medium with only 5 ng/ml 
FGF2 was used, whereas our medium contained 20 times more growth factor and 
no serum.  
We conclude that the SFM+FGF2 influenced the chondrocytes in such ways that 
not only the phenotype at the end of the monolayer culture was improved, but 
that this effect was sustained during the in vitro alginate culture. In contrast, the 
local conditions in a subcutaneous pocket in a nude mouse and the period of 
8 weeks implantation were apparently sufficient to equalize differences in gene 
expressions we observed directly after the monolayer culture. However, gene 
expression data were only obtained at the end of monolayer culture and at 
harvesting of the neo-cartilage after 8 weeks subcutaneous implantation. Whether 
the differences in gene expression at the end of monolayer culture were equalized 
instantly after implantation or whether this was a more slowly process is thus not 
known. Data from the biochemical assays and histology suggest the latter option, 
as the neo-cartilage produced with SFM+FGF2 expanded chondrocytes 
contained more GAG and collagen type II.  
Next to genes coding for matrix proteins we also determined the expression of 
Sox9, which is a nuclear transcription factor. Sox9 is an important regulatory 
factor during the process of differentiation in growth plate chondrocytes, where it 
is linked to the collagen type II expression 11, 31, 100. In addition, ectopic Sox9 has 
been shown to upregulate collagen type II expression in culture-expanded, and 
hence dedifferentiated bovine articular chondrocytes 188. Also, in a recent study 
by Tew et al. human articular chondrocytes in monolayer culture were 
transducted with Sox9 and subsequently (further) passaged 192. In Sox9-
transducted chondrocytes the collagen type II expression was increased 
compared to controls. In addition, these chondrocytes also showed a sustained 
higher collagen type II expression during subsequent pellet cultures. 
Interestingly, Marukami et al. showed that FGF2 stimulated Sox9 expression in 
murine costal chondrocytes in culture 140. And ind0eed, our data showed that 
Sox9 gene expression was higher at the end of monolayer culture  when the 
SFM+FGF2 had been used. However, the higher ratio of differentiation on 
collagen level we found with SFM+FGF2 was not caused by a (significant) 
increase in collagen type II expression, but by a significantly lower expression of 
collagen type I. Therefore, a direct causal correlation between FGF2, Sox9 and 
collagen type II is not supported by our data.  Recently, Schmid et al. also found 
no correlation between Sox9 and collagen type II expression in normal and 
osteoarthritic cartilage and suggested that Sox9 is not the key mediator of 
collagen type II expression 218. In contrast to collagen type II, our results do 
suggest a relation between FGF2, Sox9 and aggrecan expression. A relation 
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between Sox9 and aggrecan expression was previously reported by several other 
authors 11, 177.  
In conclusion, this study provides several important observations. We provide 
evidence that a defined SFM with FGF2 both increases the cell yield and reduces 
the dedifferentiation of human ear chondrocytes during monolayer expansion 
culture compared to the classically SCM. This, together with the possibility to 
minimize the use of bovine serum during the tissue engineering process by using 
autologous serum for cell attachment, these positive effects of the SFM with 
100 ng/ml FGF2 on ear chondrocytes in monolayer culture is an important step 
forward in the process of cartilage tissue engineering. 
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ABSTRACT 
Tissue engineering of cartilage consists of two steps. Firstly the cells from a 
small biopsy of patient’s own tissue have to be multiplied. During this 
multiplication process they lose their cartilage phenotype. In the second step, 
these cells have to be stimulated to re-express their cartilage phenotype and 
produce cartilage matrix. Growth factors can be used to improve cell 
multiplication, redifferentiation and production of matrix. The choice of growth 
factors should be made for each phase of the Tissue Engineering process 
separately, taking into account cell phenotype and the presence of extracellular 
matrix. This paper demonstrates some examples of the use of growth factors to 
increase the amount, the quality and the assembly of the matrix components 
produced for cartilage tissue engineering. In addition it shows that the ‘culture 
history’ (e.g. addition of growth factors during cell multiplication or preculture 
period in a 3D environment) of the cells influences the effect of growth factor 
addition. The data demonstrate the potency as well as the limitations of the use of 
growth factors in cartilage tissue engineering. 
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INTRODUCTION 
The availability of extra cartilage to reconstruct defects in articular joints or 
cartilaginous structures in the head and neck area would be of great benefit. 
Therefore much effort is put into the generation of autologous (patient’s own) 
cartilage using tissue engineering techniques. Generally, tissue engineering 
involves a two step procedure (Figure VI-1 next page). First cells are isolated 
from a small biopsy of patient’s own cartilage and expanded in-vitro to obtain the 
cell number required. This process of cell expansion is routinely carried out in 
monolayer culture. During this culture the cells gradually lose their cartilage 
phenotype in a process called dedifferentiation 210. The second step in the tissue 
engineering process involves seeding of the expanded cells in a 3D carrier and 
implantation in the defect. An in-vitro culture period can be performed before 
implantation in-vivo to induce re-expression of the cartilaginous phenotype and 
to stimulate formation of functional extracellular matrix. The formation of 
functional extracellular matrix is of utmost importance for the success of the 
graft. The matrix provides the graft with adequate mechanical properties in order 
to withstand the forces it is subjected to in-vivo. Formation of functional matrix 
can be stimulated by the use of growth factors during tissue engineering process.  
 In-vivo, growth factors are synthesised within a variety of tissues, where they act 
on their cell of origin (autocrine) or on adjacent cells (paracrine). Certain growth 
factors are also present in systemic circulation, and the same factor may act both 
as a systemic and as a local regulator of tissue metabolism. Growth factors are 
important for the metabolism of chondrocytes. They are present in synovial fluid 
and reach the chondrocytes by diffusion. Furthermore, growth factors are 
produced by the chondrocytes themselves. The extracellular matrix of cartilage 
acts as a store of growth factors that can be released when needed. Various 
growth factors have been demonstrated to be able to affect chondrocyte 
multiplication, phenotype and extracellular matrix production and thus can be 
used during both steps of the tissue engineering process (Figure VI-1 next page). 
One has to realise however, that growth factors can influence extra-cellular 
matrix formation and cellular phenotype but that a certain growth factor can have 
different effects depending on the chondrocyte phenotype and the presence of 
extracellular matrix. During the cartilage tissue engineering process, both cellular 
phenotype and the extra-cellular matrix change (Figure VI-2 next page). Thus the 
choice of growth factors must be made for each stage of the tissue engineering 
process while taking into account the desired effect as well as the phenotype and 
presence of extracellular matrix of the cells. We here present a compilation of 
experiments demonstrating that growth factors can improve the quantity and 
quality of extracellular matrix components produced in a tissue engineering 
process. The data show that the effect of a growth factor depends on possible 
treatments in previous steps of the procedure. The results may help to recognise 
the potency as well as the limitations of the use of growth factors for cartilage 
tissue engineering. 
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Figure VI-1   Schematic overview of a cartilage tissue engineering process. First cells has to be 
isolated from a small biopsy of cartilage using enzymatic digestion of the matrix. The cells are 
expanded in monolayer culture and when sufficient cells are obtained the cells are seeded in a 
3 dimensional carrier (biomaterial). The construct can then be transplanted either directly or 
after in-vitro culture to induce redifferentiation and matrix production. 
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Differentiated chondrocytes 
No extracellular matrix 
 
 
Cell Expansion in monolayer 
Chondrocytes dedifferentiate = lose their phenotype 
 
 
3D culture in alginate 
Redifferentiation of chondrocytes 
Production of extracellular matrix 
Figure VI-2   The cellular phenotype and extracellular matrix during different stages of the cartilage 
tissue engineering process. 
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MATERIALS AND METHODS 
In this paper a compilation of experiments using different types of cartilage is 
presented. Adult bovine articular cartilage was obtained from 
metacarpophalangeal joint; Rabbit ear cartilage was prepared from 3 months old 
New Zealand White rabbits; Adult human articular cartilage was obtained post-
mortem from the femoral condyle of road victims without any previous history of 
joint diseases. Young human ear cartilage was obtained from children 
undergoing surgery for correction of protruding ears. 
In all experiments, cells were isolated from full-thickness cartilage using pronase 
and collagenase digestion. For multiplication they were cultured in monolayer for 
4 passages. To achieve matrix production the chondrocytes were seeded in 1.2% 
alginate (LV) and cultured for 3 weeks. The amount of GAG 
(GlycosAminoGlycan) was determined using dimethylmethylene blue (Farndale 
assay). The amount of DNA was determined using Hoechst 33258 in a 
fluorimetric assay. Immunohistochemistry was performed on cytospin 
preparations with antibodies against collagen type II (II-II6B3, Developmental 
Studies Hybridoma Bank), procollagen type I (m38; Developmental Studies 
Hybridoma Bank) and a membrane marker for fibroblasts (11-fibrau, Imgen 
distributed by ITK diagnostics, Uithoorn, the Netherlands). 
For some of the monolayer cultures rhFGF2 (Instruchemie, Hilversem, the 
Netherlands) was used. For cultures in alginate ITS+ (1:100; Becton Dickinson 
Labware, Bedford, MA), rhIGF1 (Roche Diagnostics, Mannheim, Germany) and 
rhTGFß-2 (R&D systems, Abingdon, UK) were used.  
 
 
RESULTS AND DISCUSSION 
Matrix production 
For production of cartilage matrix a three-dimensional environment is required. 
Culture in alginate gel is a generally accepted method. To further increase the 
production of extracellular matrix, growth factors can be added to medium with 
10% serum. IGF1 (Insulin-like growth factor 1) is described to be the major 
anabolic factor for cartilage. TGFß-2 (Transforming Growth Factor ß-2) has been 
found to be able to have both stimulating and inhibitory effects on cartilage. 
Addition of IGF1 or TGFß-2 (in a dose of 10 or 25 ng/ml) to freshly isolated, 
differentiated chondrocytes in alginate increases matrix production with ~50% 
197, 198. However, the data are of limited use for tissue engineering procedures 
because normally we use multiplied chondrocytes that have lost their phenotype 
in stead of freshly isolated, differentiated chondrocytes. When added to 
dedifferentiated chondrocytes, TGFß-2 stimulates GAG production even better 
than in differentiated cells (2.2x vs 1.6x; ) 198. However, it does not stimulate re-
expression of cartilage specific collagen type II.  
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Serum-free culture 
In the serum used for previous studies, many growth factors are present in 
variable and unknown concentrations. In addition, many inhibitors of growth 
factors are also present. It has been demonstrated that the presence of serum can 
influence the effect of growth factors 207. Therefore, the use of serum in 
experiments with growth factors creates a very badly defined system with results 
that are difficult to predict and reproduce. This is why we prefer a serum-free 
culture system for tissue engineering procedures, especially when growth factors 
are supplemented. When serum in our alginate culture experiments is replaced by 
10 ng/ml IGF1 and 10 ng/ml TGFß-2, production of collagen type II in 
dedifferentiated cells can be stimulated. This stimulation of redifferentiation in 
SFM (Serum-Free Medium) with IGF1 and TGFß-2 is shown for various types of 
chondrocytes (references for rabbit ear 201; rabbit nasal septum 196; human ear 201; 
human nasal septum 196; human articular 215), although the amount of stimulation 
was variable.  
 
Matrix assembly 
Besides the amount of matrix produced, the assembly of matrix components is 
also important for the functionality of the matrix. The extra-cellular matrix of 
cartilage is structured in a pericellular compartment (~1-2 µm surrounding the 
cell), a territorial matrix (~5 µm) and an interterritorial matrix. The alginate 
culture system offers the unique possibility to quantify the accumulation of 
matrix components in cell-associated compartment (which is believed to 
correspond to the pericellular and the territorial matrix) and further-removed 
compartment (believed to correspond to the interterritorial matrix) 53.  The cell-
associated matrix is in close contact with the cell and therefore largely influences 
cell behaviour. The interterritorial matrix is supposed to be most important for 
the gross mechanical properties of the cartilage. Addition of growth factors to 
medium with serum has been demonstrated to change the assembly of GAG. 
After addition of IGF1 to differentiated bovine articular chondrocytes in alginate 
relatively more of the produced GAG is laid down in the cell-associated matrix 
than in the further-removed matrix compartment. On the contrary, addition of 
TGFß-2 shifts the deposition of GAG from the cell-associated matrix more 
towards the further-removed matrix compartment 197. Furthermore, 
dedifferentiated chondrocytes cultured in alginate in medium with 10% serum 
divide the newly synthesised GAG differently over the two compartments than 
differentiated chondrocytes do; relatively more GAG is laid down in the cell-
associated matrix of dedifferentiated cells 119. This might be a way for the cell to 
keep its direct environment as optimal as possible. When serum is replaced by 
IGF1 and TGFß-2, the division of GAG over the two compartments by 
dedifferentiated cells is comparable with differentiated cells 119. This 
demonstrates that growth factors not only affect the production of matrix 
components, but also the assembly of these components in the matrix. 
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‘Culture history’ 
The effect of a growth factor not only depends on cellular phenotype but also in a 
more general way the ‘culture history’ of the cells before addition of a growth 
factor is important for the effect of this growth factor. This not only involves the 
difference between freshly isolated, differentiated cells and culture expanded, 
dedifferentiated cells, but also more subtle differences. For example, if cells are 
surrounded by extracellular matrix, the response of the cell to growth factor 
addition can be altered. This might be explained, for example, by an interaction 
between integrins and growth factor receptors 56, 179. In the experiments described 
above, growth factors were added starting from the moment the cells were 
cultured in alginate. Before the cells were seeded into alginate they were either 
freshly isolated from the cartilage tissue or multiplied in monolayer culture in 
medium with 10% serum. In another set of experiments we demonstrated that 
TGFß-2 stimulates matrix production when supplemented to alginate cultures 
immediately, but has no effect on matrix production when addition starts off for 
the first time after 3 weeks culture in alginate 198. This appears to be due to the 
presence of extracellular matrix surrounding the cell, produced during the 3 
weeks pre-culture in alginate. Removing this previously synthesised matrix, 
makes the cells again respond to TGFß-2 by increased matrix production.  
Besides the 3D culture history, the history in 2D monolayer can also influence 
the response to growth factors during alginate culture. Addition of FGF2 
(Fibroblast Growth Factor 2) in monolayer has been demonstrated to affect the 
capacity of the cells to re-express their phenotype 73, 127. We added 5 ng/ml FGF2 
to SCM (Serum-Containing Medium) for expansion of human articular 
chondrocytes. In the subsequent alginate culture, these cells have increased 
production of GAG and collagen II upon stimulation with IGF1 and TGFß-2, 
compared to cells expanded in medium with serum alone. Finally, the effect of 
IGF1 and TGFß-2 on GAG and collagen II production in alginate culture is 
identical for cells expanded in medium in which serum had been replaced by 
ITS+ and 100 ng/ml FGF2. This shows that ITS+ and FGF2 can imitate the effect 
of serum. However, next to evaluating chondrocyte phenotype using the most 
common determinants (GAG and collagen II) we have previously demonstrated 
the usefulness of additional markers, i.e. the anti-fibroblast marker 11-fibrau, that 
can be thought of as a dedifferentiation marker 200. The 11-fibrau antibody does 
not bind to differentiated chondrocytes and binding is increased with time in 
monolayer culture when cells dedifferentiate. 11-fibrau still binds to 
chondrocytes that have been expanded in medium with serum and subsequently 
‘redifferentiated’ in alginate in SFM with IGF1 and TGFß-2. This indicates that 
these cells, although expressing collagen type II, are not (yet) fully 
redifferentiated. However, when using a SFM with ITS+ and 100 ng/ml FGF2 to 
expand the chondrocytes, expression of fibroblast marker 11-fibrau is absent 
after alginate culture. This implicates that addition of FGF2 during expansion 
culture influences the response of cells to IGF1/TGFß-2 during alginate culture. 
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A relation between the group of FGF2, Sox9 and chondrocyte matrix production 
is suggested 31. Sox9 is a transcription factor, which is responsible for the 
differentiation of mesenchymal stem cells to chondrocytes. Also, Sox9 promotes 
upregulation of several chondrocyte-specific marker genes including the genes 
for collagen type II and aggrecan. FGF2, including FGF2, can enhance the 
expression of Sox9 and can alter the response of cells to other growth factors. 
 
Conclusion and future perspectives 
In summary, growth factors can be used in different phases of the tissue 
engineering process to stimulate the formation of a functional tissue to obtain 
better results for cartilage grafting procedures. The aim is to improve mechanical 
properties of the graft and of the interface between graft and adjacent cartilage. 
This is achieved by stimulating both the formation and proper assembly of matrix 
components. The optimal choice of growth factors will vary with time during the 
tissue engineering process and depends on the changing phenotype and presence 
of extracellular matrix components. This is a highly complex process. 
Until now all in-vitro experiments to evaluate the effect of growth factors are 
performed in free-floating (unloaded) cultures. This provides valuable 
information for the use of growth factors during such an in-vitro procedure. 
However, this does not necessarily mean that these growth factors will be 
valuable for in-vivo use in the joint, for example coupled on a biomaterial or in a 
gene delivery system. In the joint, the construct will be mechanically loaded. 
Although nothing is known about the effects of growth factors during 
simultaneous loading it is very likely that there will be some effects. This will be 
an important topic of future studies in our laboratory. 
 
 
Acknowledgements 
This work was partly funded by the Dutch Technology Foundation (STW), 
applied science division of NWO and the technology programme of the Ministry 
of Economic Affairs and partly by the Dutch Ministry of Economic Affairs in a 
grant of Senter (BTS 00021). 
 
  75
 
VII 
 
Considerations on the use of ear chondrocytes as 
donor chondrocytes for cartilage tissue engineering 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GJVM van Osch, EW Mandl, H Jahr, JLM Koevoet, 
 GJ Nolst-Trenité, JAN Verhaar 
 
Biorheology 2004; 41(3-4): 411-21 
 
Chapter VII 
 
 76
Abstract 
Articular cartilage is often used for research on cartilage tissue engineering. 
However, ear cartilage is easier to harvest, with less donor-site morbidity. The 
aim of this study was to evaluate whether adult human ear chondrocytes were 
capable of producing cartilage after expansion in monolayer culture.  
Cell yield per gram ear cartilage was twice as high as for articular cartilage. 
Moreover, ear chondrocytes proliferated faster. Cell proliferation could be further 
stimulated by the use of SFM (Serum-Free Medium) with FGF2 instead of 
medium with 10% serum. To evaluate the chondrogenic capacity, the multiplied 
chondrocytes were suspended in alginate and implanted subcutaneously in 
athymic mice. After 8 weeks the constructs demonstrated a proteoglycan-rich 
matrix that contained collagen type II. Constructs of ear chondrocytes showed a 
faint staining for elastin. Quantitative RT-PCR revealed that expression of 
collagen type II was 2-fold upregulated whereas expression of collagen type I 
was 2-fold down regulated in ear chondrocytes expanded in SFM with FGF2 
compared to SCM (Serum-Containing Medium). Expression of alkaline 
phosphatase and collagen type X were low indicating the absence of terminal 
differentiation.  
We conclude that ear chondrocytes can be used as donor chondrocytes for 
cartilage tissue engineering. Furthermore, it may proof to be a promising 
alternative cell source to engineer cartilage for articular repair. 
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Introduction 
Tissue engineering techniques might offer possibilities of restoring missing or 
damaged cartilage structures. Although significant progression has been made 
during the last decade, some major problems still have to be addressed before 
widespread clinical use can be expected. The chondrocytes, being the key factor 
of tissue engineering, will largely determine the quality of the engineered tissue. 
Thus the choice of donor cell source is of utmost importance. For clinical tissue 
engineering, an autologous cell source is a prerequisite, which will limit the risk 
of infection, disease transmission and potential immune rejection. Consequently, 
treatment of cartilage defects with tissue engineering techniques will most often 
be performed with donor tissue of mature origin, as cartilage defects are most 
commonly found in adult patients 17. However, compared to immature tissues, 
mature tissues are often characterised by lower cell yield and lower metabolism, 
which could have disadvantageous effects on the quality of the engineered repair 
tissue 3, 80, 134, 196. 
Cartilage itself represents the most obvious choice as autologous cell source. 
From the various cartilage subtypes existing in the body, articular cartilage is 
most frequently used for research on cartilage tissue engineering, although some 
experiments have been published on the use of nasal septum cartilage and ear 
cartilage 19, 20, 93, 201. However, articular cartilage as a donor cell source has some  
obvious disadvantages: it is frequently harvested from a diseased joint and 
harvesting itself may induce further degenerative changes in the joint. In this 
respect, ear cartilage has the advantages that it is healthy, easy to harvest and has 
little donor-site morbidity 50, 133, 144. However, ear cartilage is elastic cartilage and 
amongst other things differs from hyaline cartilage by the presence of elastin. It 
is our goal to investigate the possibility of using ear chondrocytes as donor 
source for reconstruction of articular cartilage. The aim of this study was to 
evaluate whether adult human ear chondrocytes were capable of producing 
cartilage after expansion in monolayer culture. The performance of human ear 
chondrocytes was compared to human articular chondrocytes using data of 
various experiments previously performed in our laboratory. Also, porcine 
chondrocytes were used to compare ear and articular chondrocytes from the same 
individual cultured at similar conditions. Furthermore, addition of FGF2 
(Fibroblast Growth Factor 2) during expansion culture has been demonstrated to 
support chondrogenic capacity of bone marrow stromal chondrocytes 128. 
Therefore, in this study the effect of addition of FGF2 during expansion on 
chondrogenic capacity of expanded ear chondrocytes after subcutaneous 
implantation in mice, is evaluated. 
Chapter VII 
 
 78
Materials & Methods 
Cell sources 
Adult human cartilage from the ear (three donors) obtained as leftover material 
from patients undergoing reconstructive surgery of the nose using ear cartilage, 
was used.   
For comparative studies on ear and articular cartilage, adult human cartilage from 
healthy knees was obtained from road victims (aged 19-40 years) and 
osteoarthritic knee cartilage was obtained from donors (aged 35-70 years) 
undergoing surgery for total knee replacement. For additional data on adult 
human cartilage from the ear, material was used that was obtained as left-over 
material from donors (aged 26-52 years) undergoing meatoplasty or 
reconstructive surgery on the nasal septum using ear cartilage. In addition we 
have used cartilage from healthy knees and ears of porcine origin 
(approxemately. 4 months old). 
 
Cell isolation 
Slices of  cartilage were washed with saline and subsequently incubated in 
Pronase E (Sigma, St Louis, MO, 2 mg/ml) for 2 hours at 37 °C and in 
Collagenase B (Boehringer Mannheim, Germany;1.5 mg/ml DMEM and 10% 
fetal calf serum) overnight. The next day cell suspensions were filtered through a 
100 µm filter, centrifuged and washed with saline  
 
Monolayer culture 
Adult human ear chondrocytes were seeded at 7500 chondrocytes/cm2 or 
15000 chondrocytes/cm2 and cultured in DMEM (Life Technologies, Breda, the 
Netherlands) with 50 µg/ml gentamycin and 0.5 µg/ml fungizone with either 
10% FCS (Fetal Calf Serum) or in a SFM (Serum-Free Medium) containing 
ITS+ (1:100, Becton Dickinson, Bedford, MA) and 100 ng/ml FGF2 
(Recombinant Human, Instruchemie, Hilversum, the Netherlands) (SFM+FGF2). 
Porcine chondrocytes were seeded at 7500 chondrocytes/cm2 and cultured in 
medium with 10% FCS. Human chondrocytes used for the additional data were 
seeded at a density of 40,000 chondrocytes/cm2 and cultured in medium with 
10% FCS. When chondrocytes reached confluency they were trypsinized with 
trypsin-EDTA (Life Technologies). 
 
Subcutaneous implantation in vivo 
The expanded chondrocytes were suspended in 1.8% alginate (LV, Keltone) at a 
concentration of 20 ·106 chondrocytes/ml 149. Constructs of approximately 3 mm 
height and 8 mm diameter were prepared by polymerisation of alginate in 
102 mM CaCl2 and implanted subcutaneously in athymic mice. This experiment 
was performed with cartilage of two healthy adult human knee donors, three 
adult human ear donors, one immature human ear donor and both ear and knee 
cartilage of one pig.  
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Animals were housed under sterile conditions at the Center for Animal Research. 
After eight weeks the animals were killed by cervical dislocation and the 
constructs were harvested. Animal experiments were approved by the University 
Ethics Committee and carried out as outlined in the University guidelines for the 
care and use of laboratory animals, which in general follows the NIH 'Guide for 
the care and use of laboratory animals'. 
 
Analyses 
%QPUVTWEVU CHVGT KPXKXQ KORNCPVCVKQP YGTG FKIGUVGF KP proteinase K solution 
(1 mg/ml Proteinase K; Boehringer Mannheim, Germany) overnight at 56 °C. 
6JGCOQWPVQH&0#KPVJGDGCFUYCUOGCUWTGFHNWQTQOGVTKECNN[WUKPI*QGEJUV
F[GWUKPIECNHVJ[OWU&0#
5KIOC5V.QWKU/1CUUVCPFCTF
6JG COQWPV QH )#) 
)N[EQU#OKPQ)N[ECP YCU SWCPVKHKGF
URGEVTQRJQVQOGVTKECNN[ D[ VJG CDUQTRVKQP TCVKQ ## WUKPI C OGVCEJTQOCVKE
TGCEVKQPQH)#)YKVJFKOGVJ[NOGVJ[NGPGDNWGYKVJEJQPFTQKVKPUWNHCVG%
5JCTM
5KIOC5V.QWKU/1CUCUVCPFCTF
 
Histology 
Evaluation of tissue engineered constructs after subcutaneous implantation in 
athymic mice was performed using paraffin sections. Sections were stained with 
thionin and immunohistochemically stained for collagen II (using mab II-II6B3, 
Developmental Studies Hybridoma Bank, University of Iowa, under contract 
N01-HD-6-2915) and elastin (using mab BA4, Sigma, St Louis MO). For 
procollagen type I (using mab M38, DSHB) and a fibroblast membrane marker 
(11-Fibrau, Imgen, distributed by ITK diagnostics, Uithoorn, the Netherlands) 
cryosections were prepared. For all immunohistochemical stainings the primary 
antibodies were coupled overnight to a secondary antibody directed against 
mouse, before incubation on the sections.  
 
Gene expression of expanded adult human ear chondrocytes after subcutaneous 
implantation 
Constructs were snap frozen in LiN2 and disrupted in a Microdismembrator-S 
(B. Braun Biotech International GmbH, Melsungen, Germany). Chondrocytes 
were then homogenized in RNABee, the RNA was isopropanol precipitated and 
purified using RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany). 
Quantities and purity of extracted total RNA were determined 
spectrophotometrically at 260/280 nm. Ratios between 1.7 and 2.0 indicated 
reasonable quality. 500 ng total RNA of each sample was reverse transcribed into 
cDNA using RevertAidTM. First Strand cDNA Synthesis Kit (MBI Fermentas, 
Germany).  
Primer and probes were designed using PrimerExpress1.5 software (Applied 
Biosystems, Foster City, CA, USA) Primer sets were first tested in reverse 
transcription PCR (RT-PCR). Real-time quantitative PCR analysis was 
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performed using the ABI 7700 Sequence Detection System (Applied Biosystems) 
with the following probes:  
 
Aggrecan:   5’-GGCTACCCCGACCCCTC-3’ (hAGC1_F),  
5’-TCCACAAAGTCTTCACCTCTGTGT-3’ (hAGC1_R),  
5’-TCCCGCTACGACGCCATCTGC-3’ (hAGC1_FAM);  
 
alkaline phosphatase:5’-GACCCTTGACCCCCACAAT-3’ (hALPL_F),  
5’-GCTCGTACTGCATGTCCCCT-3’ (hALPL_R),  
5’-TGGACTACCTATTGGGTCTCTTCGAGCCA-3’ 
(hALPL_FAM);  
 
elastin:   5’-AGCCGCTAAGGCAGCCA-3’ (hELN_F),  
5’-ACCAACTACTCCCGGGCC-3’ (hELN_R),  
5’-TATGGAGCTGCTGCAGGCTTAGTGCC-3’ 
(hELN_FAM);).  
 
The primer and probe nucleotide sequences, as well as assay concentrations, for 
collagen type I, collagen type II, collagen type X, versican, and GAPDH were 
adopted from 124 All Taqman assays were performed using qPCRTM Core Kit 
(Eurogentec Nederland B.V., Maastricht, Nederland B.V.) according to user’s 
manual. Per reaction, 300 pg of gene-specific cDNA (assuming 3% mRNA) was 
amplified in 40 cycles (15 sec at 95 °C, 1 min at 60 °C) after initially activating 
Taq DNA polymerase 10 min at 95 °C.  
The Ct value for each sample was defined as the cycle number in PCR at which 
the fluorescence intensity reached a value significantly above the background. 
The Ct value of the genes of interest was subtracted from the Ct value of  
GAPDH. The level of expression for each gene was then calculated as 2Ct’gapdh’-
Ct’gene of interest’ .  The efficiency of amplification of each set of primers and probes 
was always higher than 90%. 
 
 
Results 
Cell expansion in monolayer 
Adult human ear chondrocytes (four donors) cultured for 3-4 passages at 
relatively high seeding densities (40,000 chondrocytes/cm2) in medium with 10% 
FCS, showed 3.2 ± 1.6 times multiplication in 32 ± 10 days. Chondrocytes of 
healthy knees (three donors), expanded 1.3 ± 0.4 times in 42 ± 2 days, whereas 
chondrocytes of osteoarthritic knees (5 donors) expanded 5.1 ± 4.8 times in 
52 ± 13 days. In general, articular chondrocytes more often showed problems 
with cell attachment and sometimes suddenly ceased to grow at various time 
points in the monolayer culture.  
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Using animal experiments we can compare the capacities of ear and knee 
chondrocytes of the same animal to proliferate under exactly similar conditions. 
Seeded at 7500 chondrocytes/cm2 and cultured for 28 days in medium with 
10% FCS, porcine ear chondrocytes were passaged three times and yielded 
47 times multiplication, whereas knee chondrocytes were passaged only two 
times in 28 days and cell number increased only 13 times. 
Human ear chondrocyte seeded at high densities (40,000 chondrocytes/cm2) and 
cultured in SFM with FGF2 (SFM+FGF2), expanded similar to serum containing 
conditions 150. When lower seeding densities were used (either 
7500 chondrocytes/cm2 or 15,000 chondrocytes/cm2), expansion of human ear 
chondrocytes during four weeks was significantly increased. Furthermore, with 
lower seeding densities, the use of SFM+FGF2 further increased cell expansion 
on average four times compared to SCM (Serum-Containing Medium). When 
cultured in SFM+FGF2, initial cell number was expanded 150 times when 
chondrocytes seeded at a density of 7500 chondrocytes/cm2 whereas seeded at a 
density of 15,000 chondrocytes/cm2, cell number expanded 60 times.  
 
Comparison of cell yields from donor tissue 
Besides a better capacity to proliferate, the number of vital chondrocytes isolated 
per gram of healthy mature ear cartilage was higher than per gram of healthy 
mature articular cartilage. Average cell yield of human adult healthy ear cartilage 
(three donors) was 9.7 ± 0.8·106 chondrocytes/gram of tissue, but from human 
adult healthy knee cartilage (four donors) only 4.9 ± 1.4·106 chondrocytes/gram 
of tissue were obtained. We propose that 0.5 gram of ear cartilage can be easily 
harvested from a human ear with minimal cosmetic problems, from which 5·106 
donor chondrocytes can be routinely obtained for tissue engineering purposes. 
Previously we have calculated that a minimum of 50·106  chondrocytes 
(20·106 chondrocytes/cm3 is considered to be a minimum) is needed to repair an 
average defect of 5 cm2 and thickness of 5 mm. This implies that the amount of 
donor chondrocytes has to be expanded approximately 10 times. Expansion from 
a seeding density of 7500 chondrocytes/cm2 in medium with 10% FCS would 
take approximately 3 weeks to reach 10 times multiplication, whereas it would 
take approximately 2 weeks using SFM+FGF2, considering cell expansion rates 
we found in this study. 
 
Cartilage matrix production in constructs 
At harvesting after eight weeks subcutaneous implantation in athymic mice the 
constructs with human ear chondrocytes had a cartilage-like macroscopic 
appearance. On average, the constructs contained 20 µg GAG/mg wet weight, 
being half the amount present in native articular or nasal septum cartilage 168. To 
get a fair comparison, we compared chondrocytes that had been through a similar 
expansion. Chondrocytes expanded in monolayer at a seeding density of 
7500 chondrocytes/cm2 in SCM had a similar multiplication as chondrocytes 
Chapter VII 
 
 82
expanded from 15,000 chondrocytes/cm2 in SFM+FGF2. Chondrocytes that had 
been expanded in SFM+FGF2 produced 1.5 times more GAG per milligram 
tissue than constructs with chondrocytes expanded in SCM. On histology, 
abundant GAG was visible by thionin staining. Collagen type II was expressed in 
all graft. In constructs of chondrocytes expanded in SCM the expression of 
collagen type II was lower and appeared to be mainly associated with 
chondrocytes embedded in alginate (Figure VII-1A below). In the constructs of 
chondrocytes expanded in SFM+FGF2, expression occurred though out the 
construct (Figure VII-1B below) with exception of the capsule surrounding the 
construct. 
 
 
 
 
 
 
 
 
 
Figure VII-1   Immunohistochemical staining for collagen type II of constructs generated by 
human adult ear chondrocytes expanded in monolayer from seeding density of 
7500 chondrocytes/cm2 in medium with 10% FCS (A) and from seeding density of 
15000 chondrocytes/cm2 in serum-free medium with 100 ng/ml FGF2 (B). (Magnification 200x) 
 
 
Procollagen type I staining with antibody M38 was found in the capsule and in 
the dense, more fibrous-appearing tissue in the construct, but was absent in 
chondrocytes associated with alginate. Immunohistochemical staining for elastin 
was only faintly positive. However, differences could be found within and 
between the constructs. In general, dense more fibrous-appearing tissue between 
alginate remnants showed the most intense staining for elastin (Figure VII-2A 
next page). On locations were alginate was still present (showing by amorphous 
substance between the chondrocytes), hardly any staining was found when 
chondrocytes were expanded with SFM+FGF2 (Figure VII-2B next page), 
whereas chondrocytes expanded in SCM stained positive (Figure VII-2C next 
page). In contrast, construct of human articular chondrocytes were negative for 
elastin (Figure VII-2D next page).  
 
Gene expression was determined to evaluate cellular phenotype of the neo-
cartilage harvested from the athymic mice in more detail. In human ear 
chondrocytes expanded in SCM, expression of collagen type I was always higher 
than expression of collagen type II, resulting in an expression ratio of  
 
A B
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Figure VII-2   (A): Immunohistochemical staining for elastin, (B): Example of dense fibrous 
tissue from a construct generated by ear chondrocytes; (C): Ear chondrocytes still surrounded 
by alginate, that has been expanded in monolayer from seeding density of 
7500 chondrocytes/cm2 in medium with 10% FCS, (D): Ear chondrocytes still surrounded by 
alginate, that have been expanded in monolayer from seeding density of 
15000 chondrocytes/cm2 in serum-free medium with 100 ng/ml FGF2. (Magnification 400X) 
 
 
collagen type II to collagen type I of 0.39. Expression ratio of collagen type II to 
collagen type I was 1.9 for chondrocytes expanded in SFM+FGF2. Chondrocytes 
expanded in SFM+FGF2 actually expressed two times more collagen type II and 
two times less collagen type I than chondrocytes expanded in SCM. Expressions  
of collagen were 20-40 times as high as that of GAPDH. Elastin expression of 
chondrocytes expanded in SFM+FGF2 and SCM were similar. Expression of 
elastin was 5-10 times as high as that of GAPDH. Aggrecan and versican were 
not differently expressed in the different expansion media. Expression of 
chondrocyte hypertrophy markers, such as alkaline phosphatase and collagen 
type X, were low (Table VII-1 next page). 
With the porcine cartilage it was possible to harvest enough chondrocytes to 
study the behaviour of differentiated ear and knee chondrocytes in constructs. 
This enabled us to compare the performance of differentiated chondrocytes with 
that of chondrocytes, which were culture-expanded in monolayer before seeding 
in a construct. It appeared that differentiated (seeded immediately after isolation) 
ear chondrocytes produced more GAG than differentiated articular chondrocytes. 
However, in similar experiments with ear and articular chondrocytes that had 
been expanded in monolayer culture for 28 days, this difference was absent. It 
should be noted that the ear chondrocytes were expanded more (47 times) than  
the knee chondrocytes (13 times) and were therefore probably more 
dedifferentiated. 
 
A B
C D
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 AGC versican Col 1 Col 2 Eln 
7500SCM 1.38±0.10 0.05±0.01 57.99±19.12 22.83±7.68 10.48±4.94
7500SFM+FGF2 1.89±0.30 0.06±0.02 25.05±8.13 35.63±9.44 6.25±3.37 
15000SFM+FGF2 1.79±0.16 0.05±0.01 20.06±5.33 36.58±5.12 8.36±2.33 
 
 AGC= aggrecan;    Col 1=collagen type I  
 Col 2= collagen type II;   Eln=elastin. 
 Collagen type X and alkaline phosphatase were not demonstrated because gene   
 expression was at highest 0.001. 
 
Table VII-1   Expression of genes normalized for GAPDH (mean ± sd of chondrocytes from 
three donors) in constructs of human ear chondrocytes expanded in monolayer from seeding 
density of 7500 chondrocytes/cm2 in medium with 10% FCS and from seeding density of 
7500 chondrocytes/cm2  and 15,000 chondrocytes/cm2 in serum-free medium with 100 ng/ml 
FGF2. Data on chondrocytes expanded from15,000 chondrocytes/cm2 in SCM are missing 
because not enough chondrocytes were obtained to generate a construct. 
 
 
On histology, constructs generated from ear chondrocytes and constructs 
generated from articular chondrocytes were both positive for collagen type II 
(Figure VII-3 below). 
 
 
 
 
 
 
 
Figure VII-3   (A): Immunohistochemical staining for elastin in constructs generated from 
differentiated porcine ear chondrocytes, (B): and monolayer expanded porcine ear 
chondrocytes. (Magnification 400x) 
 
 
 Constructs made from previously expanded chondrocytes appeared less positive 
than constructs from differentiated chondrocytes. Constructs of ear chondrocytes 
demonstrated elastin, especially in the more fibrous-like areas, whereas these 
areas did not stain for elastin in constructs of articular chondrocytes. Constructs 
with expanded ear chondrocytes showed less elastin than those initially seeded 
with differentiated ear chondrocytes. Also these constructs with differentiated ear 
chondrocytes more often contained the typical ‘big’ chondrocytes which are 
characteristic for the central part of ear cartilage. 
A B
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Discussion 
It has been demonstrated that ear chondrocytes can be used to generate cartilage. 
However, these studies used immature cartilage, mostly from porcine origin and 
only rarely from human tissues. Furthermore, these studies were usually 
performed with primary, differentiated chondrocytes. However, in a clinical 
setting, the donor tissue most often used will be mature and, due to the limited 
amount of donor chondrocytes, the chondrocytes have to be culture-expanded. 
Our study showed that ear chondrocytes of adult human origin were able to 
multiply in monolayer culture. Even more, the cell yields after cultures were 
always higher compared to experiments with articular chondrocytes. A serious 
side effect of monolayer expansion culture is chondrocyte dedifferentiation. 
During expansion, chondrocytes change the expression pattern from the cartilage 
specific collagen type II and aggrecan towards less functional molecules like 
collagen type I and versican. The ability to re-express the differentiated 
phenotype is, besides the ability to multiply in vitro, a crucial prerequisite to be a 
suitable donor cell source for cartilage tissue engineering. To assess whether ear 
chondrocytes possessed this ability, we subcutaneously implanted culture- 
expanded human ear chondrocytes in nude mice. Subsequent histology revealed 
cartilage–like tissue that was highly positive for collagen type II and GAG. 
Recently, Kafienah et al. 79 compared the capacity of chondrocytes from articular 
cartilage and nasal septum cartilage and concluded that human adult nasal 
chondrocytes proliferate approximately four times faster than human articular 
chondrocytes in monolayer culture. Evenmore, they possessed a markedly higher 
chondrogenic capacity, as assessed by the mRNA and protein analysis of in vitro-
engineered constructs. Our study, together with the study by Kafienah et al.79,  
clearly show a growing interest, as well as the possibilities, for the use of 
alternative cartilage types as donor tissue for articular cartilage engineering. We 
hypothesise that chondrocytes exhibit certain plasticity in the expression of their 
phenotype, which means that ear chondrocytes could be persuaded to express a 
more hyaline-like phenotype. Local environmental factors within a joint might 
provide the necessary stimuli to accomplish this. Whether ear chondrocytes can 
respond to these stimuli is not known. Furthermore, as mechanical loading is not 
physiological for ear chondrocytes it remains questionable whether these 
chondrocytes and its produced extracellular matrix can prevail itself within a 
joint. In pilot experiments we found that immature bovine ear chondrocytes 
seeded in agarose discs remained vital after four consecutive days of 5-10% 
cyclic compression. In future experiments we will investigate whether ear 
chondrocytes subjected to a mechanical stimulus will produce a more hyaline-
like matrix. So far, no data on mechanical loading of ear cartilage or ear 
chondrocytes seeded in a biomaterial are present in literature. 
Obviously, the ultimate test to assess the feasibility of using ear chondrocytes for 
articular cartilage repair would be the implantation of dedifferentiated ear 
chondrocytes in an articular cartilage defect. Again, no data are found in 
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literature. However, in reconstructive surgery of the nose, ear cartilage 
transplants have been used with success for many years to repair nasal septum 
defects, which is in fact hyaline cartilage. In a study on the fate of the implanted 
ear cartilage within the nasal septum, Min et al. 217 showed that hyaline-like neo-
cartilage was formed after 4 weeks from within the transplanted ear cartilage. In 
our opinion, this study might represent an example on how local environmental 
factors can alter cellular phenotype.  
A repair tissue that exactly resembles the native tissue might not be obligatory 
for a functional cartilage repair. In other words, cartilage repair is not similar to 
cartilage regeneration. Therefore, a sustained expression of elastin might be of 
less importance. Mechanical characteristics similar to the native tissue and good 
integrative capacities could be more important. Data on the mechanical 
characteristics of cartilage generated by ear chondrocytes are lacking and even 
data on mechanical characteristics of native ear cartilage are scarce. In 
experiments comparing characteristics of the different cartilage subtypes in 
rabbits, Naumann et al. 142 found that the aggregate modulus of ear cartilage was 
higher and the permeability was lower than that of articular cartilage. In our 
experiments we did not assess the mechanical characteristics of the neo-cartilage 
engineered with adult human ear chondrocytes.  
Summarising, in this paper we combined data from previous experiments in our 
laboratory with articular and ear chondrocytes as donor chondrocytes for 
cartilage tissue engineering. We found that both the cell yield of the donor tissue 
and monolayer expansion culture favoured the use of ear chondrocytes. Cell yield 
and performance could further be increased by the use of SFM with 100 ng/ml 
FGF2 for the expansion culture in monolayer. Furthermore, we speculated on the 
use of ear chondrocytes to engineer repair tissue for articular cartilage defects. To 
make more solid statements on this issue, the mechanical properties of 
engineered cartilage with ear chondrocytes should be assessed in future. 
Furthermore, experiments in which culture expanded ear chondrocytes, seeded 
onto a scaffold, are implanted in articular cartilage defects will be performed. 
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Abstract 
Mechanical loading of cell-seeded scaffolds could prove to be an important 
factor in cartilage tissue engineering. However, for this purpose, long-term 
loading experiments on chondrocytes are required. In this study we investigated 
the effects of preculture and subsequent pericellular matrix formation on the 
synthesis of proteoglycans by chondrocytes and the chondrocyte deformation as 
a response to mechanical loading. Agarose discs seeded with bovine 
chondrocytes were dynamically loaded in an unconfined set-up at 0.5 Hz with 
10% peak strain for 90 minutes twice a day, for a period of four days. When no 
preculture was performed, the dynamic compression significantly increased GAG 
content by 34% compared to control. However, starting the loading regime after 
four days of preculture did not result in an increase in GAG content. Using 
confocal laser-scanning microscopy, chondrocyte deformation during an applied 
static 10% mechanical gel-deformation was measured in the agarose discs 
cultures with and without preculture. The precultured chondrocytes showed 
significantly reduced cell-deformation. We conjecture that this reduction in cell 
deformation is due to pericellular matrix formation in the precultured conditions, 
which was demonstrated by histology. The produced pericellular matrix stiffens 
the cell-matrix complex and consequently protects the cell from deformation. By 
extrapolating the results from the confocal microscopy experiments to the 
dynamic loading experiments, we hypothesise that the reduction in cell-
deformation in the precultured agarose discs largely explains the lack of increase 
in proteoglycan production during the dynamic loading regime. 
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Introduction 
Mechanical loading is a key regulatory factor in cartilage homeostasis and may 
influence the development of a functional tissue during tissue engineered repair 
22, 85, 169. However, tissue engineering of cartilage is almost always performed in 
vitro, without physiological mechanical stresses and loads. Accordingly, the 
introduction of mechanical conditioning into the tissue engineering process could 
enhance the ultimate quality of the repair tissue. 
Many studies have shown effects of in vitro loading on cartilage explants. In 
general, static mechanical loading resulted in a decrease of chondrocyte 
metabolism 22-24, 30, 48, 66, 92, 97, 169, whereas dynamic mechanical loading with 
certain loading regimes enhanced chondrocyte metabolism or extracellular matrix 
production 23, 25, 92, 97, 130, 150, 185-187. The majority of these experiments were short-
term, using either gene expression levels or incorporation of radioactive labels 
into the matrix as an outcome measure of the effects of dynamic compression. To 
date, few studies have focussed on long-term loading experiments and on its 
effects on extracellular matrix content and mechanical characteristics of the cell-
seeded scaffolds 130, 131. During long-term loading experiments several factors 
may become significant which are of limited consequence during short-term 
loading experiments, complicating such experiments. Firstly, introducing cell-
seeded scaffolds into a loading device involving fluid-impermeable indentors 
results in a reduction in area available for medium diffusion, by means of placing 
indentors on top of the constructs. The subsequent retardation of 
nutrient/metabolite transport could be inhibitory for appropriate extracellular 
matrix production. Secondly, in long-term loading experiments the production of 
extracellular matrix may influence the metabolic response to loading, as it has 
been shown that the elaborated matrix can influence the cell-deformation 49, 87. 
To explore the effects of dynamic compression in cartilage tissue engineering, 
the authors have utilised a custom-designed loading device in which cell-seeded 
constructs can be placed under separate indentors. In the present study we report 
on the effects of dynamic compression applied for four consecutive days to 
bovine chondrocyte-seeded agarose gels, starting at time 0 or after 4 days of free-
swelling culture.  
 
 
Materials and Methods 
Chondrocyte Isolation 
Articular chondrocytes were isolated from the metacarpalphalangeal joints of 6-7 
months old calves. Within 4 hours after slaughter slices of cartilage were 
harvested and washed three times in physiological saline. The cartilage was 
digested by incubation in 2 mg/ml pronase (Sigma, St Louis, Mo) in 
physiological saline for 1.5 hours, followed by overnight incubation in 2 mg/ml 
collagenase B (Boehringer Mannheim, Germany) in Dulbecco’s modified eagle 
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medium (Life Technologies, Breda, the Netherlands; Glutamax-I) with 10% FCS 
(Fetal Calf Serum). The released chondrocytes were subsequently washed and 
cell viability was determined using trypan blue staining. More than 95% of the 
chondrocytes were viable. For each experiment isolated chondrocytes from three 
different joints were pooled.  
 
Agarose suspension 
Agarose (type VII, low melting point, Sigma) was added to PBS at a 
concentration of 6% (w/v) and sterilised using heating to 120 oC. The sterile 
agarose gel was cooled to 37 oC and a suspension of chondrocytes in DMEM + 
10% FCS was added, to yield a final concentration of 3% agarose with 
4·106 cells/ml. The agarose/chondrocyte suspension was transferred into a 
petridish and was incubated for 15 minutes at 4 oC. Cores were punched out of 
the gel using a biopsy punch, thus creating cell-seeded agarose discs of 8 mm in 
diameter and 3.0-3.4 mm in height. 
 
The loading device 
A loading device was designed and custom-built. Briefly, below a central air 
cylinder four (edge-welded) bellows (Hositrad Holland bv, Hoevelaken, The 
Netherlands) were mounted, permitting four cell-seeded agarose discs to be 
simultaneously subjected to dynamic loading during an experiment. A linear 
voltage displacement transducer (LVDT) was placed within each of the bellows. 
Changing the air pressure within the cylinder resulted in a displacement of the 
bellows, which was measured by the LVDT’s. A computer-controlled air valve 
regulated the air pressure within the cylinder, which was measured by a pressure 
transducer (AE Sensors, Dordrecht, The Netherlands). Labview software was 
used to control the air valve and to acquire the output of the four LVDT’s and the 
pressure transducer to a prescribed frequency and amplitude. 
To transduce the displacement from the bellows onto the agarose discs indentors 
were used, which were placed on top of the cell-seeded agarose gels and were 
guided by a custom-made cover-plate that fitted a 24-wells plate (Figure VIII-1 
next page). Accordingly, no lift-off was possible between the indentor and the 
agarose gel. During dynamic compression, the lift-off occurred between the 
bellow and the indentor (Figure VIII-1 next page). The indentors were 
manufactured from unfilled PEEK (PolyEtherEtherKetone) and had a weight of 
less than 1 gram per indentor. Negative effects of the PEEK on cell viability and 
GAG (GlycosAminoGlycan) production were ruled out in pilot experiments 
testing the feasibility to use this material in direct vicinity of cell-seeded agarose 
discs (data not shown). The indentors were 1 mm less in diameter than the wells, 
resulting in an unconfined set-up (Figure VIII-1 next page).  
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Figure VIII-1   A schematic overview of the set-up below the loading device. On top of the 
cell-seeded agarose disc a PEEK indentor was placed, which was guided by a macrolon cover 
plate that fitted a 24-wells plate. The indentor was displaced by the bellow of the loading 
device. 
 
 
Loading protocols 
A methodology involving two experimental groups was adopted, as outlined in 
Figure VIII-2 next page. In group I the loading regime was initiated two hours 
after the cell-seeded agarose discs were produced. The loading regime consisted 
of 90 minutes dynamic compression twice a day, with an one-hour break in 
between, for four consecutive days. The dynamic compression was applied with 
a sinusoidal waveform at frequency of 0.5 Hz and with an initial peak strain and 
dynamic strain of 10%. However, the actual displacement of the agarose discs 
resembled a mixture of a sinusoidal and a block-wave (Figure VIII-3 page 93). 
And due to incomplete gel-height recovery during dynamic compression, 
associated with the viscoelastic properties of the agarose, the actual dynamic 
strain on the cell-seeded agarose gels was between 5-10%, whereas the peak 
strain (measured from the initial gel-height) was not allowed to be higher than 
10% (Figure VIII-3 page 93). After four days the medium was changed (1 ml per 
disc) and the cell seeded-agarose gels were cultured for an additional three days 
in a free swelling state before harvesting. In group II, the cell-seeded agarose 
discs were cultured in a free swelling state for four days prior to initiation of the 
same loading regime as in group I. Therefore, total time in culture for cell-seeded 
agarose discs in group II was 11 days. The medium used during the experiments consisted 
of DMEM with 10% FCS and 25 µg/ml L-ascorbic acid. Two control conditions were 
employed (figure 2); one group of discs were maintained with the indentor on top 
within the loading device, but without superimposing dynamic compression, and 
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a second control group of cell-seeded agarose discs were cultured throughout in a 
free swelling state. Experiment I was performed with a total of 12 constructs per 
condition, whereas experiment II was performed with 8 constructs per condition. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure VIII-2   A schematic overview of the experiments.  
Group I: Dynamic compression, in which cell-seeded agarose gels were dynamically 
compressed at 0.5 Hz, with 5-10% peak strain, for two times 90 minutes per day. The loading 
regime was started two hours after the cell-seeded agarose discs were made and lasted four 
days. After four days the agarose gels were cultured ‘free swelling’ for an additional three days 
before harvesting. Two control conditions were made: (1) Indentor only, in which cell-seeded 
agarose discs were cultured for 4 days inside the compression device and with an indentor on 
top, but without superimposing dynamic compression. After four days the agarose gels were 
cultured ‘free swelling’ for an additional three days before harvesting. (2) Free Swelling control, 
in which cell-seeded agarose discs were cultured in a ‘free swelling’ state during the 7 days the 
experiments lasted.  
Group II: In these experiments the cell-seeded agarose discs were cultured in a free swelling 
state for four days before similar experiments as in group I were performed. As a result, the total 
duration of the experiments in group II lasted 11 days.during the experiments consisted of 
DMEM with 10% FCS and 25 µg/ml L-ascorbic acid.  
Two control conditions were employed; one group of discs were maintained with the indentor 
on top within the loading device, but without superimposing dynamic compression, and a 
second control group of cell-seeded agarose discs were cultured throughout in a free swelling 
state. Experiment I was performed with a total of 12 constructs per condition, whereas 
experiment II was performed with 8 constructs per condition. 
Fig. 2 
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Figure VIII-3   The dynamic deformation of an agarose gel of 3 mm height in time is shown for 
an initial peak strain 0.1 (=10%). During dynamic compression for 90 minutes at 0.5 Hz typical 
curves of gel deformation with an interval of 15 minutes are plotted (the actual interval of 
unloading during each cycle is not plotted). Note that from t = 0 to t = 90 the initial gel height 
and the dynamic amplitude decreases. A trend-line is plotted to underscore the decrease in 
dynamic amplitude. 
 
 
Live/dead staining 
Calcein AM and ethidium homodimer-1 (live/dead viability/cytotoxicity kit (l-
3224), Molecular Probes, Leiden, the Netherlands) were used to assess cell 
viability 24 hours after casting of the gel and at harvesting of the cell-seeded 
agarose discs. A cylindrical specimen, 2 mm in diameter, was cored out of the 
middle of each disc and washed in physiological saline before incubation in 
DMEM supplemented with 5 µM each of Calcein AM and ethidium homodimer-
1 for 45 minutes at 37 oC. The percentage of dead cells was assessed from a 
random selection of 300 cells from three separate specimens. 
 
Biochemical assays 
The samples were digested using the protocol previously described by Knight et 
al. 86. Briefly, the samples were incubated at 70 oC with L-cysteine hydrochloride 
and EDTA until molten. The samples were cooled to 40 oC before agarase 
(10 IE/ml, Sigma) and papain (2.8 IE/ml, Sigma) were added for incubation at 
40 oC overnight. The total content of DNA per sample was assessed using a 
fluorimetric assay based on the Hoechst 33258 dye as previously described 
(Chapter III, materials and methods). GAG content was measured using the 
dimethylmethylene blue assay 40. Using a microplate reader the ratio of 
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absorption at 540 nm and absorption at 595 nm was measured. The amount of 
GAG was calculated using a standard of chondroitin sulfate C (shark; Sigma). 
 
Histology 
Cell-seeded agarose discs were removed from culture at time 0 and after 4 or 8 
days of free swelling culture and fixed in formalin and embedded in paraffin. 
Sections, 5 µm in thickness, were prepared and stained with thionin according to 
Bulstra et al. 21. For collagen type II staining, the sections were incubated with 
1 mg/ml pronase and subsequently with 1% hyaluronidase. Next, normal goat 
serum was added followed by incubation with monoclonal antibodies against 
collagen type II (1:100 II-II6B3; Developmental Studies Hybridoma Bank) for 
two hours. Anti-mouse Fab-fragments conjugated with alkaline phosphatase 
(GAMAP; Immunotech, Marseille, France, 1:100) were added and detected with 
mouse monoclonal alkaline phosphate anti-alkaline phosphatase (APAAP; 
Dakopatts, Copenhagen, Denmark; 1:100). Freshly prepared neo-fuchsin 
substrate was used to achieve a positive staining for collagen type II. 
 
Confocal Microscopy 
Cell deformation at different time-points was measured using confocal 
microscopy. At time points 0, 4 and 8 days cell-seeded agarose gels, cultured in 
free-swelling conditions were cut longitudinally into half-cores and incubated 
with 10 µM Calcein-AM in DMEM+10% FCS for 45 minutes at 37 0C. 
Constructs were then mounted in a specially designed loading rig, based on that 
described by Knight et al. 86. The rig was placed on the stage of an inverted 
microscope, which was coupled to a confocal laser-scanning microscope (LSM 
410, Zeiss, Germany). Viable, calcein labelled cells were visualised using laser 
excitation at a wavelength of 488 nm and fluorescence detection at wavelengths 
of 500 nm and higher. Confocal images of individual cells were taken in the 
central region of the construct, using a 40x/0.95 objective, 8x confocal zoom and 
a confocal slit of 20 microns, resulting in images with a pixel-size of 
0.078 microns. 
For each construct approx. 6 individual cells were imaged in the unstrained state. 
The position of the centre of the cell was selected by adjusting the position of the 
focal plane during real time confocal imaging. A 10% uniaxial compressive 
strain was then applied to the construct at a strain rate of 10 %.s-1, by means of a 
plunger, which was driven by a computer controlled stepping linear actuator with 
a step size of 2.5 microns. For each sample 12 cells were imaged 8-10 minutes 
following loading. At each time-point this procedure was repeated for 3 samples. 
Ellipsoid morphology of the chondrocytes was analysed from the confocal 
images measuring the X/Y-diameter ratio of a best fitting ellipsoid (Matlab, The 
Mathworks Inc., USA). From the resulting diameter ratio’s the X-strain was 
calculated using the formula previously described 88, which is based on the 
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assumption that no change in cell-volume occurs, as has been demonstrated 
previously for isolated gels in agarose 98. 
 
Assessment of molecular diffusion 
Cell-free agarose discs were prepared using the methodology described above. 
The discs were incubated for 15 minutes in a solution containing trypan blue in 
free-swelling conditions or within the loading device, with or without the 
application of dynamic compression at 0.5 Hz. At the end of the incubation 
period the discs were removed and molecular diffusion was assessed 
qualitatively by observation of the extent of staining across the disc. 
 
Data Analysis 
Results from the biochemical assays on GAG, DNA and the live/dead staining 
were analysed using the Mann-Whitney U test. For the results from the confocal 
laser the student’s T test was used. A p-value less than 0.05 was considered to 
show a significant difference. 
 
 
Results 
The application of dynamic compression at 0.5 Hz to cell-seeded agarose discs 
without preculture (group I) induced a significant increase in GAG content of 
34% compared to the ‘indentor-only’ control group (p = 0.015, Figure VIII-4 
next page). 
However, when a 4 days preculture was employed prior to application of 
dynamic compression (group II), dynamic compression did not alter GAG 
content compared to the ‘indentor-only’ control (p = 0.6, Figure VIII-5 next 
page. In all cases GAG content was highest in the free swelling group compared 
to the other experimental conditions (p < 0.01). In group I, the live/dead staining 
demonstrated that the lowest percentage of non-viable cells were present in the 
free swelling conditions (average = 5%, SD = 0.5%) . The percentage of non-
viable cells was similar in both the dynamic compression condition and the 
‘indentor-only’ control (average = ± SD respectively 10% ± 0.5% and 9% ± 1%). 
Although the live/dead staining in group II showed a similar pattern to group I, 
the percentage of non-viable cells was higher in both the dynamic compression 
condition and the ‘indentor-only’ control compared to group I (average ± SD 
respectively 26% ± 14% and 16% ± 6%). Interestingly, DNA content was not 
significantly different between experimental conditions in both group I and II 
(data not shown). Representative micrographs, prepared from histological 
sections of cell-seeded agarose discs fixed at t=0 and after 4 or 8 days of free-
swelling culture are presented in Figure VIII-6 page 97. The data demonstrate 
that at t=0 no extracellular matrix was present. After four and eight days of free 
swelling culture an increasing amount of extracellular matrix, which stained for  
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.  * = sign for a statistical significant difference to the ‘indentor-only’ control. 
 
Figure VIII-4   The average amount of GAG per disc is shown for the experiments in group I. 
Dynamic compression significantly increased GAG production in the dynamically loaded 
agarose discs compared to the ‘indentor-only’ control. Free swelling cultures contained most 
GAG.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure VIII-5   The average amount of GAG per disc is shown for the experiments in group II. 
No difference in GAG production was observed between the dynamically loaded agarose discs 
and discs from the ‘indentor-only’ control. The most left bar represents the GAG content of the 
agarose discs at the start of the loading regime, which was after four days of free swelling 
culture. * = sign for a statistical significant difference to the ‘indentor-only’ control. 
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Figure VIII-6   Stainings on free swelling cultured cell-seeded agarose discs. The top three 
photos (A,B,C) represent the thionin staining on glycosaminoglycan at day 0, day 4 and day 8 
respectively. The bottom three photos (D,E,F) represent the staining for collagen type II at the 
same time points and maginifaction. 
 
 
both proteoglycans and collagen type II, was evident, primarily concentrated in 
the pericellular region (Figure VIII-6 above). Data from experiments to 
determine cell deformation in discs at t=0 and after 4 or 8 days of free-swelling 
culture are presented in Table VIII-1 below. The application of 10% strain to 
cell-seeded agarose discs at t=0 resulted in an mean cell deformation index (X-
axis/Y-axis) of 0.85. Following free-swelling culture for 4 or 8 days mean values 
for cell deformation index has increased to 0.92 and 0.96 respectively. These cell 
deformation indices corresponded to a cell-strain of 10.6% at t = 0 days, 5.4% at 
t = 4 days and 2.9% at t = 8 days, based an assumption of maintenance of cell 
volume during the application of strain. 
 
 
 Unstrained T=0 strained T=4 strained T=8 strained 
Cell Deformation index  1.01±0.07 0.85±0.05 * 0.92±0.04 *, # 0.96±0.04 *, # 
Cell Strain in % 0.77±4.7 10.6±3.7 * 5.4±3.6 *, # 2.9±3.0 *, # 
 
 * = sign for a statistical significant difference compared to unstrained agarose. 
 # = sign for a statistical significant difference compared to the previous time point in  
       strained agarose.  
 
TableVIII-1   The results of confocal microscopy experiments to assess the cell deformation in 
10% strained cell-seeded agarose discs at time points representing the dynamical loading 
experiments. The average value ± SD are given. The agarose discs had been cultured in a free 
swelling condition  
A B C
D E F
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Representative images of cell free discs, incubated for 15 minutes in a solution 
containing trypan blue under free-swelling conditions or within the loading 
device, with or without the application of dynamic compression at 0.5 Hz are 
presented in Figure VIII-7 below. The trypan blue, a molecule of approximately 
1 kDa was observed to diffuse throughout the agarose disc in the free swelling 
condition after 15 minutes. However, for both the dynamically compressed disc 
and the disc from the ‘indentor-only’ control the only available area for diffusion 
was via the outer ring of the gel. This was clearly shown by the fact that the dye 
only stained a 2 mm thick ring at the periphery of the gel. No enhanced dye 
distribution towards the centre of the gel was observed in the dynamically 
compressed (for 15 minutes) discs.  
 
 
 
 
 
 
   
 
Figure VIII-7   Agarose discs were cultured for 15 minutes in trypan blue to show the effects of 
introducing cell-seeded agarose discs into a loading device on the area available for medium 
diffusion. The disc in the free swelling culture was thoroughly stained within 15 minutes, 
whereas the discs in the loading device showed staining only in the peripheral ring. 
Superimposing dynamic compression did not result in better staining (comparing the ‘indentor-
only’ control with the dynamic compression). 
 
 
Discussion 
The relative absence of studies describing the effect of long-term loading on 
chondrocyte-seeded constructs compared to the enormous pool of published data 
on short-term loading effects reflects, in our opinion, the complexity of long term 
in vitro loading of cell-seeded scaffolds. Dynamic compression of cartilage, cell-
seeded scaffolds and cell-seeded hydrogels typically results in cell deformation 
and alterations in fluid pressure, fluid flows and electrochemical flows 47, 139. 
These effects, individually or in combination may mediate alterations in 
metabolic cell response. For example, it has been suggested that for dynamic 
compression at higher frequencies than 0.1 Hz and strains up to 10% the increase 
in matrix production is related to changes in cell shape and/or fluid flows 84.  
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However, introducing cell-seeded constructs into a loading device may impose 
constraints on the construct that could influence cell activity in the absence of 
loading. For example, the configurations used in the majority of loading systems 
reduce the area available for medium diffusion, due to the presence of a fluid-
impermeable indentor, which is placed on top of the constructs. It may be 
estimated that approximately 70% of the total surface are of the discs, 
representing the upper surface and peripheral surface, is available for free 
diffusion in the free swelling condition. By contrast less than 45% of the total 
surface area is available for free diffusion when the discs are mounted into the 
loading system. Indeed, qualitative analysis of molecular diffusion confirmed 
that the diffusion was impaired in the ‘indentor-only’ and ‘dynamic loading’ 
conditions, as compared to the free swelling cultures (Figure VIII-7 previous 
page). This major reduction in area available for medium diffusion is likely to be 
responsible for the significantly lower GAG content in the ‘indentor-only’ and 
‘dynamic loading’ conditions, as compared to the free swelling cultures, 
measured after 7 and 11 day protocols associated with groups I and II 
respectively. 
The loading systems used in a number of previous studies may induce alterations 
in the surface area available for diffusion, due to lift-off of the indentor from the 
construct during a proportion of the loading cycle. This phenomenon is related to 
the viscoelastic nature of hydrogels such as agarose. The system used in the 
current study overcomes this problem by ensuring that the indentor remains in 
contact with the agarose disc throughout the loading cycle. Lift-off occurs 
between the indentor and the bellows. Accordingly, alterations in metabolic 
response between ‘dynamic loading’ and ‘indentor-only’ conditions may not be 
attributed to alterations in basic diffusion profiles. It should be acknowledged, 
however, that the dynamic loading may alter the uptake of biomolecules through 
loading-induced fluid flow. No alteration in the pattern of uptake of trypan blue 
was observed, qualitatively, in this study on application of dynamic compression, 
although previous studies have reported that the uptake of radiolabelled 
thymidine and proline was enhanced by dynamic compression 97.  
In this study, an increase in GAG content was observed in response to dynamic 
compression when no preculture was performed prior to initiation of the loading 
regime. When the agarose discs were cultured for four days before the loading 
experiments started, no effect of dynamic compression on GAG production was 
observed. Biochemical analysis indicated a significant increase of GAG content 
with time in culture. Therefore, it is likely that the presence or absence of 
extracellular matrix played a crucial role in mediating mechanotransduction 
processes. To examine this effect further histological sections were prepared 
from the cell-seeded agarose discs at different time points and demonstrated 
formation of extracellular matrix, which was mainly concentrated in the 
pericellular region. In previous experiments by Knight et al. 87, the elaborate 
matrix was shown to decrease the cell deformation from day 1 to day 6 at 20% 
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gel compression. However, in the current study a maximum peak strain of 10% 
was used. Accordingly, cell deformation experiments were performed with 
parameters that replicated the loading regime adopted, to allow correlation 
between the results of the confocal experiments and dynamic compression 
experiments. A significant decrease in cell deformation was observed from 
t = 0 days to t = 4 days and a further decrease was apparent between days 4 
and 8. These data suggest that a reduction in dynamic cell deformation would be 
expected during the dynamic loading of group II discs compared to group I discs, 
even though the dynamic strain regimes are identical.  
It should be appreciated, however, that the cell deformation experiments were 
performed using static strain. Knight et al. 86 performed similar confocal 
experiments in association with dynamic gel-compression and determined that 
the resulting cell-deformation significantly decreased during the first 20 minutes 
of dynamic strain, while cell-deformation within statically compression gels 
remained constant. Knight et al. attributed this effect to permanent deformation 
of the gel constructs, which occurs following dynamic compression of 
viscoelastic materials at high strains and dynamic frequencies. A decrease in gel 
height was also observed during the dynamic compression experiments in the 
current study, which consequently resulted in a decrease dynamic gel strain, as 
the peak strain was not allowed to overshoot 10% (Figure VIII-5 page 96).  
Taken together, the lower cell deformation after 4 days of preculture, the 
decreasing cell deformation during dynamic gel compression observed by Knight 
et al. and the decrease in gel height during dynamic compression may result in 
insufficient cell deformation to elicit an increase in GAG production in group II. 
This might suggest that a higher peak strain should be used during later time 
periods in culture. For instance, D’Lima et al. showed an increase in GAG 
content in cell-seeded agarose discs after 7 days of preculture with a different 
loading regime 35. Although the peak strain was similar, frequency and the 
duration of the dynamic compression were 1 Hz and 8 hours respectively. The 
above might indicate that a loading regime needs constant adjustments as time 
progresses and conditions change, in order to obtain a sustained positive effect of 
dynamic compression on cell-seeded scaffolds. However, as regimes of virtually 
an endless combination of frequency, strain and duration of the loading can be 
thought off, finding the optimal regime for a given time point in culture is a 
difficult task, if not impossible. This underscores the need for a more 
scientifically based approach towards loading regimes and unravelling the 
mechanotransduction pathways in chondrocytes, which remain largely unknown 
yet.  
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IX 
 
General Discussion 
 
 
 
 
 
To date, surgical treatments of cartilage defects often result in fibrocartilage and 
fail to produce long-term functional cartilage repair tissue 62, 68. With tissue 
engineering techniques, opportunities have arisen to provide new treatment 
methods for cartilage repair. First generation cartilage tissue engineering 
techniques, the ACT (Autologous Chondrcyte Transplantation), have shown 
promising clinical results 15, 156, 157. However, as yet, there have been no reports 
that ACT is superior to other surgical techniques for articular cartilage repair, 
like subchondral plate drilling or mosaic plasty 62,89. For cartilage tissue 
engineering to become a superior technique for cartilage repair many problems 
have to be addressed. In this thesis we focussed on two issues concerning 
cartilage tissue engineering. Firstly, we conducted several experiments to 
enhance the chondrocyte phenotype and extracellular matrix production during 
the tissue engineering process. Secondly, we tested the feasibility of using ear 
chondrocytes as donor cells for cartilage.  
 
Chondrocyte dedifferentiation during monolayer expansion culture, searching 
ways to prevent this and develop methods to regain the differentiated phenotype 
concern a substantial part of published studies in the field of cartilage tissue 
engineering 8, 32, 36, 37, 60, 61, 73, 126, 127, 174, 206. These studies are performed under the 
assumption that less dedifferentiated, or better differentiated, chondrocytes will 
produce a better quality repair tissue. Surprisingly, only one study can be found 
in literature in which cartilage repair with differentiated chondrocytes is 
compared to cartilage repair with culture-expanded, and hence dedifferentiated, 
chondrocytes 81. This study supports the above mentioned assumptions. In fact, 
we also found that the ability to generate cartilage in a nude mouse model was 
better for both porcine knee and ear chondrocytes when primary cells were 
implanted, as opposed to culture-expanded cells (Chapter VII). Thus, 
extrapolated to cartilage tissue engineering, optimizing the monolayer expansion 
culture in such ways that chondrocyte dedifferentiation is reduced seems 
justified. To achieve this, we focussed on two important factors in monolayer
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 expansion culture: the culture medium and seeding density of cells onto the 
culture flask. Regarding the first, we used a SFM (Serum-Free Medium) with a 
serum-substitute (ITS+) and FGF2 (Fibroblast Growth Factor 2). Throughout the 
various experiments the SFM with FGF2 proved to enhance total cell yield 
significantly and to improve the cellular phenotype during monolayer expansion 
culture compared to the commonly used SCM (Serum-Containing Medium), 
Chapter III and V. Furthermore, we showed that the beneficial effects of the SFM 
with FGF2 were sustained during suspension cultures in vitro and in a nude 
mouse model (Chapter V). We can therefore conclude that the SFM with FGF2 
greatly improved our monolayer expansion culture, compared to SCM. Naturally, 
the ultimate goal will be implantation in an actual cartilage defect. How 
chondrocytes that have been expanded in the SFM with FGF2 will behave in 
such an environment, in situ, we do not know as yet. Also, we supplemented our 
SFM with only one growth factor: FGF2. It is, however, not unlikely that for 
optimal performance other growth factors should be added. Concurrently, several 
research groups are developing new expansion media. Besides FGF2, growth 
factors like TGFß-2 (Transforming Growth Factor β-2), EGF (Epithelial Growth 
Factor) and IGF1 (Insulin-like Growth Factor 1) are under investigation 20, 37, 73, 
162. Unfortunately, insufficient data have yet been published to compare the 
different expansion media. Another complicating factor is that the different 
research groups use different cell sources, i.e. nasal chondrocytes, articular 
chondrocytes, ear chondrocytes and bone marrow stromal cells, to develop and 
test their expansion media 20, 37, 73, 162. 
Next to the higher cell yield and positive actions on the chondrocyte phenotype, 
using the SFM during monolayer culture largely abolished the use of serum in 
our culture system. However, bovine serum was needed for 24 hours to promote 
cell-attachment onto the culture flask after each passage. Autologous serum or 
special pre-coated culture flasks could be an alternative for bovine serum as a 
promoter for cell-attachment and will have to be introduced in future cultures. 
 
Besides optimizing the monolayer expansion culture, the quality of the 
engineered cartilage can also be enhanced by using bioactives during subsequent 
cultures in vitro, in vivo or in situ. Previously, using the combination of IGF1 and 
TGFß-2 during in vitro suspension cultures enhanced both the re-expression of 
collagen type II and proteoglycans 199. Experiments in this thesis underscored 
these findings (Chapter III, IV, V and VII). Compared to SCM without additives 
a SFM with IGF1 and TGFß-2 increased redifferentiation of dedifferentiated 
chondrocytes. 
 
An environment with mechanical loads and stresses is physiological for articular 
cartilage in situ 171, 204, 219. Therefore, introducing controlled mechanical loading 
during the in vitro cultures for cartilage tissue engineering purposes might 
function as a promoter of redifferentiation and extracellular matrix formation. 
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Evenmore, we hypothesized that mechanical loading could push the phenotype of 
dedifferentiated ear chondrocytes towards a more articular-like phenotype and 
extracellular matrix production, so-called ‘transphenotyping’. 
Since the beginning of cartilage tissue engineering much research has been 
performed on mechanical loading on cartilage and chondrocytes in vitro. 
However, during this period of about 15 years, little significant progress has been 
made and the introduction of controlled mechanical loading as a useful tool in 
cartilage tissue engineering is far from real. To investigate controlled mechanical 
stimuli as a bioactive in the tissue engineering process, we designed and built a 
loading device that could dynamically compress cartilage constructs or cell-
seeded biomaterials. In experiments with primary (differentiated) bovine articular 
chondrocytes in agarose gels we were able to enhance the proteoglycan 
production with controlled mechanical stimuli compared to control in 
experiments lasting several days (Chapter VII). Being able to perform longer-
term loading experiments was an important criterion, as controlled mechanical 
stimuli should very likely be applied over a longer period in order to be an 
effective bioactive. However, we also showed that during longer-term loading 
experiments several factors become increasingly important. The elaborate matrix, 
for instance, will influence the reaction on the proteoglycan production of the 
chondrocyte to mechanical deformation. And to have a sustained positive effect 
of mechanical loading, the loading regime might need constant adjustments to 
changing conditions. This might well explain why so little progress has been 
made in the last 15 years to introduce mechanical loading as a bioactive in 
cartilage tissue engineering. Most loading regimes reported in literature have 
been formed by ‘trial and error’ or by modification of a previous published and 
successful loading regime, which is exactly what we used for our experiments. 
We propose the introduction of subtle and soundly based loading regimes. Future 
mechanical loading experiments for cartilage tissue engineering purposes should 
be performed in close harmony with research on chondrocyte biomechanics and 
mechanotransduction pathways. Only then significant progress can be made and 
controlled mechanical loading might be introduced as a useful tool in cartilage 
tissue engineering.  
  
Another specific aim of this thesis was to test the feasibility of using ear 
chondrocytes for articular repair. Therefore, the majority of the experiments in 
this thesis were performed with ear chondrocytes. Pursuing alternative donor 
tissues for articular repair has several generally accepted (theoretical) grounds. 
Firstly, filling one articular cartilage defect by creating another articular cartilage 
defect does not seem logical. In fact, harvesting donor cartilage from the already 
diseased joint is likely to inflict additional morbidity. Surprisingly, published 
data concerning for instance the ACT procedure and mosaic plasty fail to 
recognize and discuss the issue of donor-site morbidity. However, a recent 
publication by van Susante et al. showed that osteochondral defects, which are 
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made in mosaicplasty for harvesting purposes, did not heal and that the 
surrounding cartilage and bone deteriorated 203. A second reason to pursue 
alternative cell-sources for articular repair, which is in line with the previous 
mentioned, is the limited amount of articular cartilage that can be used for 
transplantation or donor purposes.  
Our data showed that ear cartilage yielded a higher cell amount per mg tissue 
compared to articular cartilage. Furthermore, during expansion culture a higher 
cell yield could be obtained with ear chondrocytes of both human and porcine 
origin. This applied for both our experimental SFM with FGF2 as with the 
conventional SCM (Serum-Containing Medium). Also, these culture-expanded 
ear chondrocytes proved to retain the capacity to redifferentiate during in vitro 
and in vivo suspension cultures. Thus, we can state that in our experiments ear 
chondrocytes performed at least as well as articular chondrocytes and on several 
aspects were superior to articular chondrocytes. However, with our present 
knowledge we can only speculate whether ear chondrocytes are suitable for 
articular repair. To obtain successful and long-term articular cartilage repair the 
engineered tissue might not have to resemble the native tissue.  Small differences 
in matrix content, i.e. the presence of elastin, could well be of less importance. 
Probably more important is whether the mechanical properties are consistent 
with the native tissue. Because ear cartilage has only a supportive function, no 
systematic research has been performed on its mechanical properties. In fact, a 
shortage in our experiments is that we did not assess the mechanical properties of 
our engineered cartilage. Future studies in our laboratory will therefore comprise 
research on mechanical properties of the tissue-engineered neo-cartilage from 
nude mice studies. Furthermore, the mechanical properties of native articular 
cartilage and ear cartilage will have to be assessed in order to relate the properties 
of the different tissues. 
 
At present, growth factors like FGF2 have only limited clinical use. FGF2 has 
been used as a topical agent in chronic venous ulcera, with varying results 152, 163. 
Also, FGF2 is under current investigation for treatment of acute and chronic 
lesions in the tympanic membrane 109. Until now, no adverse effects have been 
reported with respect to these clinical applications of FGF2. However, several 
considerations regarding tissue engineering and the use of growth factors should 
be made. With tissue engineering techniques cells are extracted from their natural 
environment, enzymatically isolated and subsequently artificially modified in 
vitro using culture media, scaffold matrices and growth factors.  Although no 
reports of cell aberrations or metaplasia have been reported in literature regarding 
cartilage tissue engineering, we should always bare in mind that the whole 
process could have negative effects on the chondrocyte. For instance, studies on 
cell senescence showed that in vitro expansion culture of chondrocytes resulted 
in telomere shortening similar to 30 years of aging 151. Furthermore, as FGF2 
significantly increased cell expansion in our studies, it is likely to further increase 
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telomere shortening. In fact, this has also been suggested for skin fibroblasts, 
which were cultured in the presence of FGF2 176. Thus, accelerated cell 
senescence could have implications on the long-term survival of the engineered 
repair tissue. Systemic side effects of growth factors is another issue regarding 
tissue engineering. At present, growth factors in cartilage tissue engineering are 
mostly used in an in vitro setting, making systemic effects at the time of 
implantation in situ very unlikely. However, with the development of so-called 
smart scaffolds 142 (scaffold matrices pre-loaded with growth factors) systemic 
side effects of the growth factors in the scaffold-cell construct could become 
relevant. 
 
Concluding, the main aims of this thesis, improving the chondrocytes phenotype 
and extracellular matrix production during the tissue engineering process 
together with the feasibility of using ear chondrocytes as donor cells have been 
met, although some in a preliminary state. However, with our present results and 
new knowledge we can initiate new experiments to fulfill the stated aims in a 
more advanced level. Ultimately, this should lead to a durable repair of cartilage  
defects using tissue engineering techniques.  
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Summary 
 
 
 
 
 
Articular cartilage defects pose a difficult problem in orthopaedic surgery. Unlike 
vascularized tissues such as skin and bone, cartilage has limited intrinsic repair 
capacity. Current surgical options to treat articular cartilage defects are limited 
and have a sub optimal long-term outcome. However, since 15 years new and 
promising techniques, named Tissue Engineering, have been developed to 
overcome the general shortage in donor material and organs. For orthopaedic 
surgery tissue engineering could provide a serious alternative to treat articular 
cartilage defects. First generation cartilage tissue engineering techniques, based 
upon the technique of ACT (Autologous Chondrocyte Transplantation), have 
been clinically employed in Sweden and the US for the last 13 years. Although 
the first long-term results (2-9 years) are promising, ACT has not yet been 
proven to be superior to subchondral plate perforation and osteochondral plug 
transplantation (and mosaic plasty). The resulting repair tissue resembles 
fibrocartilage at best and frequently deteriorates within time. This thesis mainly 
discusses several interventions into the cartilage tissue engineering process that 
are aimed at the improvement of the chondrocyte phenotype and extracellular 
matrix production during and after the in vitro process. Also, several experiments 
were performed with ear chondrocytes as a possible alternative cell source for 
articular cartilage tissue engineering. 
 
Chapter I is an overview of the structure and function of articular cartilage and 
ear cartilage. Furthermore, the process of cartilage tissue engineering is 
introduced and discussed. 
Chapter II  deals with the specific aims of this thesis.  The first aim was to 
improve the chondrocyte phenotype and extracellular matrix production during 
the tissue engineering process. The second aim was to test the feasibility of ear 
cartilage as donor tissue for cartilage tissue engineering.  
In Chapter III immature human ear chondrocytes were culture expanded using a 
defined SFM+FGF2 (Serum-Free Medium + Fibroblast Growth Factor 2). As a 
control the classically used SCM (Serum-Containing Medium, fetal calf serum) 
was used. Although total multiplication was comparable, the ability to regain the 
differentiated phenotype and express functional extracellular matrix molecules 
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 during subsequent suspension culture in alginate was significantly enhanced 
when the SFM with FGF2 had been used during expansion culture. 
Chapter IV describes the effect of lowering the seeding densities during 
monolayer culture and its effect on total multiplication and the redifferentiation 
capacity of immature human ear chondrocytes. A relatively low seeding density 
(7500 cells/cm2 ) requires less time and fewer passages to reach a certain cell 
yield during monolayer culture compared to high seeding densities 
(30,000 cells/cm2). Surprisingly, the subsequent redifferentiation capacity is at 
least comparable and probably better when lower seeding densities were used. 
This latter observation can probably be attributed to less time in expansion 
culture and fewer passages needed.  
In Chapter V adult human ear chondrocytes are culture expanded in the SFM 
with FGF2 at lower seeding densities (7500 cells/cm2 or 15,000 cells/cm2) and 
compared to expansion in SCM (10% FCS (Fetal Calf Serum)). Unlike the 
results of the study discussed in Chapter III, total cell yield was significantly 
higher when SFM+FGF2 had been used. With real-time PCR techniques it was 
shown that the chondrocyte dedifferentiation was less with SFM+FGF2 as 
compared to expansion in SCM, despite the higher multiplication. Next, the 
culture-expanded chondrocytes were encapsulated in alginate and cultured in 
vitro or subcutaneously implanted in nude mice. After either culture had been 
stopped the gene expressions and biochemical assays on (GlycosAminoGlycan) 
and DNA, next to immunohistochemical stainings, still favored chondrocytes that 
had been expanded with SFM+FGF2. 
In Chapter VI several considerations on the use of ear chondrocytes as donor 
cells for cartilage tissue engineering are discussed. Experiments with articular 
chondrocytes and ear chondrocytes are compared. Per mg wet tissue more cells 
could be isolated from ear cartilage than from articular cartilage. Furthermore, 
monolayer expansion culture yielded more cells in the same amount of time 
when ear chondrocytes were used. During subsequent culture in alginate beads 
both cell types re-expressed collagen II and GAG (GlycosAminoGlycan). We 
conclude that ear chondrocytes are suitable for cartilage tissue engineering in 
general and have several advantages over articular chondrocytes. However, 
whether ear chondrocytes are suitable for articular repair has to be assessed in 
future research. 
Chapter VII discusses the role of several growth factors in cartilage tissue 
engineering.  
A compilation of experiments are presented which show that the effects of 
several typical growth factors in cartilage tissue engineering FGF2, TGFβ-2 and 
IGF1 ( respectively Fibroblast Growth Factor 2, Transforming Growth Factor β-2 
and Insulin-like Growth Factor 1) are dependant upon the expressed phenotype 
and culture history of the chondrocytes. 
In Chapter VIII the effects of in vitro mechanical loading on the expressed 
extracellular matrix were investigated. Isolated bovine articular chondrocytes 
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were encapsulated in an agarose gel and subjected to dynamic mechanical 
loading via a custom-made loading device. Compared to control the dynamically 
loaded cell-seeded agarose gels produced more GAG when the loading regime 
(two times 90 minutes loading per day for four days with a frequency of 0.5 Hz 
and a peak strain of 10%) was started 2 hours after the gels had been made. 
When a preculture of 4 days preceded the loading regime no additional effect of 
the dynamic loading on the GAG production was observed compared to the static 
control. After 4 days of preculture a pericellular matrix was formed and the  cell-
strain decreased. We hypothesized that the decreased cell-strain after 4 days of 
preculture was responsible for the absent effect of dynamic loading on the GAG 
production. Therefore, we propose that loading regimes should be adjusted to the 
changing conditions (i.e. extracellular matrix deposition) during mechanical 
loading experiments. 
Chapter IX discusses the overall finding of this thesis. We conclude that the 
aims of this thesis have been met, although in a preliminary state. By using a 
defined SFM with FGF2 in combination with low seeding densities during 
monolayer expansion culture we have been able to enhance our cell yield and at 
the same time improve the chondrocyte phenotype. Furthermore, we were able to 
stimulate extracellular matrix production with in vitro mechanical loading. Taken 
together, for cartilage tissue engineering purposes this could imply a better 
quality repair tissue. Alongside, we found that ear chondrocytes are a suitable 
cell source for cartilage tissue engineering. Whether ear chondrocytes are 
suitable for articular repair will have to be assessed in future experiments. 
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XI 
 
Samenvatting 
 
 
 
 
 
Kraakbeendefecten in gewrichten herstellen blijft een uitdaging in de 
orthopaedische chirurgie. In tegenstelling tot bijvoorbeeld huid en bot heeft 
kraakbeen geen bloedvoorziening en daardoor beperkte intrinsieke capaciteit tot 
genezing. Naast pijn en functiebeperking kunnen kraakbeendefecten aanleiding 
geven tot gegeneraliseerde artrose binnen het gewricht. Huidige chirurgische 
behandeltechnieken bestaan uit het opboren van de subchondrale plaat en het 
transplanteren van osteochondrale pluggen (zogenaamde mozaïekplastiek).  
Echter, sinds 15 jaar worden nieuwe technieken vanuit de technische en 
medische wetenschap gebundeld om nieuwe weefsels te genereren in het 
laboratorium. Deze technieken worden samengevat onder de naam ‘tissue 
engineering’. Sinds een kleine tien jaar worden tissue-engineeringproducten 
toegepast om kraakbeen defecten te behandelen (voornamelijk in Zweden en de 
Verenigde Staten). Deze techniek, de autologe chondrocytentransplantatie ACT 
(Autologous Chondrcyte Transplantation), wordt beschouwd als de eerste 
generatie tissue engineering van kraakbeen. Bij deze behandelmethode worden 
autologe gewrichtschondrocyten in het laboratorium vermenigvuldigd en in het 
kraakbeendefect achter een periostlapje teruggeplaatst. Hoewel de eerste 
langetermijnresultaten bemoedigend zijn, zijn er nog geen bewijzen dat ACT 
superieur is aan chirurgische behandeltechnieken voor kraakbeendefecten zoals 
het opboren van de subchondrale plaat en de mozaïekplastiek met osteochondrale 
pluggen. Meestal bestaat het weefsel uit fibreus kraakbeen, met inferieure 
kwaliteiten ten opzichte van hyalien kraakbeen. Een belangrijk aspect van zowel 
dierproeven als hernieuwde kijkoperaties na de ACT-procedure is dat er een 
relatie bestaat tussen de kwaliteit van het ‘littekenweefsel’ en de functionele en 
histologische resultaten op langere termijn. Het optimaliseren van de tissue-
engineeringtechnieken om de kwaliteit van het te genereren herstelweefsel te 
verhogen lijkt dus zinvol; dit is het hoofddoel van dit proefschrift. Het tweede 
doel van dit proefschrift is de haalbaarheid van een alternatieve bron van 
donorcellen voor het repareren van gewrichtskraakbeen: oorchondrocyten. 
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Hoofdstuk I geeft een algemene inleiding tot de structuur en samenstelling van 
kraakbeen. Daarnaast worden huidige chirurgische technieken voor het herstel 
van gewrichtskraakbeen besproken. Als laatste wordt het proces ‘tissue 
engineering van kraakbeen’ geïntroduceerd en nader belicht.  
In Hoofdstuk II worden de specifieke doelstellingen van dit proefschrift 
besproken. Ten eerste het verbeteren van het fenotype en de daarmee 
samenhangende extracellulaire matrixproductie van de chondrocyten gedurende 
het proces van tissue engineering. En als tweede het gebruik van 
oorchondrocyten voor tissue engineering van kraakbeen in het algemeen en 
gewrichtskraakbeen in het bijzonder. 
In Hoofdstuk III worden experimenten besproken waarin onvolwassen 
oorchondrocyten werden vermenigvuldigd in een serumvrij kweekmedium met 
FGF2 (Fibroblast Growth Factor 2). Dit werd vergeleken met vermenigvuldiging 
in het standaard serumhoudende kweekmedium. Hoewel de totale celopbrengst 
vergelijkbaar was, was tijdens additionele kweken de capaciteit tot re-expressie 
van kraakbeen-specifieke moleculen hoger wanneer het serumvrije medium met 
FGF2 was gebruikt tijdens de expansiekweek. 
In Hoofdstuk IV komen expansiekweken aan de orde, waarbij het aantal cellen 
per oppervlakte-eenheid bij het begin van de kweek, kortweg de inzaaidichtheid 
genoemd, verschillend is. Het gaat daarbij om kweken met onvolwassen, 
menselijke oorchondrocyten. Het doel van deze experimenten was het verkrijgen 
van voldoende cellen gedurende de expansiekweek om kraakbeen te genereren, 
uitgaande van een bepaalde hoeveelheid donorcellen. Om een gemiddeld 
kraakbeendefect te vullen zal ongeveer een 20-voudige vermenigvuldiging nodig 
zijn. Sinds lange tijd is bekend dat bij lagere inzaaidichtheden de cellen zich 
vaker vermenigvuldigen voordat ze in de kweek tegen elkaar aan groeien. Echter, 
vaker vermenigvuldigen geeft ook meer dedifferentiatie. Uit de experimenten 
beschreven in Hoofdstuk IV blijkt dat met een lage inzaaidichtheid (3500 en 
7500 cellen/cm2 ) de vereiste 20-voudige vermenigvuldiging in kortere tijd wordt 
bereikt dan met een hogere inzaaidichtheid (15.000 en 30.000 cellen/cm2). 
Daarnaast blijkt dat de capaciteit tot re-expressie van het gedifferentieerde 
fenotype (dat zijn de cellen als product van hun erfelijke aanleg en de door hen 
ondergane invloeden uit hun leefomgeving) groter is voor de cellen die zijn 
vermenigvuldigd met een lagere inzaaidichtheid. Voor tissue engineering van 
kraakbeen met chondrocyten lijkt het gebruik van korte expansiekweken met een 
lagere inzaaidichtheid en minder passages gunstig voor het behoud van fenotype. 
In Hoofdstuk V worden volwassen humane oorchondrocyten vermenigvuldigd 
met lage inzaaidichtheden in serum-vrij kweekmedium met FGF2 of in 
serumhoudend kweekmedium. In tegenstelling tot de experimenten beschreven in 
Hoofdstuk III wordt nu wel een significante hogere celopbrengst (met dezelfde 
inzaaidichtheid) bereikt met het serum-vrije medium met FGF2. Met behulp van 
real-time PCR technieken blijken de cellen die met behulp van het serum-vrije 
medium met FGF2 zijn vermenigvuldigd minder te zijn gededifferentieerd aan 
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het eind van de expansiekweek, ondanks de significante hogere 
vermenigvuldiging. Na de expansiekweek worden de chondrocyten uit beide 
groepen (serumvrij met FGF2 of serumhoudend) gesuspendeerd in alginaat en 
verder in vitro gekweekt onder gelijke condities en ook subcutaan geimplanteerd 
in naakte muizen. Het blijkt dat de cellen die zijn vermenigvuldigd in het serum-
vrije medium met FGF2 beter in staat zijn om een kraakbeen-achtige matrix te 
produceren dan cellen die zijn vermenigvuldigd in serumhoudend kweekmedium. 
Ergo, het gunstiger (minder gededifferentieerde) fenotype aan het eind van de 
expansiekweek wordt tot expressie gebracht dan wel vastgehouden gedurende 
verdere kweken in vitro en tevens na implantatie in vivo. 
Hoofdstuk VI bepreekt overwegingen omtrent het gebruik van oorchondrocyten 
als donorcellen voor het generen van gewrichtskraakbeen. Experimenten met 
beide typen kraakbeencellen worden vergeleken. Per mg weefsel levert 
oorkraakbeen meer donor cellen op dan gewrichtskraakbeen. Daarnaast blijkt dat 
expansiekweken met oorchondrocyten een grotere celopbrenst hebben. Beide 
celtypen vertonen een vergelijkbare capaciteit tot re-expressie van de juiste 
extracellulaire matrix componenten (bijvoorbeeld collageen type II). Wij 
concluderen dat oorchondrocyten geschikt zijn voor tissue engineering van 
kraakbeen. Of oorchondrocyten geschikt zijn voor het herstel van 
gewrichtskraakbeen zal moeten blijken uit toekomstige experimenten. 
Het gebruik van groeifactoren, zoals onder andere FGF2, IGF1 (Insulin-like 
Growth Factor 1) en TGFβ-2 (Transforming Growth Factor β-2), staat centraal in 
Hoofdstuk VII. Verschillende experimenten met deze groeifactoren worden 
besproken. Groeifactoren kunnen zeer waardevol zijn voor tissue engineering van 
kraakbeen. Belangrijk is dat het effect van de diverse groeifactoren afhankelijk 
kan zijn van factoren zoals bijvoorbeeld eerdere kweken of aanwezigheid van 
extracellulaire matrixcomponenten.  
In Hoofdstuk VIII wordt een zelf ontworpen en vervaardigd belastingapparaat 
geïntroduceerd waarmee kraakbeen of chondrocyten in een biomateriaal 
mechanisch kunnen worden belast door middel van compressie. De 
achterliggende gedachte is dat mechanische prikkels belangrijk zijn voor de 
homeostase van kraakbeen en chondrocyten. Mechanische prikkels gedurende 
het proces van tissue engineering zouden de (gededifferentieerde) chondrocyt 
kunnen verleiden tot de expressie van de juiste (redifferentiatie) en meer 
extracellulaire matrix componenten. In dit kader werd begonnen met 
experimenten waarbij gewrichtschondrocyten van kalveren in een schijfje 
agarosegel werden ingebracht en vervolgens cyclisch werden gecomprimeerd (tot 
90% van de oorspronkelijke hoogte) gedurende vier dagen. De hoeveelheid 
aanwezige GAG (GlycosAminoGlycan) aan het eind van de experimenten was 
hoger dan in de controlegroep. Dit werd overigens alleen waargenomen als aan 
het begin van de experimenten nog geen extracellulaire matrix aanwezig was in 
de agarose. Na een voorkweek van vier dagen, die resulteerde in een 
pericellulaire matrix productie, was de resulterende celcompressie als gevolg van 
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de 10% compressie van het agaroseschijfje significant lager (ongeveer 4%) en 
werd geen effect meer gezien van cyclische compressie. Uit deze experimenten 
blijkt dat de aanwezige extracellulaire matrix en de productie hiervan een grote 
invloed kan hebben op mechanische belasting experimenten met kraakbeen of 
chondrocyten. Toekomstige experimenten zullen moeten uitwijzen of 
mechanische prikkels gedurende het proces van tissue engineering een 
waardevolle aanvulling kunnen zijn als modulator van het fenotype en de 
daarmee samenhangende extracellulaire matrixproductie. 
Hoofdstuk IX is de discussie. De gestelde doelen van dit proefschrift zijn 
bereikt, waarbij sommige voornamelijk in een beginfase. Door het gebruik van 
lage inzaaidichtheden in combinatie met het serum-vrije kweekmedium met 
FGF2 gedurende de expansiekweek zijn we in staat gebleken om zowel de 
celopbrengst te verhogen als de mate van dedifferentiatie te verkleinen. Met 
behulp van het zelf ontworpen en vervaardigde belastingapparaat en met de 
resultaten van de eerste reeks experimenten hebben wij een aanzet gegeven tot 
een nieuwe reeks experimenten in ons laboratorium waaruit moet blijken of 
mechanische compressie de kwaliteit van het gegenereerde kraakbeen kan 
verbeteren.  
Een substantieel deel van de experimenten in dit proefschrift zijn uitgevoerd met 
oorchondrocyten. Gedurende deze experimenten is gebleken dat oorchondrocyten 
geschikt zijn voor tissue engineering van kraakbeen. Of met behulp van 
oorchondrocyten een succesvol herstel van gewrichtskraakbeen kan worden 
bewerkstelligd zal nog moeten blijken.  
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